DrugBank ID,Product Name,Manufacturer,National Drug Code,Dosage Form,Route of Administration,Dosage Information,Country,Regulatory Agency
DB00001,Refludan,Bayer,50419-150,Powder,Intravenous,50 mg/1mL,US,FDA NDC
DB00001,Refludan,Bayer,,"Powder, for solution",Intravenous,50 mg / vial,Canada,DPD
DB00001,Refludan,Celgene Europe Limited,,"Injection, solution, concentrate",Intravenous,50 mg,EU,EMA
DB00001,Refludan,Celgene Europe Limited,,"Injection, solution, concentrate",Intravenous,50 mg,EU,EMA
DB00001,Refludan,Celgene Europe Limited,,"Injection, solution, concentrate",Intravenous,20 mg,EU,EMA
DB00001,Refludan,Celgene Europe Limited,,"Injection, solution, concentrate",Intravenous,20 mg,EU,EMA
DB00002,Erbitux,ImClone LLC,66733-948,Solution,Intravenous,2 mg/1mL,US,FDA NDC
DB00002,Erbitux,ImClone LLC,66733-958,Solution,Intravenous,2 mg/1mL,US,FDA NDC
DB00002,Erbitux,"Imclone, Llc",,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00002,Erbitux,Merck Europe B.V.,,"Injection, solution",Intravenous,5 mg/ml,EU,EMA
DB00002,Erbitux,Merck Europe B.V.,,"Injection, solution",Intravenous,5 mg/ml,EU,EMA
DB00003,Pulmozyme,"Genentech, Inc.",50242-100,Solution,Respiratory (inhalation),1 mg/1mL,US,FDA NDC
DB00003,Pulmozyme 1mg/ml,Hoffmann La Roche,,Solution,Respiratory (inhalation),1 mg / mL,Canada,DPD
DB00004,Ontak,Eisai Limited,62856-603,"Injection, solution",Intravenous,150 ug/1mL,US,FDA NDC
DB00005,Benepali,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Benepali,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Benepali,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Benepali,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Benepali,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Benepali,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Benepali,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Brenzys,"Samsung Bioepis Co., Ltd.",,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00005,Brenzys,"Samsung Bioepis Co., Ltd.",,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00005,Enbrel,"Physicians Total Care, Inc.",54868-5444,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,"Physicians Total Care, Inc.",54868-4782,Kit,Subcutaneous,,US,FDA NDC
DB00005,Enbrel,A-S Medication Solutions,50090-3531,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,A-S Medication Solutions,50090-4490,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-435,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-445,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-425,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,25 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-455,Solution,Subcutaneous,25 mg/0.5mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-456,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-446,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-021,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-032,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-010,Solution,Subcutaneous,25 mg/0.5mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-044,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,58406-055,Solution,Subcutaneous,25 mg/0.5mL,US,FDA NDC
DB00005,Enbrel,A-S Medication Solutions,50090-4590,Solution,Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Enbrel,Immunex Corporation,,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00005,Enbrel,Immunex Corporation,,"Kit; Liquid; Powder, for solution",Subcutaneous,,Canada,DPD
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,10 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Enbrel,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Erelzi,Sandoz Canada Incorporated,,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00005,Erelzi,Sandoz Canada Incorporated,,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00005,Erelzi,Sandoz Canada Incorporated,,Solution,Subcutaneous,25 mg / 0.5 mL,Canada,DPD
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Erelzi,Sandoz,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Eticovo,"Samsung Bioepis Co., Ltd.",71202-004,"Injection, solution",Subcutaneous,25 mg/0.5mL,US,FDA NDC
DB00005,Eticovo,"Samsung Bioepis Co., Ltd.",71202-003,"Injection, solution",Subcutaneous,50 mg/1mL,US,FDA NDC
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,50 mg,EU,EMA
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Nepexto,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,25 mg,EU,EMA
DB00005,Rymti,Lupin Pharma,,Solution,Subcutaneous,25 mg / 0.5 mL,Canada,DPD
DB00005,Rymti,Lupin Pharma,,Solution,Subcutaneous,50 mg / 1 mL,Canada,DPD
DB00005,Rymti,Lupin Pharma,,Solution,Subcutaneous,50 mg / 1 mL,Canada,DPD
DB00005,Truemed Group LLC,Truemed Group LLC,82922-013,"Injection, powder, for solution",Intramuscular,25 mg/25mg,US,FDA NDC
DB00006,Angiomax,Cardinal Health,55154-2275,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Angiomax,The Medicines Company,65293-001,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Angiomax,Sandoz Inc,0781-3447,Injection,Intravenous,250 mg/1,US,FDA NDC
DB00006,Angiomax,Sandoz Canada Incorporated,,"Powder, for solution",Intravenous,250 mg / vial,Canada,DPD
DB00006,Angiomax RTU,"MAIA Pharmaceuticals, Inc.",70511-141,"Injection, solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Angiox,The Medicines Company,,,Intravenous,250 mg,EU,EMA
DB00006,Bivalirudin,"Accord Healthcare, Inc.",16729-275,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/5mL,US,FDA NDC
DB00006,Bivalirudin,Cipla USA Inc.,69097-601,Injection,Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Mylan Institutional LLC,67457-256,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/5mL,US,FDA NDC
DB00006,Bivalirudin,Eugia US LLC,55150-210,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Dr. Reddy's Laboratories Limited,55111-652,Injection,Intracavernous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Sandoz Inc,0781-3158,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Sandoz Inc,0781-9158,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,"Hainan Shuangcheng Pharmaceuticals Co., Ltd.",52958-034,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,"Athenex Pharmaceutical Division, Llc.",70860-402,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,"Fresenius Kabi USA, LLC",63323-562,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Apotex Corp,60505-6101,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,"Hospira, Inc.",0409-8300,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Sagent Pharmaceuticals,25021-405,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Meitheal Pharmaceuticals Inc.,71288-427,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/5mL,US,FDA NDC
DB00006,Bivalirudin,"Civica, Inc.",72572-035,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,"Slate Run Pharmaceuticals, Llc",70436-025,"Injection, powder, lyophilized, for suspension",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,Sandoz Canada Incorporated,,"Powder, for solution",Intravenous,250 mg / vial,Canada,DPD
DB00006,Bivalirudin,"Par Pharmaceutical, Inc.",42023-622,"Injection, solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,"Avenacy, Inc.",83634-400,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin,"Pharma Packaging Solutions, LLC dba Tjoapack LLC",75929-217,"Injection, powder, lyophilized, for solution",Intravenous,250 mg/1,US,FDA NDC
DB00006,Bivalirudin for Injection,Fresenius Kabi,,"Powder, for solution",Intravenous,250 mg / vial,Canada,DPD
DB00006,Bivalirudin for Injection,Juno Pharmaceuticals Corp.,,"Powder, for solution",Intravenous,250 mg / vial,Canada,DPD
DB00006,Bivalirudin for Injection,Dr Reddy's Laboratories Ltd,,"Powder, for solution",Intravenous,250 mg / vial,Canada,DPD
DB00006,Bivalirudin for Injection,Formative Pharma Inc.,,"Powder, for solution",Intravenous,250 mg / vial,Canada,DPD
DB00006,Bivalirudin in 0.9% Sodium Chloride,Baxter Healthcare Corporation,0338-9572,Injection,Intravenous,250 mg/50mL,US,FDA NDC
DB00006,Bivalirudin in 0.9% Sodium Chloride,Baxter Healthcare Corporation,0338-9576,Injection,Intravenous,500 mg/100mL,US,FDA NDC
DB00006,Bivalirudin Injection,Avir Pharma Inc.,,Solution,Intravenous,5 mg / mL,Canada,DPD
DB00006,Bivalirudin RTU,"Athenex Pharmaceutical Division, Llc.",70860-403,"Injection, solution",Intravenous,5 mg/1mL,US,FDA NDC
DB00007,Camcevi,Accord Healthcare Inc,,,Subcutaneous,42 mg / syr,Canada,DPD
DB00007,Camcevi,"Accord BioPharma, Inc.",69448-014,"Injection, emulsion",Subcutaneous,42 mg/0.37g,US,FDA NDC
DB00007,Camcevi,"Foresee Pharmaceuticals Co., Ltd.",72851-042,"Injection, emulsion",Subcutaneous,42 mg/1mL,US,FDA NDC
DB00007,Camcevi,Accord Healthcare S.L.U.,,,Subcutaneous,42 mg,EU,EMA
DB00007,Eligard,Sanofi Aventis,0024-0793,Kit,Subcutaneous,7.5 mg/0.25mL,US,FDA NDC
DB00007,Eligard,Sanofi Aventis,0024-0222,Kit,Subcutaneous,22.5 mg/0.375mL,US,FDA NDC
DB00007,Eligard,Sanofi Aventis,0024-0610,Kit,Subcutaneous,30 mg/0.5mL,US,FDA NDC
DB00007,Eligard,Sanofi Aventis,0024-0605,Kit,Subcutaneous,45 mg/0.375mL,US,FDA NDC
DB00007,Eligard,TOLMAR PHARMACEUTICALS INC.,62935-752,Kit,Subcutaneous,7.5 mg/0.25mL,US,FDA NDC
DB00007,Eligard,TOLMAR PHARMACEUTICALS INC.,62935-222,Kit,Subcutaneous,22.5 mg/0.375mL,US,FDA NDC
DB00007,Eligard,TOLMAR PHARMACEUTICALS INC.,62935-302,Kit,Subcutaneous,30 mg/0.5mL,US,FDA NDC
DB00007,Eligard,TOLMAR PHARMACEUTICALS INC.,62935-452,Kit,Subcutaneous,45 mg/0.375mL,US,FDA NDC
DB00007,Eligard,TOLMAR Inc.,62935-753,Kit,Subcutaneous,7.5 mg/0.25mL,US,FDA NDC
DB00007,Eligard,TOLMAR Inc.,62935-223,Kit,Subcutaneous,22.5 mg/0.375mL,US,FDA NDC
DB00007,Eligard,TOLMAR Inc.,62935-303,Kit,Subcutaneous,30 mg/0.5mL,US,FDA NDC
DB00007,Eligard,TOLMAR Inc.,62935-453,Kit,Subcutaneous,45 mg/0.375mL,US,FDA NDC
DB00007,Eligard,Tolmar International Ltd.,,"Injection, powder, for suspension, extended release",Subcutaneous,7.5 mg / syr,Canada,DPD
DB00007,Eligard,Tolmar International Ltd.,,"Injection, powder, for suspension, extended release",Subcutaneous,22.5 mg / syr,Canada,DPD
DB00007,Eligard,Tolmar International Ltd.,,"Injection, powder, for suspension, extended release",Subcutaneous,30 mg / syr,Canada,DPD
DB00007,Eligard,Tolmar International Ltd.,,"Injection, powder, for suspension, extended release",Subcutaneous,45 mg / syr,Canada,DPD
DB00007,Eligard,TOLMAR Inc.,62935-461,"Injection, suspension, extended release",Subcutaneous,45 mg/0.375mL,US,FDA NDC
DB00007,Eligard,TOLMAR Inc.,62935-756,"Injection, suspension, extended release",Subcutaneous,7.5 mg/0.25mL,US,FDA NDC
DB00007,Eligard,TOLMAR Inc.,62935-227,"Injection, suspension, extended release",Subcutaneous,22.5 mg/0.375mL,US,FDA NDC
DB00007,Eligard,TOLMAR Inc.,62935-306,"Injection, suspension, extended release",Subcutaneous,30 mg/0.5mL,US,FDA NDC
DB00007,Fensolvi,TOLMAR Inc.,62935-153,"Injection, suspension, extended release; Kit",Subcutaneous,45 mg/0.375mL,US,FDA NDC
DB00007,Fensolvi,TOLMAR Inc.,62935-163,"Injection, suspension, extended release",Subcutaneous,45 mg/0.375mL,US,FDA NDC
DB00007,Leuprolide Acetate,Genzyme Corporation,49884-368,Kit,Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,"Eon Labs, Inc.",0185-7400,"Injection, solution",Subcutaneous,1 mg/.2mL,US,FDA NDC
DB00007,Leuprolide Acetate,"Teva Parenteral Medicines, Inc.",0703-4014,Kit,Subcutaneous; Topical,1 mg/0.2mL,US,FDA NDC
DB00007,Leuprolide Acetate,Sun Pharma Global Inc.,41616-936,Kit,Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,Genzyme Corporation,0182-3154,Kit,Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,"Sun Pharmaceutical Industries, Inc.",47335-936,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,Sandoz Inc,0781-4003,Kit,Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,VGYAAN Pharmaceuticals LLC,72664-611,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,bryant ranch prepack,63629-8821,Kit,Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,Eugia US LLC,55150-478,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,Northstar RxLLC,16714-572,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate,Amneal Pharmaceuticals LLC,70121-2537,Kit,Subcutaneous,,US,FDA NDC
DB00007,Leuprolide Acetate,Northstar RxLLC,72603-344,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00007,Leuprolide Acetate Depot,Cipla USA Inc.,69097-909,"Injection, powder, lyophilized, for suspension, extended release; Kit",Intramuscular,22.5 mg/2mL,US,FDA NDC
DB00007,Leuprolide Acetate Injection,Novopharm Limited,,Liquid,Subcutaneous,5 mg / mL,Canada,DPD
DB00007,Lupaneta Pack,AbbVie Inc.,0074-1053,"Injection, powder, lyophilized, for suspension; Kit; Tablet",Intramuscular; Oral; Topical,,US,FDA NDC
DB00007,Lupaneta Pack,AbbVie Inc.,0074-1052,"Injection, powder, lyophilized, for suspension; Kit; Tablet",Intramuscular; Oral; Topical,,US,FDA NDC
DB00007,Lupron,Abbvie,0074-3612,Kit,Subcutaneous; Topical,5 mg/1mL,US,FDA NDC
DB00007,Lupron,Tap Pharmaceutical Products Inc.,0300-3612,Kit,Subcutaneous; Topical,5 mg/1mL,US,FDA NDC
DB00007,Lupron,Abbvie,,Solution,Subcutaneous,5 mg / mL,Canada,DPD
DB00007,Lupron Depot,"Physicians Total Care, Inc.",54868-2825,Kit,Intramuscular; Topical,3.75 mg/1mL,US,FDA NDC
DB00007,Lupron Depot,TAP Pharmaceuticals Inc.,0300-3641,"Injection, powder, lyophilized, for suspension",Intramuscular,3.75 mg/1mL,US,FDA NDC
DB00007,Lupron Depot,Abbott Laboratories,0074-3132,"Injection, powder, lyophilized, for suspension",Intramuscular,3.75 mg/1mL,US,FDA NDC
DB00007,Lupron Depot,Abbott Laboratories,0074-3154,"Injection, powder, lyophilized, for suspension",Intramuscular,7.5 mg/1mL,US,FDA NDC
DB00007,Lupron Depot,Abbott Laboratories,0074-3306,"Injection, powder, lyophilized, for suspension",Intramuscular,11.25 mg/1mL,US,FDA NDC
DB00007,Lupron Depot,Abbott Laboratories,0074-3330,"Injection, powder, lyophilized, for suspension",Intramuscular,15 mg/1mL,US,FDA NDC
DB00007,Lupron Depot,Abbott Laboratories,0074-3680,"Injection, powder, lyophilized, for suspension",Intramuscular,30 mg/1.5mL,US,FDA NDC
DB00007,Lupron Depot,AbbVie Inc.,0074-3641,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular; Topical,,US,FDA NDC
DB00007,Lupron Depot,AbbVie Inc.,0074-3473,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,45 mg/1.5mL,US,FDA NDC
DB00007,Lupron Depot,AbbVie Inc.,0074-3683,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,30 mg/1.5mL,US,FDA NDC
DB00007,Lupron Depot,AbbVie Inc.,0074-3642,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,7.5 mg/1mL,US,FDA NDC
DB00007,Lupron Depot,AbbVie Inc.,0074-3346,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,22.5 mg/1.5mL,US,FDA NDC
DB00007,Lupron Depot,AbbVie Inc.,0074-3663,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,11.25 mg/1.5mL,US,FDA NDC
DB00007,Lupron Depot,Abbvie,,"Injection, powder, for suspension, extended release",Intramuscular,7.5 mg / syr,Canada,DPD
DB00007,Lupron Depot,Abbvie,,"Injection, powder, for suspension, extended release",Intramuscular,3.75 mg / syr,Canada,DPD
DB00007,Lupron Depot,Abbvie,,"Injection, powder, for suspension, extended release",Intramuscular,22.5 mg / syr,Canada,DPD
DB00007,Lupron Depot,Abbvie,,"Injection, powder, for suspension, extended release",Intramuscular,30 mg / syr,Canada,DPD
DB00007,Lupron Depot,Abbvie,,"Injection, powder, for suspension, extended release",Intramuscular,11.25 mg / syr,Canada,DPD
DB00007,Lupron Depot,Abbvie,,"Injection, powder, for suspension, extended release",Intramuscular,11.25 mg / vial,Canada,DPD
DB00007,Lupron Depot,Abbvie,,"Injection, powder, for suspension, extended release",Intramuscular,15 mg / vial,Canada,DPD
DB00007,Lupron Depot Ped,Takeda Pharmaceutical Company LTD,11532-1452,"Injection, powder, lyophilized, for suspension",Intramuscular,11.25 mg/1mL,US,FDA NDC
DB00007,Lupron Depot Ped,Takeda Pharmaceutical Company LTD,11532-1453,"Injection, powder, lyophilized, for suspension",Intramuscular,15 mg/1mL,US,FDA NDC
DB00007,Lupron Depot Ped,Takeda Pharmaceutical Company LTD,11532-1454,"Injection, powder, lyophilized, for suspension",Intramuscular,7.5 mg/1mL,US,FDA NDC
DB00007,Lupron Depot-PED,Remedy Repack,52125-736,Kit,Intramuscular; Topical,11.25 mg/1mL,US,FDA NDC
DB00007,Lupron Depot-PED,AbbVie Inc.,0074-2282,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,11.25 mg/1mL,US,FDA NDC
DB00007,Lupron Depot-PED,AbbVie Inc.,0074-2440,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,15 mg/1mL,US,FDA NDC
DB00007,Lupron Depot-PED,AbbVie Inc.,0074-2108,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,7.5 mg/1mL,US,FDA NDC
DB00007,Lupron Depot-PED,AbbVie Inc.,0074-3779,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,11.25 mg/1.5mL,US,FDA NDC
DB00007,Lupron Depot-PED,AbbVie Inc.,0074-9694,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,30 mg/1.5mL,US,FDA NDC
DB00007,Lupron Depot-PED,AbbVie Inc.,0074-3575,"Injection, powder, lyophilized, for suspension; Kit",Intramuscular,45 mg/1.5mL,US,FDA NDC
DB00007,Viadur,Bayer Pharmaceuticals Corporation,0026-9711,Kit,Subcutaneous; Topical,,US,FDA NDC
DB00007,Zeulide Depot,Verity Pharmaceuticals Inc.,,"Injection, powder, for suspension, extended release; Kit",Intramuscular,3.75 mg / vial,Canada,DPD
DB00007,Zeulide Depot,Verity Pharmaceuticals Inc.,,"Injection, powder, for suspension, extended release; Kit",Intramuscular,22.5 mg / vial,Canada,DPD
DB00008,Pegasys,"Genentech, Inc.",0004-0360,"Injection, solution",Subcutaneous,135 ug/0.5mL,US,FDA NDC
DB00008,Pegasys,Roche Pharmaceuticals,0004-0352,"Injection, solution",Subcutaneous,180 ug/0.5mL,US,FDA NDC
DB00008,Pegasys,"Genentech, Inc.",0004-0350,"Injection, solution",Subcutaneous,180 ug/1mL,US,FDA NDC
DB00008,Pegasys,"Genentech, Inc.",0004-0357,"Injection, solution",Subcutaneous,180 ug/0.5mL,US,FDA NDC
DB00008,Pegasys,"Genentech, Inc.",0004-0365,"Injection, solution",Subcutaneous,180 ug/0.5mL,US,FDA NDC
DB00008,Pegasys,Zr Pharma& Gmbh,,Solution,Subcutaneous,180 mcg / 0.5 mL,Canada,DPD
DB00008,Pegasys,Hoffmann La Roche,,Solution,Subcutaneous,180 mcg / mL,Canada,DPD
DB00008,Pegasys,pharmaand GmbH,82154-0449,"Injection, solution",Subcutaneous,180 ug/1mL,US,FDA NDC
DB00008,Pegasys,pharmaand GmbH,82154-0451,"Injection, solution",Subcutaneous,180 ug/0.5mL,US,FDA NDC
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,135 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,180 μg,EU,EMA
DB00008,Pegasys,Zr Pharma& Gmb H,,"Injection, solution",Subcutaneous,90 μg,EU,EMA
DB00008,Pegasys Rbv,Hoffmann La Roche,,Solution; Tablet,Oral; Subcutaneous,,Canada,DPD
DB00008,Pegasys Rbv,Hoffmann La Roche,,Solution; Tablet,Oral; Subcutaneous,,Canada,DPD
DB00009,Activase,"Genentech, Inc.",50242-044,"Injection, powder, lyophilized, for solution; Kit",Intravenous,50 mg/50mL,US,FDA NDC
DB00009,Activase,"Genentech, Inc.",50242-085,"Injection, powder, lyophilized, for solution; Kit",Intravenous,100 mg/100mL,US,FDA NDC
DB00009,Activase RT-PA,Hoffmann La Roche,,"Liquid; Powder, for solution",Intravenous,,Canada,DPD
DB00009,Activase RT-PA,Hoffmann La Roche,,"Liquid; Powder, for solution",Intravenous,,Canada,DPD
DB00009,Activase RT-PA Inj,Hoffmann La Roche,,"Powder, for solution",Intravenous,50 mg/50mL,Canada,DPD
DB00009,Activase RT-PA Inj,Hoffmann La Roche,,"Powder, for solution",Intravenous,50 mg/50mL,Canada,DPD
DB00009,Activase RT-PA Inj,Hoffmann La Roche,,"Powder, for solution",Intravenous,50 mg/50mL,Canada,DPD
DB00009,Cathflo,Hoffmann La Roche,,"Powder, for solution",Intravenous,2 mg / vial,Canada,DPD
DB00009,Cathflo Activase,"Genentech, Inc.",50242-041,"Injection, powder, lyophilized, for solution",Intravenous,2.2 mg/2mL,US,FDA NDC
DB00009,Lysatec RT - Pa,"Genentech, Inc.",,"Powder, for solution",Intravenous,,Canada,DPD
DB00011,Wellferon Inj 10 000 000unit/ml,The Wellcome Foundation Ltd.,,Liquid,Intramuscular; Subcutaneous,10000000 unit / mL,Canada,DPD
DB00011,Wellferon Inj 3000000unit/ml,The Wellcome Foundation Ltd.,,Liquid,Intramuscular; Subcutaneous,3000000 unit / mL,Canada,DPD
DB00012,Aranesp,"Physicians Total Care, Inc.",54868-5428,"Injection, solution",Intravenous; Subcutaneous,200 ug/0.4mL,US,FDA NDC
DB00012,Aranesp,"Physicians Total Care, Inc.",54868-5429,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.6mL,US,FDA NDC
DB00012,Aranesp,"Physicians Total Care, Inc.",54868-5867,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-014,Solution,Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-015,Solution,Intravenous; Subcutaneous,300 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-010,Solution,Intravenous; Subcutaneous,25 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-011,Solution,Intravenous; Subcutaneous,40 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-012,Solution,Intravenous; Subcutaneous,60 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-013,Solution,Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-054,Solution,Intravenous; Subcutaneous,150 ug/0.75mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-044,"Injection, solution",Intravenous; Subcutaneous,200 ug/0.4mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-046,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.6mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-048,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-039,"Injection, solution",Intravenous; Subcutaneous,60 ug/0.3mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-041,"Injection, solution",Intravenous; Subcutaneous,100 ug/0.5mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-043,"Injection, solution",Intravenous; Subcutaneous,150 ug/0.3mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-090,"Injection, solution",Intravenous; Subcutaneous,25 ug/0.42mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-091,"Injection, solution",Intravenous; Subcutaneous,40 ug/0.4mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-092,"Injection, solution",Intravenous; Subcutaneous,60 ug/0.3mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-093,"Injection, solution",Intravenous; Subcutaneous,100 ug/0.5mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-094,"Injection, solution",Intravenous; Subcutaneous,150 ug/0.3mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-095,"Injection, solution",Intravenous; Subcutaneous,200 ug/0.4mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-096,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.6mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-097,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-037,"Injection, solution",Intravenous; Subcutaneous,40 ug/.4mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-058,"Injection, solution",Intravenous; Subcutaneous,25 ug/0.42mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-053,Solution,Intravenous; Subcutaneous,150 ug/0.75mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-098,"Injection, solution",Intravenous; Subcutaneous,10 ug/0.4mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-006,Solution,Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-110,Solution,Intravenous; Subcutaneous,300 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-002,Solution,Intravenous; Subcutaneous,25 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-003,Solution,Intravenous; Subcutaneous,40 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-004,Solution,Intravenous; Subcutaneous,60 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-005,Solution,Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-028,"Injection, solution",Intravenous; Subcutaneous,200 ug/0.4mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-111,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.6mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-032,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-057,"Injection, solution",Intravenous; Subcutaneous,25 ug/0.42mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-021,"Injection, solution",Intravenous; Subcutaneous,40 ug/0.4mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-023,"Injection, solution",Intravenous; Subcutaneous,60 ug/0.3mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-025,"Injection, solution",Intravenous; Subcutaneous,100 ug/0.5mL,US,FDA NDC
DB00012,Aranesp,AMGEN INC,55513-027,"Injection, solution",Intravenous; Subcutaneous,150 ug/0.3mL,US,FDA NDC
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,25 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,40 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,25 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,15 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,60 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,325 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,40 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,10 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,15 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,20 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,30 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,50 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,80 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,150 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,500 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,10 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,15 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,20 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,30 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,50 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,80 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,150 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,500 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,130 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,130 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,25 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,25 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,200 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,200 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp,Amgen Europe B.V.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Aranesp -(hsa-free),Amgen,,Solution,Intravenous; Subcutaneous,40 mcg / mL,Canada,DPD
DB00012,Aranesp -(hsa-free),Amgen,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00012,Aranesp -(hsa-free),Amgen,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00012,Aranesp -(hsa-free),Amgen,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,25 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,25 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,10 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,15 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,20 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,30 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,40 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,50 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,60 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,80 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,100 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,150 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,300 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,500 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,10 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,15 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,20 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,30 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,40 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,50 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,60 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,80 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,100 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,150 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,300 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,500 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,10 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,15 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,20 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,30 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,40 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,50 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,60 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,80 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,100 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,150 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,300 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,500 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Intravenous; Subcutaneous,130 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,130 μg,EU,EMA
DB00012,Nespo,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,130 μg,EU,EMA
DB00013,Kinlytic,"ImaRx Therapeutics, Inc.",24430-1003,"Injection, powder, lyophilized, for solution",Intravenous,250000 [iU]/5mL,US,FDA NDC
DB00013,Kinlytic (urokinase for Injection),Microbix Biosystems Inc,,"Powder, for solution",Intravenous,250000 unit / vial,Canada,DPD
DB00013,Kinlytic Open-cath,Microbix Biosystems Inc,,"Powder, for solution",Intravenous,5000 unit / vial,Canada,DPD
DB00014,Zoladex,AstraZeneca Pharmaceuticals LP,0310-0950,Implant,Subcutaneous,3.6 mg/1,US,FDA NDC
DB00014,Zoladex,AstraZeneca Pharmaceuticals LP,0310-0951,Implant,Subcutaneous,10.8 mg/1,US,FDA NDC
DB00014,Zoladex,Tersera Therapeutics Llc,70720-950,Implant,Subcutaneous,3.6 mg/1,US,FDA NDC
DB00014,Zoladex,Tersera Therapeutics Llc,70720-951,Implant,Subcutaneous,10.8 mg/1,US,FDA NDC
DB00014,Zoladex,A-S Medication Solutions,50090-3466,Implant,Subcutaneous,3.6 mg/1,US,FDA NDC
DB00014,Zoladex,A-S Medication Solutions,50090-2027,Implant,Subcutaneous,3.6 mg/1,US,FDA NDC
DB00014,Zoladex,Tersera Therapeutics Llc,,Implant,Subcutaneous,3.6 mg,Canada,DPD
DB00014,Zoladex LA,Tersera Therapeutics Llc,,Implant,Subcutaneous,10.8 mg,Canada,DPD
DB00015,Rapilysin,Actavis Group Ptc Ehf.,,"Injection, powder, for solution",Intravenous,10 U,EU,EMA
DB00015,Retavase,Ekr Therapeutics,24477-041,Kit,Intravenous,1.81 mg/1mL,US,FDA NDC
DB00015,Retavase,Ekr Therapeutics,24477-040,Kit,Intravenous,1.81 mg/1mL,US,FDA NDC
DB00015,Retavase,"Chiesi USA, Inc.",10122-143,Kit,Intravenous,1.81 mg/1mL,US,FDA NDC
DB00015,Retavase,"Chiesi USA, Inc.",10122-141,Kit,Intravenous,1.81 mg/1mL,US,FDA NDC
DB00015,Retavase,Ekr Therapeutics,,"Powder, for solution",Intravenous,10.4 unit / vial,Canada,DPD
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Abseamed,Medice Arzneimittel Pütter Gmb H  Co. Kg,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Binocrit,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Biopoin,Teva,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.3ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,7000 IU/0.7ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,9000 IU/0.9ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Epoetin Alfa Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1ml,EU,EMA
DB00016,Epogen,Amgen,55513-823,Solution,Intravenous; Subcutaneous,40000 1/1mL,US,FDA NDC
DB00016,Epogen,AMGEN INC,55513-126,Solution,Intravenous; Subcutaneous,2000 [iU]/1mL,US,FDA NDC
DB00016,Epogen,AMGEN INC,55513-267,Solution,Intravenous; Subcutaneous,3000 [iU]/1mL,US,FDA NDC
DB00016,Epogen,AMGEN INC,55513-148,Solution,Intravenous; Subcutaneous,4000 [iU]/1mL,US,FDA NDC
DB00016,Epogen,AMGEN INC,55513-144,Solution,Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Epogen,AMGEN INC,55513-283,Solution,Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Epogen,AMGEN INC,55513-478,Solution,Intravenous; Subcutaneous,20000 [iU]/1mL,US,FDA NDC
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eporatio,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/1.0ml,EU,EMA
DB00016,Eprex Sterile Solution,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,20000 unit / 0.5 mL,Canada,DPD
DB00016,Eprex Sterile Solution,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,30000 unit / 0.75 mL,Canada,DPD
DB00016,Eprex Sterile Solution 10000iu/1.0ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,10000 unit / mL,Canada,DPD
DB00016,Eprex Sterile Solution 10000iu/ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,10000 unit / mL,Canada,DPD
DB00016,Eprex Sterile Solution 1000iu/0.5ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,1000 unit / 0.5 mL,Canada,DPD
DB00016,Eprex Sterile Solution 20000iu/ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,20000 unit / mL,Canada,DPD
DB00016,Eprex Sterile Solution 2000iu/0.5ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,2000 unit / 0.5 mL,Canada,DPD
DB00016,Eprex Sterile Solution 2000iu/ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,2000 unit / mL,Canada,DPD
DB00016,Eprex Sterile Solution 3000iu/0.3ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,3000 unit / 0.3 mL,Canada,DPD
DB00016,Eprex Sterile Solution 40000iu/ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,40000 unit / mL,Canada,DPD
DB00016,Eprex Sterile Solution 4000iu/0.4ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,4000 unit / 0.4 mL,Canada,DPD
DB00016,Eprex Sterile Solution 4000iu/ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,4000 unit / mL,Canada,DPD
DB00016,Eprex Sterile Solution 5000iu/0.5ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,5000 unit / 0.5 mL,Canada,DPD
DB00016,Eprex Sterile Solution 6000 Iu/0.6 Ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,6000 unit / 0.6 mL,Canada,DPD
DB00016,Eprex Sterile Solution 8000 Iu/0.8 Ml,Janssen Pharmaceuticals,,Solution,Intravenous; Subcutaneous,8000 unit / 0.8 mL,Canada,DPD
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, powder, for solution",Intravenous; Subcutaneous,50000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,500 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,500 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,2000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,2000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,3000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,3000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,5000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,5000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,10000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,20000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,20000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,4000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,4000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,6000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,6000 IU,EU,EMA
DB00016,Neorecormon,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,30000 IU,EU,EMA
DB00016,Neorecormon Guard,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,10000 IU,EU,EMA
DB00016,Neorecormon Guard,Roche Registration Gmb H,,"Injection, solution",Intravenous; Subcutaneous,30000 IU,EU,EMA
DB00016,Procrit,"Physicians Total Care, Inc.",54868-2523,"Injection, solution",Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Physicians Total Care, Inc.",54868-5802,"Injection, solution",Intravenous; Subcutaneous,40000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Physicians Total Care, Inc.",54868-5673,"Injection, solution",Intravenous; Subcutaneous,20000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Janssen Products, LP",59676-302,"Injection, solution",Intravenous; Subcutaneous,2000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Janssen Products, LP",59676-303,"Injection, solution",Intravenous; Subcutaneous,3000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Janssen Products, LP",59676-304,"Injection, solution",Intravenous; Subcutaneous,4000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Janssen Products, LP",59676-310,"Injection, solution",Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Janssen Products, LP",59676-340,"Injection, solution",Intravenous; Subcutaneous,40000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Janssen Products, LP",59676-312,"Injection, solution",Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Procrit,"Janssen Products, LP",59676-320,"Injection, solution",Intravenous; Subcutaneous,20000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Vifor (International) Inc.,59353-002,"Injection, solution",Intravenous; Subcutaneous,2000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Vifor (International) Inc.,59353-003,"Injection, solution",Intravenous; Subcutaneous,3000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Vifor (International) Inc.,59353-004,"Injection, solution",Intravenous; Subcutaneous,4000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Vifor (International) Inc.,59353-010,"Injection, solution",Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Laboratories Div Pfizer Inc,0069-1305,"Injection, solution",Intravenous; Subcutaneous,2000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Laboratories Div Pfizer Inc,0069-1306,"Injection, solution",Intravenous; Subcutaneous,3000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Laboratories Div Pfizer Inc,0069-1307,"Injection, solution",Intravenous; Subcutaneous,4000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Laboratories Div Pfizer Inc,0069-1308,"Injection, solution",Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Laboratories Div Pfizer Inc,0069-1309,"Injection, solution",Intravenous; Subcutaneous,40000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Vifor (International) Inc.,59353-120,"Injection, solution",Intravenous; Subcutaneous,20000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Vifor (International) Inc.,59353-220,"Injection, solution",Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Laboratories Div Pfizer Inc,0069-1311,"Injection, solution",Intravenous; Subcutaneous,20000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Laboratories Div Pfizer Inc,0069-1318,"Injection, solution",Intravenous; Subcutaneous,10000 [iU]/1mL,US,FDA NDC
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Retacrit,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,1000 IU/0.3ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,2000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,3000 IU/0.9ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,4000 IU/0.4ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,5000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,6000 IU/0.6ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,8000 IU/0.8ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,10000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,20000 IU/0.5ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,30000 IU/0.75ml,EU,EMA
DB00016,Silapo,Stada Arzneimittel Ag,,"Injection, solution",Intravenous; Subcutaneous,40000 IU/1.0ml,EU,EMA
DB00017,Apo-calcitonin Injectable,Apotex Corporation,,Liquid,Intramuscular; Subcutaneous,200 unit / mL,Canada,DPD
DB00017,Apo-calcitonin Nasal Spray,Apotex Corporation,,Solution,Nasal,200 unit / spray,Canada,DPD
DB00017,Calcimar,Sanofi Aventis,,Solution,Intramuscular; Subcutaneous,200 unit / mL,Canada,DPD
DB00017,"Calcitonin (salmon) Injection, BP",Sterimax Inc,,Solution,Intramuscular; Subcutaneous,200 unit / mL,Canada,DPD
DB00017,Calcitonin Salmon,"Physicians Total Care, Inc.",54868-6323,"Spray, metered",Nasal,200 [iU]/0.09mL,US,FDA NDC
DB00017,Calcitonin Salmon,Sandoz,0781-6320,"Spray, metered",Nasal,200 [iU]/1,US,FDA NDC
DB00017,Calcitonin Salmon,Apotex Corp.,60505-0823,"Spray, metered",Nasal,200 [iU]/1,US,FDA NDC
DB00017,Calcitonin Salmon,"Par Pharmaceutical, Inc.",49884-161,"Spray, metered",Nasal,200 [iU]/0.09mL,US,FDA NDC
DB00017,Calcitonin Salmon,"Bachem Americas, Inc.",52416-116,Powder,Not applicable,1 g/1g,US,FDA NDC
DB00017,Calcitonin Salmon,bryant ranch prepack,63629-2152,"Spray, metered",Nasal,200 [iU]/0.09mL,US,FDA NDC
DB00017,Calcitonin Salmon,Hikma Pharmaceuticals USA Inc.(dba Leucadia Pharmaceuticals),24201-400,"Injection, solution",Intramuscular; Subcutaneous,200 [USP'U]/1mL,US,FDA NDC
DB00017,Calcitonin Salmon,"Par Pharmaceutical, Inc.",42023-205,"Injection, solution",Intramuscular; Subcutaneous,200 [iU]/1mL,US,FDA NDC
DB00017,Calcitonin Salmon,bryant ranch prepack,72162-2128,"Spray, metered",Nasal,200 [iU]/1,US,FDA NDC
DB00017,Caltine Inj 100 Unit/ml (1ml Amp),Ferring Pharmaceuticals,,Liquid,Intramuscular; Subcutaneous,100 unit / mL,Canada,DPD
DB00017,Caltine Inj 100unit/ml (0.5ml Amp),Ferring Pharmaceuticals,,Liquid,Intramuscular; Subcutaneous,100 unit / mL,Canada,DPD
DB00017,Forcaltonin,Unigene Laboratories Inc.,,"Injection, solution",Intramuscular; Intravenous; Subcutaneous,100 IU,EU,EMA
DB00017,Fortical,"Physicians Total Care, Inc.",54868-5499,"Spray, metered",Nasal,2200 [iU]/1mL,US,FDA NDC
DB00017,Fortical,"Upsher-Smith Laboratories, Inc.",0245-0008,"Spray, metered",Nasal,2200 [iU]/1mL,US,FDA NDC
DB00017,Miacalcin,"Physicians Total Care, Inc.",54868-3827,"Spray, metered",Nasal,200 [iU]/1,US,FDA NDC
DB00017,Miacalcin,Novartis,0078-0149,"Injection, solution",Intramuscular; Subcutaneous,200.0 [iU]/1.0mL,US,FDA NDC
DB00017,Miacalcin,Sebela Pharmaceuticals Inc.,54766-149,"Injection, solution",Intramuscular,200 [iU]/1mL,US,FDA NDC
DB00017,Miacalcin,Novartis,0078-0311,"Spray, metered",Nasal,200 [iU]/1,US,FDA NDC
DB00017,Miacalcin,Mylan Institutional LLC,67457-675,"Injection, solution",Intramuscular; Subcutaneous,200 [USP'U]/1mL,US,FDA NDC
DB00017,Miacalcin,Mylan Institutional LLC,72078-038,"Injection, solution",Intramuscular; Subcutaneous,200 [USP'U]/1mL,US,FDA NDC
DB00017,Miacalcin,Mylan Institutional LLC,72078-039,"Injection, solution",Intramuscular; Subcutaneous,200 [USP'U]/1mL,US,FDA NDC
DB00017,Miacalcin Injection 200iu/ml,Novartis,,Liquid,Intramuscular; Intravenous; Subcutaneous,200 unit / mL,Canada,DPD
DB00017,Miacalcin Nasal Spray 200 Iu,Novartis,,Spray,Nasal,200 unit / act,Canada,DPD
DB00017,Pro-calcitonin - 200,Pro Doc Limitee,,Solution,Nasal,200 unit / spray,Canada,DPD
DB00017,Sandoz-calcitonin NS,Sandoz Canada Incorporated,,Liquid,Nasal,200 unit / spray,Canada,DPD
DB00018,Alferon,AIM ImmunoTech Inc,54746-001,Injection,Subcutaneous,5000000 [arb'U]/1mL,US,FDA NDC
DB00019,Cegfila,Mundipharma Corporation (Ireland) Limited,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Fulphila,Mylan Institutional LLC,67457-833,Injection,Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Fulphila,Biosimilar Collaborations Ireland Limited,,Solution,Subcutaneous,10 mg / mL,Canada,DPD
DB00019,Fulphila,Biocon Biologics Inc.,83257-005,Injection,Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Fulphila,Viatris Limited,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Fulphila,Viatris Limited,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Fylnetra,Amneal Pharmaceuticals LLC,70121-1627,Injection,Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Grasustek,Juta Pharma Gmb H,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Lapelga,Apotex Corporation,,Solution,Subcutaneous,6 mg / 0.6 mL,Canada,DPD
DB00019,Lapelga,Apotex Corporation,,Solution,Subcutaneous,6 mg / 0.6 mL,Canada,DPD
DB00019,Neulasta,"Physicians Total Care, Inc.",54868-5229,Injection,Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Neulasta,AMGEN INC,55513-192,Injection; Kit,Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Neulasta,AMGEN INC,55513-190,Injection,Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Neulasta,Amgen,,Solution,Subcutaneous,10 mg / mL,Canada,DPD
DB00019,Neulasta,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Neulasta,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Neulasta,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Neulasta,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Neupopeg,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Neupopeg,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Neupopeg,Dompé Biotec S.P.A.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Nyvepria,Pfizer Laboratories Div Pfizer Inc,0069-0324,"Injection, solution",Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Nyvepria,Pfizer Canada Ulc,,Solution,Subcutaneous,6 mg / 0.6 mL,Canada,DPD
DB00019,Nyvepria,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Pelgraz,Accord Healthcare S.L.U.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Pelgraz,Accord Healthcare S.L.U.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Pelmeg,Mundipharma Corporation (Ireland) Limited,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Ristempa,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Ristempa,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Ristempa,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Stimufend,"Fresenius Kabi USA, LLC",65219-371,"Injection, solution",Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Stimufend,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Udenyca,Coherus BioSciences Inc,70114-101,"Injection, solution",Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Udenyca,Coherus BioSciences Inc,70114-120,"Injection, solution",Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Udenyca,Coherus BioSciences Inc,70114-130,"Injection, solution",Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Udenyca,Era Consulting Gmb H,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00019,Ziextenzo,Sandoz Inc,61314-866,Injection,Subcutaneous,6 mg/0.6mL,US,FDA NDC
DB00019,Ziextenzo,Sandoz Canada Incorporated,,Solution,Subcutaneous,6 mg / 0.6 mL,Canada,DPD
DB00019,Ziextenzo,Sandoz,,"Injection, solution",Subcutaneous,6 mg,EU,EMA
DB00020,Leukine,Genzyme Corporation,58468-0181,Liquid,Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00020,Leukine,Genzyme Corporation,58468-0180,"Injection, powder, for solution",Intravenous; Subcutaneous,250 ug/1mL,US,FDA NDC
DB00020,Leukine,"Physicians Total Care, Inc.",54868-3188,Liquid,Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00020,Leukine,Bayer,50419-050,Liquid,Subcutaneous,500 ug/1mL,US,FDA NDC
DB00020,Leukine,Bayer,50419-002,"Injection, powder, for solution",Subcutaneous,250 ug/1mL,US,FDA NDC
DB00020,Leukine,Sanofi Aventis,0024-5844,Liquid,Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00020,Leukine,Sanofi Aventis,0024-5843,"Injection, powder, for solution",Intravenous; Subcutaneous,250 ug/1mL,US,FDA NDC
DB00020,Leukine,Berlex,50419-595,Liquid,Subcutaneous,500 ug/1mL,US,FDA NDC
DB00020,Leukine,"Partner Therapeutics, Inc.",71837-5843,"Injection, powder, lyophilized, for solution",Intravenous; Subcutaneous,250 ug/1mL,US,FDA NDC
DB00020,Leukine,"Partner Therapeutics, Inc",71837-5844,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Pegetron,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,PegIntron,"Physicians Total Care, Inc.",54868-5036,"Injection, powder, lyophilized, for solution",Subcutaneous,150 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Limited,0085-1368,Kit,Subcutaneous,50 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Limited,0085-1291,Kit,Subcutaneous,80 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Limited,0085-1304,Kit,Subcutaneous,120 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Limited,0085-1279,Kit,Subcutaneous,150 ug/0.5mL,US,FDA NDC
DB00022,PegIntron,Merck Sharp & Dohme Corp.,0085-1902,"Injection, powder, lyophilized, for solution",Subcutaneous,50 ug/0.5mL,US,FDA NDC
DB00022,PegIntron,Merck Sharp & Dohme Corp.,0085-1903,"Injection, powder, lyophilized, for solution",Subcutaneous,80 ug/0.5mL,US,FDA NDC
DB00022,PegIntron,Merck Sharp & Dohme Corp.,0085-1904,"Injection, powder, lyophilized, for solution",Subcutaneous,120 ug/0.5mL,US,FDA NDC
DB00022,PegIntron,Merck Sharp & Dohme Corp.,0085-1905,"Injection, powder, lyophilized, for solution",Subcutaneous,150 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-1323,"Injection, powder, lyophilized, for solution",Subcutaneous,50 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-1316,"Injection, powder, lyophilized, for solution",Subcutaneous,80 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-1297,"Injection, powder, lyophilized, for solution",Subcutaneous,120 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-1370,"Injection, powder, lyophilized, for solution",Subcutaneous,150 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-4353,"Injection, powder, for solution; Kit",Subcutaneous,50 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-4354,"Injection, powder, for solution; Kit",Subcutaneous,80 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-4355,"Injection, powder, for solution; Kit",Subcutaneous,120 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme Corp.,0085-4356,"Injection, powder, for solution; Kit",Subcutaneous,150 ug/0.5mL,US,FDA NDC
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,50 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,80 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,100 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,120 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Pegintron,Merck Sharp & Dohme B.V.,,"Injection, powder, for solution",Subcutaneous,150 mcg,EU,EMA
DB00022,Sylatron,Merck Sharp & Dohme Limited,0085-1388,Kit,Subcutaneous,40 ug/0.1mL,US,FDA NDC
DB00022,Sylatron,Merck Sharp & Dohme Limited,0085-1287,Kit,Subcutaneous,60 ug/0.1mL,US,FDA NDC
DB00022,Sylatron,Merck Sharp & Dohme Limited,0085-1312,Kit,Subcutaneous,120 ug/0.1mL,US,FDA NDC
DB00022,Sylatron,Merck Sharp & Dohme Corp.,0085-4347,Kit,Subcutaneous,40 ug/0.1mL,US,FDA NDC
DB00022,Sylatron,Merck Sharp & Dohme Corp.,0085-4348,Kit,Subcutaneous,60 ug/0.1mL,US,FDA NDC
DB00022,Sylatron,Merck Sharp & Dohme Corp.,0085-4349,Kit,Subcutaneous,120 ug/0.1mL,US,FDA NDC
DB00022,Unitron Peg,Merck Ltd.,,"Powder, for solution",Subcutaneous,74 mcg / vial,Canada,DPD
DB00022,Unitron Peg,Merck Ltd.,,"Powder, for solution",Subcutaneous,118.4 mcg / vial,Canada,DPD
DB00022,Unitron Peg,Merck Ltd.,,"Powder, for solution",Subcutaneous,177.6 mcg / vial,Canada,DPD
DB00022,Unitron Peg,Merck Ltd.,,"Powder, for solution",Subcutaneous,222 mcg / vial,Canada,DPD
DB00022,Victrelis Triple,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Victrelis Triple,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Victrelis Triple,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00022,Victrelis Triple,Merck Ltd.,,"Capsule; Powder, for solution",Oral; Subcutaneous,,Canada,DPD
DB00023,Elspar,Lundbeck Inc.,67386-411,"Injection, powder, lyophilized, for solution",Intramuscular; Intravenous,10000 [iU]/1,US,FDA NDC
DB00023,Kidrolase,Jazz Pharmaceuticals France Sas,,"Powder, for solution",Intramuscular; Intravenous,10000 unit / vial,Canada,DPD
DB00023,Rylaze,"Jazz Pharmaceuticals, Inc.",68727-900,Injection,Intramuscular,20 mg/1mL,US,FDA NDC
DB00023,Spectrila,Medac Gesellschaft Fuer Klinische Spezialpraeparate Mb H,,"Injection, powder, for solution",Intravenous,10000 U,EU,EMA
DB00023,Spectrila,Medac Gesellschaft Fuer Klinische Spezialpraeparate Mb H,,"Injection, powder, for solution",Intravenous,10000 U,EU,EMA
DB00024,Thyrogen,Genzyme Corporation,58468-0030,"Injection, powder, lyophilized, for solution",Intramuscular,0.9 mg/1mL,US,FDA NDC
DB00024,Thyrogen,Genzyme Corporation,58468-1849,"Injection, powder, for solution; Kit",Intramuscular,0.9 mg/1mL,US,FDA NDC
DB00024,Thyrogen,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,"Powder, for solution",Intramuscular,0.9 mg / vial,Canada,DPD
DB00024,Thyrogen,Sanofi B.V.,,"Injection, powder, for solution",Intramuscular,0.9 mg,EU,EMA
DB00024,Thyrogen,Sanofi B.V.,,"Injection, powder, for solution",Intramuscular,0.9 mg,EU,EMA
DB00025,Advate,Baxter Healthcare Corporation,0944-2941,Kit,Intravenous,50 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2942,Kit,Intravenous,100 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2943,Kit,Intravenous,200 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2944,Kit,Intravenous,300 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2945,Kit,Intravenous,400 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2946,Kit,Intravenous,600 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2960,Kit,Intravenous,50 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2961,Kit,Intravenous,100 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2962,Kit,Intravenous,200 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxter Healthcare Corporation,0944-2963,Kit,Intravenous,300 [iU]/1mL,US,FDA NDC
DB00025,Advate,"Takeda Pharmaceuticals America, Inc.",0944-3051,"Injection, powder, lyophilized, for solution; Kit",Intravenous,125 [iU]/1mL,US,FDA NDC
DB00025,Advate,"Takeda Pharmaceuticals America, Inc.",0944-3052,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/1mL,US,FDA NDC
DB00025,Advate,"Takeda Pharmaceuticals America, Inc.",0944-3053,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/1mL,US,FDA NDC
DB00025,Advate,"Takeda Pharmaceuticals America, Inc.",0944-3054,"Injection, powder, lyophilized, for solution; Kit",Intravenous,750 [iU]/1mL,US,FDA NDC
DB00025,Advate,"Takeda Pharmaceuticals America, Inc.",0944-3045,"Injection, powder, lyophilized, for solution; Kit",Intravenous,400 [iU]/1mL,US,FDA NDC
DB00025,Advate,"Takeda Pharmaceuticals America, Inc.",0944-3046,"Injection, powder, lyophilized, for solution; Kit",Intravenous,600 [iU]/1mL,US,FDA NDC
DB00025,Advate,"Takeda Pharmaceuticals America, Inc.",0944-3047,"Injection, powder, lyophilized, for solution; Kit",Intravenous,800 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxalta US Inc.,0944-2964,Kit,Intravenous,400 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxalta US Inc.,0944-2965,Kit,Intravenous,600 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxalta US Inc.,0944-2948,Kit,Intravenous,800 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxalta US Inc.,0944-2921,Kit,Intravenous,125 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxalta US Inc.,0944-2922,Kit,Intravenous,250 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxalta US Inc.,0944-2923,Kit,Intravenous,500 [iU]/1mL,US,FDA NDC
DB00025,Advate,Baxalta US Inc.,0944-2924,Kit,Intravenous,750 [iU]/1mL,US,FDA NDC
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1500 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00025,Advate,Baxter Healthcare Corporation,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Advate,Baxter Healthcare Corporation,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1500 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1500 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,1500 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00025,Advate,Takeda,,"Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1500 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1500 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1500 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Advate,Takeda Manufacturing Austria Ag,,"Injection, powder, for solution",Intravenous,1500 IU,EU,EMA
DB00025,Adynovate,"Takeda Pharmaceuticals Amercia, Inc.",0944-4622,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,"Takeda Pharmaceuticals Amercia, Inc.",0944-4623,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,"Takeda Pharmaceuticals Amercia, Inc.",0944-4626,"Injection, powder, lyophilized, for solution; Kit",Intravenous,750 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,"Takeda Pharmaceuticals Amercia, Inc.",0944-4624,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,"Takeda Pharmaceuticals Amercia, Inc.",0944-4627,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1500 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,"Takeda Pharmaceuticals Amercia, Inc.",0944-4625,"Injection, powder, lyophilized, for solution; Kit",Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,"Takeda Pharmaceuticals Amercia, Inc.",0944-4628,"Injection, powder, lyophilized, for solution; Kit",Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4252,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4254,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4260,"Injection, powder, lyophilized, for solution; Kit",Intravenous,750 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4256,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4262,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1500 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4258,"Injection, powder, lyophilized, for solution; Kit",Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4264,"Injection, powder, lyophilized, for solution; Kit",Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4132,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4133,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4134,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4135,"Injection, powder, lyophilized, for solution; Kit",Intravenous,750 [iU]/2mL,US,FDA NDC
DB00025,Adynovate,Baxalta US Inc.,0944-4136,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1500 [iU]/2mL,US,FDA NDC
DB00025,Helixate FS,CSL BEHRING LLC,0053-8131,Kit,Intravenous,250 [iU]/2.5mL,US,FDA NDC
DB00025,Helixate FS,CSL BEHRING LLC,0053-8132,Kit,Intravenous,500 [iU]/2.5mL,US,FDA NDC
DB00025,Helixate FS,CSL BEHRING LLC,0053-8133,Kit,Intravenous,1000 [iU]/2.5mL,US,FDA NDC
DB00025,Helixate FS,CSL BEHRING LLC,0053-8134,Kit,Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00025,Helixate FS,CSL BEHRING LLC,0053-8135,Kit,Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00025,Helixate FS,Bayer HealthCare LLC,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Helixate FS,Bayer HealthCare LLC,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Helixate FS,Bayer HealthCare LLC,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Helixate FS,Bayer HealthCare LLC,,"Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00025,Helixate FS,Bayer HealthCare LLC,,"Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00025,Helixate Nexgen,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Helixate Nexgen,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Helixate Nexgen,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Helixate Nexgen,Bayer Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Helixate Nexgen,Bayer Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Iblias,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Iblias,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Iblias,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Iblias,Bayer Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Iblias,Bayer Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Kogenate - Pws IV 1000I.U./vial,Bayer,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Kogenate - Pws IV 250I.U./vial,Bayer,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Kogenate - Pws IV 500I.U./vial,Bayer,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Kogenate Bayer,Bayer Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Kogenate FS,Bayer,0026-3795,Kit,Intravenous,1000 [iU]/2.5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer,0026-3793,Kit,Intravenous,500 [iU]/2.5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer,0026-3792,Kit,Intravenous,250 [iU]/2.5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer,0026-3796,Kit,Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer,0026-3797,Kit,Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer HealthCare LLC,0026-3785,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/2.5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer HealthCare LLC,0026-3783,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/2.5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer HealthCare LLC,0026-3782,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/2.5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer HealthCare LLC,0026-3786,"Injection, powder, lyophilized, for solution; Kit",Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer HealthCare LLC,0026-3787,"Injection, powder, lyophilized, for solution; Kit",Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00025,Kogenate FS,Bayer,,"Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00025,Kogenate FS -(with Bio-set),Bayer,,"Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00025,Kogenate FS -(with Bio-set),Bayer,,"Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00025,Kogenate Pws 1000iu/vial,Miles Inc.   Pharmaceutical Division,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Kogenate Pws 250iu/vial,Miles Inc.   Pharmaceutical Division,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Kogenate Pws 500iu/vial,Miles Inc.   Pharmaceutical Division,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer HealthCare LLC,0026-3821,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/2.5mL,US,FDA NDC
DB00025,Kovaltry,Bayer HealthCare LLC,0026-3822,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/2.5mL,US,FDA NDC
DB00025,Kovaltry,Bayer HealthCare LLC,0026-3824,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/2.5mL,US,FDA NDC
DB00025,Kovaltry,Bayer HealthCare LLC,0026-3826,"Injection, powder, lyophilized, for solution; Kit",Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00025,Kovaltry,Bayer HealthCare LLC,0026-3828,"Injection, powder, lyophilized, for solution; Kit",Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer,,"Kit; Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00025,Kovaltry,Bayer Ag,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00025,Novoeight,Novo Nordisk,0169-7825,"Injection, powder, lyophilized, for solution; Kit",Intravenous,62.5 [iU]/1mL,US,FDA NDC
DB00025,Novoeight,Novo Nordisk,0169-7850,"Injection, powder, lyophilized, for solution; Kit",Intravenous,125 [iU]/1mL,US,FDA NDC
DB00025,Novoeight,Novo Nordisk,0169-7810,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/1mL,US,FDA NDC
DB00025,Novoeight,Novo Nordisk,0169-7815,"Injection, powder, lyophilized, for solution; Kit",Intravenous,375 [iU]/1mL,US,FDA NDC
DB00025,Novoeight,Novo Nordisk,0169-7820,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/1mL,US,FDA NDC
DB00025,Novoeight,Novo Nordisk,0169-7830,"Injection, powder, lyophilized, for solution; Kit",Intravenous,750 [iU]/1mL,US,FDA NDC
DB00025,Recombinate,"Takeda Pharmaceuticals America, Inc.",0944-2841,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/5mL,US,FDA NDC
DB00025,Recombinate,"Takeda Pharmaceuticals America, Inc.",0944-2842,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/5mL,US,FDA NDC
DB00025,Recombinate,"Takeda Pharmaceuticals America, Inc.",0944-2843,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/5mL,US,FDA NDC
DB00025,Recombinate,"Takeda Pharmaceuticals America, Inc.",0944-2844,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1500 [iU]/5mL,US,FDA NDC
DB00025,Recombinate,"Takeda Pharmaceuticals America, Inc.",0944-2845,"Injection, powder, lyophilized, for solution; Kit",Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00025,Recombinate,Baxalta US Inc.,0944-2831,"Injection, powder, lyophilized, for solution; Kit",Intravenous,25 [iU]/1mL,US,FDA NDC
DB00025,Recombinate,Baxalta US Inc.,0944-2832,"Injection, powder, lyophilized, for solution; Kit",Intravenous,50 [iU]/1mL,US,FDA NDC
DB00025,Recombinate,Baxalta US Inc.,0944-2833,"Injection, powder, lyophilized, for solution; Kit",Intravenous,100 [iU]/1mL,US,FDA NDC
DB00025,Recombinate Pws Inj 1000I.U./vial,Baxter Healthcare Corporation,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00025,Recombinate Pws Inj 250I.U./vial,Baxter Healthcare Corporation,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00025,Recombinate Pws Inj 500I.U./vial,Baxter Healthcare Corporation,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),66658-234,"Injection, solution",Subcutaneous,100 mg/0.67mL,US,FDA NDC
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,Solution,Subcutaneous,150 mg / mL,Canada,DPD
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,"Injection, solution",Subcutaneous,100 mg,EU,EMA
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,"Injection, solution",Subcutaneous,100 mg,EU,EMA
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,"Injection, solution",Subcutaneous,100 mg,EU,EMA
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,"Injection, solution",Subcutaneous,100 mg/0.67ml,EU,EMA
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,"Injection, solution",Subcutaneous,100 mg/0.67ml,EU,EMA
DB00026,Kineret,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,"Injection, solution",Subcutaneous,100 mg/0.67ml,EU,EMA
DB00027,Antibiotic Cream,Cellchem Pharmaceuticals Inc.,,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Cream,Canadian Custom Packaging Company,,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Cream,Technilab Pharma Inc.,,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Cream for Kids,"Taro Pharmaceuticals, Inc.",,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Cream for Kids,Cellchem Pharmaceuticals Inc.,,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Cream Plus Pain Relief,Cellchem Pharmaceuticals Inc.,,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Cream Plus Pain Relief,Canadian Custom Packaging Company,,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Cream Plus Pain Relief for Kids,Canadian Custom Packaging Company,,Cream,Topical,,Canada,DPD
DB00027,Antibiotic Drops,Sandoz Canada Incorporated,,Solution,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Antibiotic Ear Drops,Sandoz Canada Incorporated,,Solution / drops,Auricular (otic),,Canada,DPD
DB00027,Antibiotic Eye Drops,Sandoz Canada Incorporated,,Solution / drops,Ophthalmic,,Canada,DPD
DB00027,Antibiotic Plus Pain Relief Cream,"Taro Pharmaceuticals, Inc.",,Cream,Topical,,Canada,DPD
DB00027,Complete Antibiotic Ointment,"Taro Pharmaceuticals, Inc.",,Ointment,Topical,,Canada,DPD
DB00027,Kenacomb Cream,"Westwood Squibb, Division Of Bristol Myers Squibb Canada Inc.",,Cream,Topical,,Canada,DPD
DB00027,Kenacomb Mild Cream,"Westwood Squibb, Division Of Bristol Myers Squibb Canada Inc.",,Cream,Topical,,Canada,DPD
DB00027,Kenacomb Mild Ointment,"Westwood Squibb, Division Of Bristol Myers Squibb Canada Inc.",,Ointment,Topical,,Canada,DPD
DB00027,Kenacomb Ointment,"Westwood Squibb, Division Of Bristol Myers Squibb Canada Inc.",,Ointment,Topical,,Canada,DPD
DB00027,Kenacomb Ont,"Squibb Canada Inc., Division Of Bristol Myers Squibb Canada Inc.",,Ointment,Topical,,Canada,DPD
DB00027,Lidecomb Cream,Medicis Pharmaceutical Corporation,,Cream,Topical,,Canada,DPD
DB00027,Lidosporin Cream,Glaxo Wellcome,,Cream,Topical,,Canada,DPD
DB00027,Lidosporin Cream,Warner Lambert Canada Inc.,,Cream,Topical,,Canada,DPD
DB00027,Mecomb Crm 0.1%,Medic Laboratory LtÉe,,Cream,Topical,,Canada,DPD
DB00027,Neocidin,Major,0904-3016,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neomycin and Polymyxin B Sulfates and Gramicidin,"Physicians Total Care, Inc.",54868-6253,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neomycin and Polymyxin B Sulfates and Gramicidin,Rebel Distributors,21695-528,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neomycin and Polymyxin B Sulfates and Gramicidin,"Dispensing Solutions, Inc.",55045-1194,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neomycin and Polymyxin B Sulfates and Gramicidin,A S Medication Solutions,54569-1188,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neomycin and Polymyxin B Sulfates and Gramicidin,"Paddock Laboratories, Inc.",0574-4009,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neomycin and Polymyxin B Sulfates and Gramicidin,Bausch & Lomb Incorporated,24208-790,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neomycin and Polymyxin B Sulfates and Gramicidin,A-S Medication Solutions,50090-0247,Solution / drops,Ophthalmic,,US,FDA NDC
DB00027,Neosporin,"Physicians Total Care, Inc.",54868-0593,Solution,Ophthalmic,,US,FDA NDC
DB00027,Neosporin,Pfizer Laboratories Div Pfizer Inc,61570-045,Solution,Ophthalmic,,US,FDA NDC
DB00027,Neosporin Antibiotic Cream,Glaxosmithkline Inc,,Cream,Topical,,Canada,DPD
DB00027,Neosporin Eye-ear Solution,Glaxosmithkline Inc,,Solution,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Odan-spor,Odan Laboratories Ltd,,Liquid,Ophthalmic,,Canada,DPD
DB00027,Optimyxin,Euro Pharm International Canada Inc,,Solution / drops,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Optimyxin Plus,Euro Pharm International Canada Inc,,Solution,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Original Antibiotic Cream,"Taro Pharmaceuticals, Inc.",,Cream,Topical,,Canada,DPD
DB00027,Original Antibiotic Cream,Crls,,Cream,Topical,,Canada,DPD
DB00027,"Polycidin Eye, Ear Drops",Novartis Ophthalmics Novartis Pharmaceuticals (Canada) Inc,,Liquid,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Polysporin Antibiotic Burn Cream,Warner Lambert Canada Inc.,,Cream,Topical,,Canada,DPD
DB00027,Polysporin Antibiotic Cream,Johnson & Johnson,,Cream,Topical,,Canada,DPD
DB00027,Polysporin Burn Formula Cream,Glaxo Wellcome,,Cream,Topical,,Canada,DPD
DB00027,Polysporin Cold Sore Ointment,Johnson & Johnson,,Ointment,Topical,,Canada,DPD
DB00027,Polysporin Complete,Johnson & Johnson,,Ointment,Topical,,Canada,DPD
DB00027,Polysporin Cream,Glaxo Wellcome,,Cream,Topical,,Canada,DPD
DB00027,Polysporin Eye and Ear Drops Sterile,Johnson & Johnson,,Solution / drops,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Polysporin Eye and Ear Drops Sterile,Glaxo Wellcome,,Solution / drops,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Polysporin for Kids,Johnson & Johnson,,Cream,Topical,,Canada,DPD
DB00027,Polysporin for Stitches,Johnson & Johnson,,Ointment,Topical,,Canada,DPD
DB00027,Polysporin Plus Pain Relief,Johnson & Johnson,,Cream,Topical,,Canada,DPD
DB00027,Polysporin Triple Antibiotic Ointment,Johnson & Johnson,,Ointment,Topical,,Canada,DPD
DB00027,Polysporin Triple Antibiotic Ointment,Glaxo Wellcome,,Ointment,Topical,,Canada,DPD
DB00027,Polysporin Triple Antibiotic Ointment,Warner Lambert Canada Inc.,,Ointment,Topical,,Canada,DPD
DB00027,Polytopic Cream,Sandoz Canada Incorporated,,Cream,Topical,,Canada,DPD
DB00027,Sandoz Opticort,Sandoz Canada Incorporated,,Solution,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Sofracort,Sanofi Aventis,,Solution / drops,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Sofracort Ear/eye Ointment,Roussel Canada Inc.,,Ointment,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Sofracort Eye/ear Drops,Roussel Canada Inc.,,Solution / drops,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Sofracort Sterile Ear/eye Drops,Hoechst Roussel Canada Inc.,,Solution / drops,Topical,,Canada,DPD
DB00027,Sofracort Sterile Ear/eye Ointment,Aventis Pharma Ltd.,,Ointment,Auricular (otic); Ophthalmic,,Canada,DPD
DB00027,Sofracort Sterile Ear/eye Ointment,Hoechst Roussel Canada Inc.,,Ointment,Topical,,Canada,DPD
DB00027,Soframycin Nasal Spray,Searchlight Pharma Inc,,Spray,Nasal,,Canada,DPD
DB00027,Soframycin Nasal Spray,Hoechst Roussel Canada Inc.,,Spray,Nasal,,Canada,DPD
DB00027,Soframycin Nasal Spray,Roussel Canada Inc.,,Spray,Nasal,,Canada,DPD
DB00027,Soframycin Ointment,Roussel Canada Inc.,,Ointment,Topical,,Canada,DPD
DB00027,Soframycin Skin Ointment,Hoechst Roussel Canada Inc.,,Ointment,Topical,,Canada,DPD
DB00027,Soframycin Skin Ointment,Searchlight Pharma Inc,,Ointment,Topical,,Canada,DPD
DB00027,Teva-triacomb,TEVA Canada Limited,,Cream,Topical,,Canada,DPD
DB00027,Theraderm Cream,Bimeda Mtc Animal Health Inc,,Cream,Topical,,Canada,DPD
DB00027,Triple Antibiotic Ointment,Cellchem Pharmaceuticals Inc.,,Ointment,Topical,,Canada,DPD
DB00027,Triple Antibiotic Ointment,Canadian Custom Packaging Company,,Ointment,Topical,,Canada,DPD
DB00027,Triple Antibiotic Ointment,"Taro Pharmaceuticals, Inc.",,Ointment,Topical,,Canada,DPD
DB00027,Triple Antibiotic Ointment,"Melaleuca, Inc.",,Ointment,Topical,,Canada,DPD
DB00027,Triple Antibiotic Ointment,Jamp Pharma Corporation,,Ointment,Topical,,Canada,DPD
DB00027,Viaderm Kc Crm,"Taro Pharmaceuticals, Inc.",,Cream,Topical,,Canada,DPD
DB00027,Viaderm Kc Ont,"Taro Pharmaceuticals, Inc.",,Ointment,Topical,,Canada,DPD
DB00028,Alyglo,GC Biopharma Corp.,61476-104,Liquid,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Asceniv,"Adma Biologics, Inc.",69800-0250,Liquid,Intravenous,5 g/50mL,US,FDA NDC
DB00028,Bivigam,"Kedrion Biopharma, Inc.",76125-918,"Injection, solution",Intravenous,1 g/10mL,US,FDA NDC
DB00028,Bivigam,"Adma Biologics, Inc.",69800-6502,"Injection, solution",Intravenous,5 g/50mL,US,FDA NDC
DB00028,Bivigam,"Adma Biologics, Inc.",69800-6503,"Injection, solution",Intravenous,10 g/100mL,US,FDA NDC
DB00028,Bivigam,"ADMA Biologics, Inc",59730-6502,"Injection, solution",Intravenous,5 g/50mL,US,FDA NDC
DB00028,Bivigam,"ADMA Biologics, Inc",59730-6503,"Injection, solution",Intravenous,10 g/100mL,US,FDA NDC
DB00028,Carimune Nanofiltered,Csl Behring Ag,44206-416,"Injection, powder, lyophilized, for solution",Intravenous,3 g/1,US,FDA NDC
DB00028,Carimune Nanofiltered,Csl Behring Ag,44206-417,"Injection, powder, lyophilized, for solution",Intravenous,6 g/1,US,FDA NDC
DB00028,Carimune Nanofiltered,Csl Behring Ag,44206-418,"Injection, powder, lyophilized, for solution",Intravenous,12 g/1,US,FDA NDC
DB00028,Cutaquig,Octapharma USA Inc,68982-810,Solution,Subcutaneous,165 mg/1mL,US,FDA NDC
DB00028,Cutaquig,Pfizer Laboratories Div Pfizer Inc,0069-1061,Solution,Subcutaneous,165 mg/1mL,US,FDA NDC
DB00028,Cutaquig,Pfizer Laboratories Div Pfizer Inc,0069-1802,Solution,Subcutaneous,165 mg/1mL,US,FDA NDC
DB00028,Cutaquig,Pfizer Laboratories Div Pfizer Inc,0069-1476,Solution,Subcutaneous,165 mg/1mL,US,FDA NDC
DB00028,Cutaquig,Pfizer Laboratories Div Pfizer Inc,0069-1960,Solution,Subcutaneous,165 mg/1mL,US,FDA NDC
DB00028,Cutaquig,Pfizer Laboratories Div Pfizer Inc,0069-1509,Solution,Subcutaneous,165 mg/1mL,US,FDA NDC
DB00028,Cutaquig,Pfizer Laboratories Div Pfizer Inc,0069-1965,Solution,Subcutaneous,165 mg/1mL,US,FDA NDC
DB00028,Cutaquig,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Subcutaneous,1 g / 6 mL,Canada,DPD
DB00028,Cutaquig,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Subcutaneous,1.65 g / 10 mL,Canada,DPD
DB00028,Cutaquig,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Subcutaneous,2 g / 12 mL,Canada,DPD
DB00028,Cutaquig,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Subcutaneous,3.3 g / 20 mL,Canada,DPD
DB00028,Cutaquig,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Subcutaneous,4 g / 24 mL,Canada,DPD
DB00028,Cutaquig,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Subcutaneous,8 g / 48 mL,Canada,DPD
DB00028,Cuvitru,"Takeda Pharmaceuticals America, Inc.",0944-2850,"Injection, solution",Subcutaneous,200 mg/1mL,US,FDA NDC
DB00028,Cuvitru,Takeda,,Solution,Subcutaneous,200 mg / mL,Canada,DPD
DB00028,Flebogamma,Grifols,61953-0003,"Injection, solution",Intravenous,0.5 g/10mL,US,FDA NDC
DB00028,Flebogamma 10%,"Instituto Grifols, S.A.",,Solution,Intravenous,100 mg / mL,Canada,DPD
DB00028,Flebogamma 5%,"Instituto Grifols, S.A.",,Solution,Intravenous,50 mg / mL,Canada,DPD
DB00028,Flebogamma DIF,"GRIFOLS USA, LLC",61953-0004,"Injection, solution",Intravenous,0.05 g/1mL,US,FDA NDC
DB00028,Flebogamma Dif,"GRIFOLS USA, LLC",61953-0005,"Injection, solution",Intravenous,5 g/50mL,US,FDA NDC
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,50 mg/ml,EU,EMA
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,50 mg/ml,EU,EMA
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,50 mg/ml,EU,EMA
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,50 mg/ml,EU,EMA
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,50 mg/ml,EU,EMA
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Flebogamma Dif,"Instituto Grifols, S.A.",,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,GamaSTAN,"GRIFOLS USA, LLC",13533-335,"Injection, solution",Intramuscular,0.165 g/1mL,US,FDA NDC
DB00028,Gamastan,"GRIFOLS USA, LLC",13533-635,"Injection, solution",Intramuscular,0.165 g/1mL,US,FDA NDC
DB00028,Gamastan,"Cutter Med & Biol, Division Of Miles Canada Ltd.",,Liquid,Intramuscular,16.5 %,Canada,DPD
DB00028,Gamastan,Grifols Therapeutics Llc,,Solution,Intramuscular,18 %,Canada,DPD
DB00028,Gamastan S/d,Grifols Therapeutics Llc,,Solution,Intramuscular,18 %,Canada,DPD
DB00028,Gamimune N 10% (iv),Talecris Biotherapeutics Inc,,Solution,Intravenous,100 mg / mL,Canada,DPD
DB00028,Gamimune N 5% (iv),Talecris Biotherapeutics Inc,,Solution,Intravenous,50 mg / mL,Canada,DPD
DB00028,Gamimune N Inj 5% (iv),"Cutter Med & Biol, Division Of Miles Canada Ltd.",,Liquid,Intravenous,50 mg / mL,Canada,DPD
DB00028,GAMMAGARD Liquid,"Takeda Pharmaceuticals America, Inc.",0944-2700,"Injection, solution",Intravenous; Subcutaneous,100 mg/1mL,US,FDA NDC
DB00028,GAMMAGARD Liquid,Takeda,,Solution,Intravenous,10 %,Canada,DPD
DB00028,Gammagard S/d,"Takeda Pharmaceuticals America, Inc.",0944-2656,"Injection, powder, lyophilized, for solution; Kit",Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Gammagard S/d,"Takeda Pharmaceuticals America, Inc.",0944-2658,"Injection, powder, lyophilized, for solution; Kit",Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Gammagard S/d,Baxalta US Inc.,0944-2623,Kit,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Gammagard S/d,Baxalta US Inc.,0944-2625,Kit,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Gammagard S/d,Baxalta US Inc.,0944-2627,Kit,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Gammagard S/d,Baxalta US Inc.,0944-2620,Kit,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Gammagard S/d,Baxalta US Inc.,0944-2655,Kit,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Gammagard S/d,Takeda,,"Kit; Powder, for solution; Solution",Intravenous,10 g / vial,Canada,DPD
DB00028,Gammagard S/d,Baxalta Canada Corporation,,"Powder, for solution",Intravenous,2.5 g / vial,Canada,DPD
DB00028,Gammagard S/d,Takeda,,"Kit; Powder, for solution; Solution",Intravenous,5 g / vial,Canada,DPD
DB00028,Gammagard S/d (iv),Baxter Laboratories,,"Powder, for solution",Intravenous,0.5 g / vial,Canada,DPD
DB00028,Gammaked,"Kedrion Biopharma, Inc.",76125-900,Injection,Intravenous; Subcutaneous,10 g/100mL,US,FDA NDC
DB00028,Gammaplex,Bio Products Laboratory Limited,64208-8234,Solution,Intravenous,5 g/100mL,US,FDA NDC
DB00028,Gammaplex,Bio Products Laboratory Limited,64208-8235,Solution,Intravenous,5 g/50mL,US,FDA NDC
DB00028,Gammar Inj 165mg/ml,Armour Pharmaceutical Co.,,Liquid,Intramuscular,165 mg / mL,Canada,DPD
DB00028,Gamunex,Grifols,13533-645,Injection,Intravenous,1 g/1g,US,FDA NDC
DB00028,Gamunex,Grifols Therapeutics Llc,,Solution,Intravenous; Subcutaneous,10 g / 100 mL,Canada,DPD
DB00028,Gamunex-C,"GRIFOLS USA, LLC",13533-800,Injection,Intravenous; Subcutaneous,10 g/100mL,US,FDA NDC
DB00028,Hizentra,Csl Behring Ag,44206-451,Liquid,Subcutaneous,0.2 g/1mL,US,FDA NDC
DB00028,Hizentra,Csl Behring Ag,44206-452,Liquid,Subcutaneous,0.2 g/1mL,US,FDA NDC
DB00028,Hizentra,Csl Behring Ag,44206-454,Liquid,Subcutaneous,0.2 g/1mL,US,FDA NDC
DB00028,Hizentra,Csl Behring Ag,44206-455,Liquid,Subcutaneous,0.2 g/1mL,US,FDA NDC
DB00028,Hizentra,Csl Behring Ag,44206-456,Liquid,Subcutaneous,0.2 g/1mL,US,FDA NDC
DB00028,Hizentra,Csl Behring Ag,44206-457,Liquid,Subcutaneous,0.2 g/1mL,US,FDA NDC
DB00028,Hizentra,Csl Behring Ag,44206-458,Liquid,Subcutaneous,0.2 g/1mL,US,FDA NDC
DB00028,Hizentra,Csl Behring,,Solution,Subcutaneous,200 mg / mL,Canada,DPD
DB00028,Hizentra,Csl Behring,,Solution,Subcutaneous,200 mg / mL,Canada,DPD
DB00028,Hizentra,Csl Behring,,Solution,Subcutaneous,200 mg / mL,Canada,DPD
DB00028,Hizentra,Csl Behring,,Solution,Subcutaneous,200 mg / mL,Canada,DPD
DB00028,Hizentra,Csl Behring,,Solution,Subcutaneous,200 mg / mL,Canada,DPD
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hizentra,Csl Behring,,"Injection, solution",Subcutaneous,200 mg/ml,EU,EMA
DB00028,Hyqvia,"Takeda Pharmaceuticals America, Inc.",0944-2510,Kit; Solution,Subcutaneous,,US,FDA NDC
DB00028,Hyqvia,"Takeda Pharmaceuticals America, Inc.",0944-2511,Kit; Solution,Subcutaneous,,US,FDA NDC
DB00028,Hyqvia,"Takeda Pharmaceuticals America, Inc.",0944-2512,Kit; Solution,Subcutaneous,,US,FDA NDC
DB00028,Hyqvia,"Takeda Pharmaceuticals America, Inc.",0944-2513,Kit; Solution,Subcutaneous,,US,FDA NDC
DB00028,Hyqvia,"Takeda Pharmaceuticals America, Inc.",0944-2514,Kit; Solution,Subcutaneous,,US,FDA NDC
DB00028,Hyqvia,Takeda,,Solution,Subcutaneous,,Canada,DPD
DB00028,Hyqvia,Takeda,,Solution,Subcutaneous,,Canada,DPD
DB00028,Hyqvia,Takeda,,Solution,Subcutaneous,,Canada,DPD
DB00028,Hyqvia,Takeda,,Solution,Subcutaneous,,Canada,DPD
DB00028,Hyqvia,Takeda,,Solution,Subcutaneous,,Canada,DPD
DB00028,Hyqvia,Baxalta Innovations Gmb H,,"Injection, solution",Subcutaneous,100 mg/ml,EU,EMA
DB00028,Hyqvia,Baxalta Innovations Gmb H,,"Injection, solution",Subcutaneous,100 mg/ml,EU,EMA
DB00028,Hyqvia,Baxalta Innovations Gmb H,,"Injection, solution",Subcutaneous,100 mg/ml,EU,EMA
DB00028,Hyqvia,Baxalta Innovations Gmb H,,"Injection, solution",Subcutaneous,100 mg/ml,EU,EMA
DB00028,Hyqvia,Baxalta Innovations Gmb H,,"Injection, solution",Subcutaneous,100 mg/ml,EU,EMA
DB00028,Igivnex,Grifols Therapeutics Llc,,Solution,Intravenous; Subcutaneous,10 g / 100 mL,Canada,DPD
DB00028,Immune Globulin Intravenous (human) 5%,Bayer,,Liquid,Intravenous,50 mg / mL,Canada,DPD
DB00028,"Immune Globulin Intravenous (human), 10%",Talecris Biotherapeutics Inc,,Solution,Intravenous,10 g / 100 mL,Canada,DPD
DB00028,"Immune Globulin Intravenous (human), 5%",Talecris Biotherapeutics Inc,,Solution,Intravenous,5 g / 100 mL,Canada,DPD
DB00028,Immune Serum Globulin (human),Grifols Therapeutics Llc,,Solution,Intramuscular,18 %,Canada,DPD
DB00028,Iveegam Immuno 5000mg (iv),Baxter Ag,,"Kit; Liquid; Powder, for solution",Intravenous,,Canada,DPD
DB00028,Iypoly,Whoniz,82462-102,"Aerosol, spray",Nasal,0.15 g/100mL,US,FDA NDC
DB00028,Iypoly,Whoniz,82462-103,"Aerosol, spray",Nasal,,US,FDA NDC
DB00028,Kiovig,Takeda Manufacturing Austria Ag,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Kiovig,Takeda Manufacturing Austria Ag,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Kiovig,Takeda Manufacturing Austria Ag,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Kiovig,Takeda Manufacturing Austria Ag,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Kiovig,Takeda Manufacturing Austria Ag,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Kiovig,Takeda Manufacturing Austria Ag,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Octagam,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Intravenous,100 mg / mL,Canada,DPD
DB00028,Octagam 5%,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Intravenous,50 mg / mL,Canada,DPD
DB00028,Octagam Immune Globulin (Human),Octapharma Pharmazeutika Produktionsgesellschaft M.B.H.,67467-843,Solution,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Octapharma Ab,68209-843,Solution,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Octapharma USA Inc,68982-850,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Octapharma USA Inc,68982-840,Solution,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-6339,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-6237,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-6111,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-6550,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-6002,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-8476,Solution,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-8451,Solution,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-8425,Solution,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Octagam Immune Globulin (Human),Pfizer Laboratories Div Pfizer Inc,0069-8400,Solution,Intravenous,50 mg/1mL,US,FDA NDC
DB00028,Panzyga,Octapharma USA Inc,68982-820,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Pfizer Laboratories Div Pfizer Inc,0069-1011,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Pfizer Laboratories Div Pfizer Inc,0069-1109,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Pfizer Laboratories Div Pfizer Inc,0069-1224,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Pfizer Laboratories Div Pfizer Inc,0069-1312,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Pfizer Laboratories Div Pfizer Inc,0069-1415,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Pfizer Laboratories Div Pfizer Inc,0069-1558,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Octapharma USA Inc,68982-822,Solution,Intravenous,100 mg/1mL,US,FDA NDC
DB00028,Panzyga,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Intravenous,100 mg / mL,Canada,DPD
DB00028,Privigen,Csl Behring Ag,44206-436,Liquid,Intravenous,5 g/50mL,US,FDA NDC
DB00028,Privigen,Csl Behring Ag,44206-437,Liquid,Intravenous,10 g/100mL,US,FDA NDC
DB00028,Privigen,Csl Behring Ag,44206-438,Liquid,Intravenous,20 g/200mL,US,FDA NDC
DB00028,Privigen,Csl Behring Ag,44206-439,Liquid,Intravenous,40 g/400mL,US,FDA NDC
DB00028,Privigen,Csl Behring,,Solution,Intravenous,10 %,Canada,DPD
DB00028,Privigen,Csl Behring,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Privigen,Csl Behring,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Privigen,Csl Behring,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Privigen,Csl Behring,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Privigen,Csl Behring,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Privigen,Csl Behring,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Privigen,Csl Behring,,"Injection, solution",Intravenous,100 mg/ml,EU,EMA
DB00028,Sandoglobulin Nf Liquid,Csl Behring,,Solution,Intravenous,120 g / L,Canada,DPD
DB00028,Vivaglobin,Csl Behring,0053-7596,Solution,Subcutaneous,160 mg/1mL,US,FDA NDC
DB00028,Vivaglobin,Csl Behring,,Solution,Subcutaneous,160 mg / mL,Canada,DPD
DB00028,Winrho,"Cangene BioPharma, LLC",53270-3120,Liquid,Intramuscular; Intravenous,600 [iU]/1mL,US,FDA NDC
DB00028,Winrho,"Cangene BioPharma, LLC",53270-3500,Liquid,Intramuscular; Intravenous,2500 [iU]/1mL,US,FDA NDC
DB00028,Winrho,"Cangene BioPharma, LLC",53270-3100,Liquid,Intramuscular; Intravenous,5000 [iU]/1mL,US,FDA NDC
DB00028,Winrho,"Cangene BioPharma, LLC",53270-3000,Liquid,Intramuscular; Intravenous,15000 [iU]/1mL,US,FDA NDC
DB00028,Winrho,"Cangene BioPharma, LLC",53270-3300,Liquid,Intramuscular; Intravenous,1500 [iU]/1mL,US,FDA NDC
DB00028,Xembify,"GRIFOLS USA, LLC",13533-810,Solution,Subcutaneous,200 mg/1mL,US,FDA NDC
DB00028,Xembify,Grifols Therapeutics Llc,,Solution,Subcutaneous,20 %,Canada,DPD
DB00029,Eminase 30 Units,Well Spring Pharmaceutical Corporation,,"Powder, for solution",Intravenous,30 unit / 5 mL,Canada,DPD
DB00030,Actraphane 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Actraphane 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Actraphane 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Actraphane 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 30 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 40 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 40 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 40 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 50 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 50 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actraphane 50 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,40 iu/ml,EU,EMA
DB00030,Actrapid,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,40 iu/ml,EU,EMA
DB00030,Actrapid,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,40 iu/ml,EU,EMA
DB00030,Actrapid,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Flexpen,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Flexpen,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Flexpen,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Innolet,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Innolet,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Innolet,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Penfill,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Penfill,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Actrapid Penfill,Novo Nordisk,,"Injection, solution",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Afrezza,Mannkind Corporation,47918-004,"Powder, metered",Respiratory (inhalation),4 1/1,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-008,"Powder, metered",Respiratory (inhalation),8 1/1,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-048,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-048,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-084,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-084,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-840,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-840,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Sanofi Aventis,0024-5874,"Powder, metered",Respiratory (inhalation),4 1/1,US,FDA NDC
DB00030,Afrezza,Sanofi Aventis,0024-5884,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Sanofi Aventis,0024-5884,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Sanofi Aventis,0024-5882,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Sanofi Aventis,0024-5882,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Sanofi Aventis,0024-5894,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Sanofi Aventis,0024-5894,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-882,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-882,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-894,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-894,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-884,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-884,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-874,"Powder, metered",Respiratory (inhalation),4 [arb'U]/1,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-878,"Powder, metered",Respiratory (inhalation),8 [arb'U]/1,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-891,"Powder, metered",Respiratory (inhalation),12 [arb'U]/1,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-880,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-880,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-898,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-898,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-902,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-902,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-902,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-903,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-903,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Afrezza,Mannkind Corporation,47918-903,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Entuzity Kwikpen,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,500 unit / mL,Canada,DPD
DB00030,Exubera,Pfizer Inc.,0069-0707,"Aerosol, powder",Respiratory (inhalation),1 mg/1,US,FDA NDC
DB00030,Exubera,Pfizer Inc.,0069-0724,"Aerosol, powder",Respiratory (inhalation),3 mg/1,US,FDA NDC
DB00030,Exubera,Pfizer Inc.,0069-0050,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Exubera,Pfizer Inc.,0069-0050,Kit,Respiratory (inhalation),,US,FDA NDC
DB00030,Humalog 70/30,"Physicians Total Care, Inc.",54868-2746,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin 10/90 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 10/90 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 10/90 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 10/90 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 20/80 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 20/80 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 20/80 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 20/80 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 30/70 (insulin Human Biosynth Inj),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 30/70 (insulin Human Biosynth Inj),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 30/70 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 30/70 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 40/60 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 40/60 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 40/60 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 40/60 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 50/50,Eli Lilly & Co. Ltd.,0002-9515,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin 50/50 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 50/50 Cartridge,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 50/50 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 50/50 Inj,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Humulin 70/30,A-S Medication Solutions,50090-0444,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin 70/30,Eli Lilly and Company,0002-8770,"Injection, suspension",Subcutaneous,100,US,FDA NDC
DB00030,Humulin 70/30,Eli Lilly and Company,0002-8715,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin 70/30 70/30,REMEDYREPACK INC.,52125-415,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin 70/30 KwikPen,Eli Lilly and Company,0002-8803,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin L,Eli Lilly & Co. Ltd.,0002-8415,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin N,"Physicians Total Care, Inc.",54868-1429,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin N,A-S Medication Solutions,50090-0352,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin N,Eli Lilly and Company,0002-8730,"Injection, suspension",Subcutaneous,100,US,FDA NDC
DB00030,Humulin N,Eli Lilly and Company,0002-8315,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin N,Eli Lilly and Company,0002-8805,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin N,Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,100 unit/mL,Canada,DPD
DB00030,Humulin N (cartridge),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Humulin N (kwikpen),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Humulin R,"Physicians Total Care, Inc.",54868-3619,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin R,A-S Medication Solutions,50090-0353,"Injection, solution",Parenteral,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin R,Eli Lilly and Company,0002-8215,"Injection, solution",Parenteral,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin R,Eli Lilly & Co. Ltd.,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit/mL,Canada,DPD
DB00030,Humulin R,Eli Lilly and Company,0002-0213,"Injection, solution",Parenteral,100 [iU]/1mL,US,FDA NDC
DB00030,Humulin R (kwikpen),Eli Lilly & Co. Ltd.,,Solution,Intramuscular; Subcutaneous,100 unit/mL,Canada,DPD
DB00030,Humulin R Cartridge,Eli Lilly & Co. Ltd.,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Humulin R U-500,Eli Lilly and Company,0002-8501,"Injection, solution",Subcutaneous,500 [iU]/1mL,US,FDA NDC
DB00030,Humulin R U-500 KwikPen,Eli Lilly and Company,0002-8824,"Injection, solution",Subcutaneous,500 [iU]/1mL,US,FDA NDC
DB00030,Humulin U,Eli Lilly & Co. Ltd.,0002-8615,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Inpremzia,Baxter Holding B.V.,,"Injection, solution",Intravenous,1 IU/ml,EU,EMA
DB00030,Insulatard,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Insulatard,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Insulatard,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Insulatard,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulatard Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Infusat,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Infusat,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insulin Human Winthrop Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Basal,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 15,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 25,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 30,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Comb 50,Sanofi Aventis Deutschland Gmb H,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Implantable,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intraperitoneal,400 IU/ml,EU,EMA
DB00030,Insuman Implantable,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intraperitoneal,400 IU/ml,EU,EMA
DB00030,Insuman Infusat,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Infusat,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,40 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Insuman Rapid,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Lente Purified Pork Insulin Inj,Eli Lilly & Co. Ltd.,,,Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Mixtard 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Mixtard 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Mixtard 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 iu/ml,EU,EMA
DB00030,Mixtard 30,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 30 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 40 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 40 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 40 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 50 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 50 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Mixtard 50 Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 iu/ml,EU,EMA
DB00030,Myxredlin,Baxter Healthcare Corporation,0338-0126,"Injection, solution",Intravenous,1.00 [iU]/1mL,US,FDA NDC
DB00030,Myxredlin,Baxter Laboratories,,Solution,Intravenous,1 unit / mL,Canada,DPD
DB00030,Novolin 70/30,"Physicians Total Care, Inc.",54868-3474,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin 70/30,Novo Nordisk,59060-1837,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin 70/30,A S Medication Solutions,54569-2918,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin 70/30,TYA Pharmaceuticals,64725-1837,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin 70/30,Remedy Repack,61786-713,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin 70/30,Novo Nordisk,0169-3477,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin 70/30,Novo Nordisk,0169-2317,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin 70/30,Novo Nordisk,0169-1837,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin 70/30,Novo Nordisk,0169-3007,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin 70/30,A-S Medication Solutions,50090-0403,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin Ge 10/90 Penfill Inj Sus,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 10/90 Penfill Inj Sus,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 20/80 Penfill Inj Sus,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 20/80 Penfill Inj Sus,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 30/70,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 30/70,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 30/70 Penfill,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 30/70 Penfill,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 40/60 Penfill,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 40/60 Penfill,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 50/50 Penfill,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge 50/50 Penfill,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolin Ge Nph,Novo Nordisk,,Suspension,Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Novolin Ge Nph Penfill,Novo Nordisk,,Suspension,Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Novolin Ge Toronto,Novo Nordisk,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Novolin Ge Toronto Penfill,Novo Nordisk,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Novolin N,"Physicians Total Care, Inc.",54868-2380,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin N,Novo Nordisk,59060-1834,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin N,TYA Pharmaceuticals,64725-1834,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin N,Novo Nordisk,0169-3474,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin N,Novo Nordisk,0169-2314,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,Novolin N,Novo Nordisk,0169-1834,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin N,Novo Nordisk,0169-3004,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin N,A-S Medication Solutions,50090-0498,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin N,A-S Medication Solutions,50090-6565,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,"Physicians Total Care, Inc.",54868-3598,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,Novo Nordisk Inc.,59060-1833,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,TYA Pharmaceuticals,64725-1833,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,Novo Nordisk,0169-3473,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,Novo Nordisk,0169-2313,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,A-S Medication Solutions,50090-0497,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,"Nucare Pharmaceuticals,inc.",68071-1701,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,Novo Nordisk,0169-1833,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin R,Novo Nordisk,0169-3003,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolin70/30 70/30,Remedy Repack,52125-414,"Injection, suspension",Subcutaneous,100 [USP'U]/1mL,US,FDA NDC
DB00030,NovolinN N,Remedy Repack,61786-651,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00030,Novolinset Ge 30/70 Inj Sus,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolinset Ge 30/70 Inj Sus,Novo Nordisk,,Suspension,Subcutaneous,,Canada,DPD
DB00030,Novolinset Ge Nph Inj Sus 100u/ml,Novo Nordisk,,Suspension,Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Novolinset Ge Toronto Inj Liq 100u/ml,Novo Nordisk,,Liquid,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00030,Protaphane,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Protaphane,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Protaphane,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane,Novo Nordisk,,"Injection, suspension",Subcutaneous,40 IU/ml,EU,EMA
DB00030,Protaphane,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Flexpen,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Innolet,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Protaphane Penfill,Novo Nordisk,,"Injection, suspension",Subcutaneous,100 IU/ml,EU,EMA
DB00030,Velosulin,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Velosulin,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00030,Velosulin,Novo Nordisk,,"Injection, solution",Intravenous; Subcutaneous,100 IU/ml,EU,EMA
DB00031,Metalyse,Boehringer Ingelheim,,"Injection, powder, for solution",Intravenous,8000 units,EU,EMA
DB00031,Metalyse,Boehringer Ingelheim,,"Injection, powder, for solution",Intravenous,10000 units,EU,EMA
DB00031,TNKase,"Genentech, Inc.",50242-038,Kit,Intravenous; Topical,,US,FDA NDC
DB00031,TNKase,"Genentech, Inc.",50242-120,"Injection, powder, lyophilized, for solution; Kit",Intravenous,52.5 mg/50mg,US,FDA NDC
DB00031,TNKase,Hoffmann La Roche,,"Powder, for solution",Intravenous,50 mg / vial,Canada,DPD
DB00031,TNKase,"Genentech, Inc.",50242-176,"Injection, powder, lyophilized, for solution; Kit",Intravenous,52.5 mg/50mg,US,FDA NDC
DB00032,Menopur,Ferring Pharmaceuticals,,"Powder, for solution",Subcutaneous,75 unit / vial,Canada,DPD
DB00032,Repronex,Ferring Pharmaceuticals,,"Powder, for solution",Intramuscular; Subcutaneous,75 unit / vial,Canada,DPD
DB00033,Actimmune,Inter Mune,64116-011,"Injection, solution",Subcutaneous,100 ug/0.5mL,US,FDA NDC
DB00033,Actimmune,"Horizon Therapeutics USA, Inc.",75987-111,"Injection, solution",Subcutaneous,100 ug/0.5mL,US,FDA NDC
DB00033,Actimmune,"Hznp Usa, Inc.",42238-111,"Injection, solution",Subcutaneous,100 ug/0.5mL,US,FDA NDC
DB00034,Roferon A Soln Inj 6 Million,Hoffmann La Roche,,Liquid,Intramuscular; Subcutaneous,6000000 unit / mL,Canada,DPD
DB00034,Roferon A Sterile Pws 18m Unit/vial,Hoffmann La Roche,,"Powder, for solution",Intramuscular; Subcutaneous,18000000 unit / vial,Canada,DPD
DB00034,Roferon A Sterile Pws 3m Unit/vial,Hoffmann La Roche,,"Powder, for solution",Intramuscular; Subcutaneous,3000000 unit / vial,Canada,DPD
DB00034,Roferon A Sterile Pws 9m Unit/vial,Hoffmann La Roche,,"Powder, for solution",Intramuscular; Subcutaneous,9000000 unit / vial,Canada,DPD
DB00034,Roferon-A,"Genentech, Inc.",0004-2015,"Injection, solution",Subcutaneous,11.1 ug/0.5mL,US,FDA NDC
DB00034,Roferon-A,"Genentech, Inc.",0004-2016,"Injection, solution",Subcutaneous,22.2 ug/0.5mL,US,FDA NDC
DB00034,Roferon-A,"Genentech, Inc.",0004-2017,"Injection, solution",Subcutaneous,33.3 ug/0.5mL,US,FDA NDC
DB00034,Roferon-A Sol Inj 3million Iu/vial,Hoffmann La Roche,,Liquid,Intramuscular; Subcutaneous,3000000 unit / mL,Canada,DPD
DB00034,Roferon-A Soln-liq Im Sc 4.5million I.u/ml,Hoffmann La Roche,,Liquid,Intramuscular; Subcutaneous,4500000 IU/mL,Canada,DPD
DB00034,Roferon-A Soln-liq Im Sc 9million I.U./ml,Hoffmann La Roche,,Solution,Intramuscular; Subcutaneous,9000000 IU/ml,Canada,DPD
DB00034,Roferon-A Solution 18 Million I.U./3ml,Hoffmann La Roche,,Solution,Intramuscular; Subcutaneous,18000000 IU/3mL,Canada,DPD
DB00034,Roferon-A Solution 3 Million I.U./ml,Hoffmann La Roche,,Solution,Intramuscular; Subcutaneous,3 m / mL,Canada,DPD
DB00034,Roferon-A Solution 6 Million I.U./ml,Hoffmann La Roche,,Solution,Intramuscular; Subcutaneous,6000000 IU/mL,Canada,DPD
DB00034,Roferon-A Solution Inj 36000000unit/ml,Hoffmann La Roche,,Solution,Intramuscular; Subcutaneous,36000000 unit / mL,Canada,DPD
DB00034,Roferon-A Solution Inj. 9million I.U./0.9ml,Hoffmann La Roche,,Solution,Intramuscular; Subcutaneous,9000000 unit / .9 mL,Canada,DPD
DB00035,Apo-desmopressin,Apotex Corporation,,Tablet,Oral,0.1 mg,Canada,DPD
DB00035,Apo-desmopressin,Apotex Corporation,,Tablet,Oral,0.2 mg,Canada,DPD
DB00035,Bipazen,Kvr Pharmaceuticals Inc.,,Solution,Intramuscular; Intravenous; Subcutaneous,4 mcg / mL,Canada,DPD
DB00035,Ddavp,"Physicians Total Care, Inc.",54868-3889,Solution,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Ddavp,Ferring Pharmaceuticals Inc.,55566-2600,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Ddavp,Ferring Pharmaceuticals Inc.,55566-2700,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Ddavp,Ferring Pharmaceuticals Inc.,55566-2300,Injection,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Ddavp,Ferring Pharmaceuticals Inc.,55566-2200,Injection,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Ddavp,Ferring Pharmaceuticals Inc.,55566-2500,Spray,Nasal,0.1 ug/1mL,US,FDA NDC
DB00035,Ddavp,Ferring Pharmaceuticals Inc.,55566-2400,Spray,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Ddavp,sanofi-aventis U.S. LLC,0075-2452,Solution,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Ddavp,sanofi-aventis U.S. LLC,0075-2451,Solution,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Ddavp,sanofi-aventis U.S. LLC,0075-0016,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Ddavp,sanofi-aventis U.S. LLC,0075-0026,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Ddavp Inj 4mcg/ml,Ferring Pharmaceuticals,,Liquid,Intramuscular; Intravenous; Subcutaneous,4 mcg / mL,Canada,DPD
DB00035,Ddavp Melt,Ferring Pharmaceuticals,,"Tablet, orally disintegrating",Sublingual,60 mcg,Canada,DPD
DB00035,Ddavp Melt,Ferring Pharmaceuticals,,"Tablet, orally disintegrating",Sublingual,120 mcg,Canada,DPD
DB00035,Ddavp Melt,Ferring Pharmaceuticals,,"Tablet, orally disintegrating",Sublingual,240 mcg,Canada,DPD
DB00035,DDAVP Rhinal Tube,sanofi-aventis U.S. LLC,0075-2450,Solution,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Ddavp Rhinyle,Ferring Pharmaceuticals,,Solution,Nasal,0.1 mg / mL,Canada,DPD
DB00035,Ddavp Spray,Ferring Pharmaceuticals,,"Aerosol, metered",Nasal,10 mcg / act,Canada,DPD
DB00035,Ddavp Tablets 0.1mg,Ferring Pharmaceuticals,,Tablet,Oral,0.1 mg,Canada,DPD
DB00035,Ddavp Tablets 0.2mg,Ferring Pharmaceuticals,,Tablet,Oral,0.2 mg,Canada,DPD
DB00035,Desmopressin,Meliapharm Inc,,Tablet,Oral,0.1 mg,Canada,DPD
DB00035,Desmopressin,Meliapharm Inc,,Tablet,Oral,0.2 mg,Canada,DPD
DB00035,Desmopressin Acetate,"Physicians Total Care, Inc.",54868-1129,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Physicians Total Care, Inc.",54868-5602,Solution,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Watson Pharmaceuticals,0591-2225,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Watson Pharmaceuticals,0591-2226,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Ncs Health Care Of Ky, Inc Dba Vangard Labs",0615-7549,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Barr Laboratories,0555-0232,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Barr Laboratories,0555-0233,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Av Kare, Inc.",42291-241,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Av Kare, Inc.",42291-242,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Amerincan Health Packaging,68084-084,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Amerincan Health Packaging,68084-085,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Teva,0093-7316,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Teva,0093-7317,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Amerincan Health Packaging,60687-109,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Amerincan Health Packaging,60687-120,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Mylan Institutional,51079-446,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Carilion Materials Management,68151-1281,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Sagent Pharmaceuticals,25021-461,"Injection, solution",Intravenous; Subcutaneous,40 ug/10mL,US,FDA NDC
DB00035,Desmopressin Acetate,Sagent Pharmaceuticals,25021-460,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Ferring Pharmaceuticals,55566-5060,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Ferring Pharmaceuticals,55566-5061,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Sun Pharmaceutical Industries, Inc.",62756-161,Solution,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,"Actavis Pharma, Inc.",0591-2464,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Actavis Pharma, Inc.",0591-2465,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,NorthStar Rx LLC,16714-883,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,NorthStar Rx LLC,16714-884,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Sun Pharmaceutical Industries, Inc.",47335-788,Solution,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,AvPAK,50268-220,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,AvPAK,50268-221,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin acetate,"Teva Parenteral Medicines, Inc.",0703-5051,Injection,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin acetate,"Teva Parenteral Medicines, Inc.",0703-5054,Injection,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Impax Generics,0115-1646,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Impax Generics,0115-1647,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,American Health Packaging,68084-606,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,American Health Packaging,68084-604,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Glenmark Pharmaceuticals Inc.,Usa",68462-275,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Glenmark Pharmaceuticals Inc.,Usa",68462-276,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Amring Pharmaceuticals Inc.,69918-101,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Amring Pharmaceuticals Inc.,69918-201,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Amring Pharmaceuticals, Inc.",69918-501,Spray,Nasal,10 ug/0.1mL,US,FDA NDC
DB00035,Desmopressin Acetate,"Bachem Americas, Inc.",52416-108,Powder,Not applicable,1 g/1g,US,FDA NDC
DB00035,Desmopressin Acetate,"Hospira, Inc.",0409-2265,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,BluePoint Laboratories,68001-233,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,BluePoint Laboratories,68001-234,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"KVK-Tech, Inc.",10702-169,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,"KVK-Tech, Inc.",10702-170,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,BluePoint Laboratories,68001-325,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,BluePoint Laboratories,68001-326,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Zydus Lifesciences Limited,70771-1314,Spray,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Zydus Pharmaceuticals USA Inc.,68382-384,Spray,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,"Sun Pharmaceutical Industries, Inc.",62756-529,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Ubi Pharma Inc.,72843-459,Injection,Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Apotex Corp.,60505-0257,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Apotex Corp.,60505-0258,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Amring Pharmaceuticals Inc.,69918-901,Solution,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Amring Pharmaceuticals Inc.,69918-899,Solution,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-489,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-490,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Dr.Reddys' Laboratories Inc,43598-931,Injection,Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Bauch & Lomb Incorporated,24208-342,Solution,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Ferring Pharmaceuticals Inc.,55566-5020,Solution,Nasal,0.1 mg/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Prasco Laboratories,66993-025,Spray,Nasal,10 ug/0.1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Ferring Pharmaceuticals Inc.,55566-5030,Solution,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Ferring Pharmaceuticals Inc.,55566-5040,Solution,Intravenous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,bryant ranch prepack,63629-4816,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Apotex Corp.,60505-0815,Spray,Nasal,10 ug/1,US,FDA NDC
DB00035,Desmopressin Acetate,Northstar RxLLC,16714-015,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Ubi Pharma Inc.,72843-461,Injection,Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Ubi Pharma Inc.,72843-440,Injection,Intravenous; Subcutaneous,40 ug/10mL,US,FDA NDC
DB00035,Desmopressin Acetate,"Athenex Pharmaceutical Division, Llc.",70860-454,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,"AMERICAN REGENT, INC.",0517-4310,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,REMEDYREPACK INC.,70518-3125,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,REMEDYREPACK INC.,70518-3148,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,REMEDYREPACK INC.,70518-3149,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,REMEDYREPACK INC.,70518-3493,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Dr. Reddy's Laboratories Inc.,43598-053,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Gland Pharma Limited,68083-550,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,Gland Pharma Limited,68083-549,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,"Northwind Pharmaceuticals, LLC",51655-461,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Sun Pharmaceutical Industries Limited,70095-026,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,American Health Packaging,60687-721,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,American Health Packaging,60687-732,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,BluePoint Laboratories,68001-574,Tablet,Oral,0.1 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,BluePoint Laboratories,68001-575,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,Sun Pharmaceutical Industries Limited,70095-031,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,"Fresenius Kabi USA, LLC",65219-293,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,"Fresenius Kabi USA, LLC",65219-295,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,bryant ranch prepack,72162-2101,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,bryant ranch prepack,72162-2129,Spray,Nasal,10 ug/1,US,FDA NDC
DB00035,Desmopressin Acetate,"Avenacy, Inc.",83634-451,"Injection, solution",Intravenous; Subcutaneous,4 ug/1mL,US,FDA NDC
DB00035,Desmopressin Acetate,bryant ranch prepack,71335-2342,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Acetate,bryant ranch prepack,63629-3257,Tablet,Oral,0.2 mg/1,US,FDA NDC
DB00035,Desmopressin Spray,Aa Pharma Inc,,"Spray, metered",Nasal,10 mcg / act,Canada,DPD
DB00035,Desmopressin Tablets,Rainbow Pharmaceuticals Inc,,Tablet,Oral,0.1 mg,Canada,DPD
DB00035,Desmopressin Tablets,Rainbow Pharmaceuticals Inc,,Tablet,Oral,0.2 mg,Canada,DPD
DB00035,Minirin,Ferring Pharmaceuticals,,"Aerosol, metered",Nasal,10 mcg / act,Canada,DPD
DB00035,Minirin,Ferring Pharmaceuticals,,Tablet,Oral,0.1 mg,Canada,DPD
DB00035,Nocdurna,Ferring Pharmaceuticals Inc.,55566-5050,Tablet,Sublingual,27.7 ug/1,US,FDA NDC
DB00035,Nocdurna,Ferring Pharmaceuticals Inc.,55566-5070,Tablet,Sublingual,55.3 ug/1,US,FDA NDC
DB00035,Nocdurna,"Antares Pharma, Inc.",54436-325,Tablet,Sublingual,27.7 ug/1,US,FDA NDC
DB00035,Nocdurna,"Antares Pharma, Inc.",54436-350,Tablet,Sublingual,55.3 ug/1,US,FDA NDC
DB00035,Nocdurna,Ferring Pharmaceuticals,,"Tablet, orally disintegrating",Sublingual,25 mcg,Canada,DPD
DB00035,Nocdurna,Ferring Pharmaceuticals,,"Tablet, orally disintegrating",Sublingual,50 mcg,Canada,DPD
DB00035,Noctiva,"Avadel Specialty Pharmaceuticals, Llc",71758-106,"Spray, metered",Nasal,0.83 ug/1,US,FDA NDC
DB00035,Noctiva,"Avadel Specialty Pharmaceuticals, Llc",71758-107,"Spray, metered",Nasal,1.66 ug/1,US,FDA NDC
DB00035,Nu-desmopressin Spray,Nu Pharm Inc,,"Spray, metered",Nasal,0.1 g / L,Canada,DPD
DB00035,Octostim Liq Inj. 15mcg/ml,Ferring Pharmaceuticals,,Solution,Intravenous; Subcutaneous,15 mcg / mL,Canada,DPD
DB00035,Octostim Spray,Ferring Pharmaceuticals,,Spray,Nasal,150 mcg / act,Canada,DPD
DB00035,PMS-desmopressin,Pharmascience Inc,,Tablet,Oral,0.1 mg,Canada,DPD
DB00035,PMS-desmopressin,Pharmascience Inc,,Tablet,Oral,0.2 mg,Canada,DPD
DB00035,Stimate,Csl Behring,0053-2453,"Spray, metered",Nasal,1.5 mg/1mL,US,FDA NDC
DB00035,Stimate,CSL BEHRING LLC,0053-6871,"Spray, metered",Nasal,1.5 mg/1mL,US,FDA NDC
DB00035,Teva-desmopressin,TEVA Canada Limited,,Tablet,Oral,0.1 mg,Canada,DPD
DB00035,Teva-desmopressin,TEVA Canada Limited,,Tablet,Oral,0.2 mg,Canada,DPD
DB00036,Cevenfacta,Laboratoire Francais Du Fractionnement Et Des Biotechnologies,,"Injection, powder, for solution",Intravenous,45 KIU,EU,EMA
DB00036,Cevenfacta,Laboratoire Francais Du Fractionnement Et Des Biotechnologies,,"Injection, powder, for solution",Intravenous,90 KIU,EU,EMA
DB00036,Cevenfacta,Laboratoire Francais Du Fractionnement Et Des Biotechnologies,,"Injection, powder, for solution",Intravenous,225 KIU,EU,EMA
DB00036,Niastase,Novo Nordisk,,"Powder, for solution",Intravenous,1.2 mg / vial,Canada,DPD
DB00036,Niastase,Novo Nordisk,,"Powder, for solution",Intravenous,2.4 mg / vial,Canada,DPD
DB00036,Niastase,Novo Nordisk,,"Powder, for solution",Intravenous,4.8 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,1 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,2 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,5 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,8 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,1 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,2 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,5 mg / vial,Canada,DPD
DB00036,Niastase RT,Novo Nordisk,,"Kit; Powder, for solution",Intravenous,8 mg / vial,Canada,DPD
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,50 KIU,EU,EMA
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,100 KIU,EU,EMA
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,250 KIU,EU,EMA
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,400 KIU,EU,EMA
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,50 KIU,EU,EMA
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,100 KIU,EU,EMA
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,250 KIU,EU,EMA
DB00036,Novoseven,Novo Nordisk,,"Injection, powder, for solution",Intravenous,400 KIU,EU,EMA
DB00036,NovoSeven RT,Novo Nordisk,0169-7010,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,NovoSeven RT,Novo Nordisk,0169-7020,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,NovoSeven RT,Novo Nordisk,0169-7050,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,NovoSeven RT,Novo Nordisk,0169-7040,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,NovoSeven RT,Novo Nordisk,0169-7201,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,NovoSeven RT,Novo Nordisk,0169-7202,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,NovoSeven RT,Novo Nordisk,0169-7205,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,NovoSeven RT,Novo Nordisk,0169-7208,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,Sevenfact,Laboratoire Français du Fractionnement et des Biotechnologies Société Anonyme (LFB S.A.),71127-1000,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1 mg/1mL,US,FDA NDC
DB00036,Sevenfact,Laboratoire Français du Fractionnement et des Biotechnologies Société Anonyme (LFB S.A.),71127-5000,"Injection, powder, lyophilized, for solution; Kit",Intravenous,5 mg/1mL,US,FDA NDC
DB00038,Neumega,"Wyeth Bio Pharma Division Of Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc.",58394-004,Kit,Subcutaneous,5 mg/1mL,US,FDA NDC
DB00039,Kepivance,Amgen,55513-520,Injection,Intravenous,6.25 mg/1mL,US,FDA NDC
DB00039,Kepivance,SWEDISH ORPHAN BIOVITRUM AB (PUBL),66658-112,"Injection, powder, lyophilized, for solution",Intravenous,6.25 mg/1.2mL,US,FDA NDC
DB00039,Kepivance,SWEDISH ORPHAN BIOVITRUM AB (PUBL),,"Powder, for solution",Intravenous,6.25 mg / vial,Canada,DPD
DB00039,Kepivance,SWEDISH ORPHAN BIOVITRUM AB (PUBL),66658-113,"Injection, powder, lyophilized, for solution",Intravenous,5.16 mg/1.2mL,US,FDA NDC
DB00040,Baqsimi,Eli Lilly and Company,0002-6145,Powder,Nasal,3 mg/1,US,FDA NDC
DB00040,Baqsimi,Eli Lilly & Co. Ltd.,,Powder,Nasal,3 mg / container,Canada,DPD
DB00040,Baqsimi,"Amphastar Pharmaceuticals, Inc.",0548-8351,Powder,Nasal,3 mg/1,US,FDA NDC
DB00040,Baqsimi,"Amphastar Pharmaceuticals, Inc.",0548-8352,Powder,Nasal,3 mg/1,US,FDA NDC
DB00040,Baqsimi,Eli Lilly Nederland B.V.,,,,3 mg,EU,EMA
DB00040,Baqsimi,Eli Lilly Nederland B.V.,,,,3 mg,EU,EMA
DB00040,Glucag0n,"HF Acquisition Co LLC, DBA HealthFirst",51662-1323,Kit,Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,GlucaGen,Bedford Pharmaceuticals,55390-004,Kit,Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,GlucaGen,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0260,Kit,Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,GlucaGen,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0053,"Injection, powder, for solution",Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,GlucaGen,Novo Nordisk,,"Kit; Powder, for solution",Intramuscular,1 mg / vial,Canada,DPD
DB00040,GlucaGen HypoKit,Novo Nordisk,0169-7065,"Injection, powder, for solution; Kit",Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,GlucaGen HypoKit,Novo Nordisk,,"Kit; Powder, for solution",Intramuscular,1 mg / vial,Canada,DPD
DB00040,Glucagon,"Physicians Total Care, Inc.",54868-5070,Kit,Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,Glucagon,TYA Pharmaceuticals,64725-8031,Kit,Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,Glucagon,A-S Medication Solutions,50090-0639,Kit,Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,Glucagon,"Fresenius Kabi USA, LLC",63323-596,"Injection, powder, lyophilized, for solution",Intramuscular; Intravenous,1 mg/1mL,US,FDA NDC
DB00040,Glucagon,"Fresenius Kabi USA, LLC",63323-582,Kit,Intramuscular; Intravenous,,US,FDA NDC
DB00040,Glucagon,"HF Acquisition Co LLC, DBA HealthFirst",51662-1498,Kit,Intramuscular; Intravenous,,US,FDA NDC
DB00040,Glucagon,Eli Lilly and Company,0002-8031,"Injection, powder, for solution; Kit",Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,Glucagon,"Fresenius Kabi USA, LLC",63323-593,Kit,Intramuscular; Intravenous,,US,FDA NDC
DB00040,Glucagon,"Fresenius Kabi USA, LLC",63323-594,Kit,Intramuscular; Intravenous,,US,FDA NDC
DB00040,Glucagon,"Amphastar Pharmaceuticals, Inc.",0548-5850,"Injection, powder, for solution; Kit",Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,Glucagon,Eli Lilly & Co. Ltd.,,"Kit; Powder, for solution",Intramuscular; Intravenous; Subcutaneous,1 mg / vial,Canada,DPD
DB00040,Glucagon,A-S Medication Solutions,50090-6550,"Injection, powder, for solution; Kit",Intramuscular; Intravenous; Subcutaneous,1 mg/1mL,US,FDA NDC
DB00040,Glucagon Ampoule 666 1mg,Eli Lilly & Co. Ltd.,,"Powder, for solution",Intramuscular; Intravenous; Subcutaneous,1 mg / mL,Canada,DPD
DB00040,Gvoke HypoPen 0.5 mg Auto-Injector,"Xeris Pharmaceuticals, Inc.",72065-120,"Injection, solution",Subcutaneous,0.5 mg/0.1mL,US,FDA NDC
DB00040,Gvoke HypoPen 1 mg Auto-Injector,"Xeris Pharmaceuticals, Inc.",72065-121,"Injection, solution",Subcutaneous,1 mg/0.2mL,US,FDA NDC
DB00040,Gvoke Kit,"Xeris Pharmaceuticals, Inc.",72065-140,"Injection, solution",Subcutaneous,1 mg/0.2mL,US,FDA NDC
DB00040,Gvoke Kit Vial,"Xeris Pharmaceuticals, Inc.",72065-141,"Injection, solution",Subcutaneous,1 mg/0.2mL,US,FDA NDC
DB00040,Gvoke PFS 0.5 mg Pre-filled Syringe,"Xeris Pharmaceuticals, Inc.",72065-130,"Injection, solution",Subcutaneous,0.5 mg/0.1mL,US,FDA NDC
DB00040,Gvoke PFS 1 mg Pre-filled Syringe,"Xeris Pharmaceuticals, Inc.",72065-131,"Injection, solution",Subcutaneous,1 mg/0.2mL,US,FDA NDC
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,0.5 mg,EU,EMA
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,0.5 mg,EU,EMA
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,0.5 mg,EU,EMA
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,0.5 mg,EU,EMA
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,1 mg,EU,EMA
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,1 mg,EU,EMA
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,1 mg,EU,EMA
DB00040,Ogluo,Tetris Pharma B.V,,"Injection, solution",Subcutaneous,1 mg,EU,EMA
DB00041,Proleukin,"Physicians Total Care, Inc.",54868-5596,Injection,Intravenous,1.1 mg/1mL,US,FDA NDC
DB00041,Proleukin,Novartis,0078-0495,Injection,Intravenous,1.1 mg/1mL,US,FDA NDC
DB00041,Proleukin,Prometheus Laboratories Inc.,65483-116,"Injection, powder, lyophilized, for solution",Intravenous,1.1 mg/1mL,US,FDA NDC
DB00041,Proleukin,Clinigen Limited,76310-022,"Injection, powder, lyophilized, for solution",Intravenous,1.1 mg/1mL,US,FDA NDC
DB00041,Proleukin,Sterimax Inc,,"Powder, for solution",Intravenous,22000000 unit / vial,Canada,DPD
DB00041,Proleukin,"Iovance Biotherapeutics, Inc",73776-022,"Injection, powder, lyophilized, for solution",Intravenous,1.1 mg/1mL,US,FDA NDC
DB00042,Myobloc,"Solstice Neurosciences, LLC",10454-710,"Injection, solution",Intramuscular,2500 [USP'U]/0.5mL,US,FDA NDC
DB00042,Myobloc,"Solstice Neurosciences, LLC",10454-711,"Injection, solution",Intramuscular,5000 [USP'U]/1mL,US,FDA NDC
DB00042,Myobloc,"Solstice Neurosciences, LLC",10454-712,"Injection, solution",Intramuscular,10000 [USP'U]/2mL,US,FDA NDC
DB00042,Myobloc,"Solstice Neurosciences, Llc, A Wholly Owned Subsidiary Of Us Worldmeds, Llc",,Solution,Intramuscular,5000 unit / mL,Canada,DPD
DB00042,Neurobloc,Sloan Pharma S.A.R.L,,"Injection, solution",Intramuscular,5000 U/ml,EU,EMA
DB00042,Neurobloc,Sloan Pharma S.A.R.L,,"Injection, solution",Intramuscular,5000 U/ml,EU,EMA
DB00042,Neurobloc,Sloan Pharma S.A.R.L,,"Injection, solution",Intramuscular,5000 U/ml,EU,EMA
DB00042,Neurobloc,Sloan Pharma S.A.R.L,,"Injection, solution",Intramuscular,5000 U/ml,EU,EMA
DB00043,Xolair,Novartis,,"Powder, for solution",Subcutaneous,150 mg / vial,Canada,DPD
DB00043,Xolair,Novartis,,Solution,Subcutaneous,75 mg / 0.5 mL,Canada,DPD
DB00043,Xolair,Novartis,,Solution,Subcutaneous,150 mg / mL,Canada,DPD
DB00043,Xolair,"Genentech, Inc.",50242-040,"Injection, solution",Subcutaneous,150 mg/1.2mL,US,FDA NDC
DB00043,Xolair,"Genentech, Inc.",50242-227,"Injection, solution",Subcutaneous,300 mg/2mL,US,FDA NDC
DB00043,Xolair,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,300 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,300 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,300 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,300 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,300 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,300 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,75 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair,Novartis Europharm Limited,,"Injection, solution",Subcutaneous,150 mg,EU,EMA
DB00043,Xolair PFS,"Genentech, Inc.",50242-214,"Injection, solution",Subcutaneous,75 mg/0.5mL,US,FDA NDC
DB00043,Xolair PFS,"Genentech, Inc.",50242-215,"Injection, solution",Subcutaneous,150 mg/1mL,US,FDA NDC
DB00044,Luveris,Emd Serono,44087-1375,Kit,Subcutaneous,82.5 [iU]/1mL,US,FDA NDC
DB00044,Luveris,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Subcutaneous,75 unit / vial,Canada,DPD
DB00044,Luveris,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,450 unit / 0.72 mL,Canada,DPD
DB00044,Luveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00044,Luveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00044,Luveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00044,Luveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00044,Luveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00044,Luveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00044,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,"Kit; Powder, for solution",Subcutaneous,,Canada,DPD
DB00044,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,,Canada,DPD
DB00044,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,,Canada,DPD
DB00044,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,,Canada,DPD
DB00044,Pergoveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,,EU,EMA
DB00044,Pergoveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,,EU,EMA
DB00044,Pergoveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,,EU,EMA
DB00044,Pergoveris,Merck Europe B.V.,,"Injection, solution",Subcutaneous,,EU,EMA
DB00044,Pergoveris,Merck Europe B.V.,,"Injection, solution",Subcutaneous,,EU,EMA
DB00044,Pergoveris,Merck Europe B.V.,,"Injection, solution",Subcutaneous,,EU,EMA
DB00046,Admelog,REMEDYREPACK INC.,70518-2399,"Injection, solution",Intravenous; Subcutaneous,100 U/1mL,US,FDA NDC
DB00046,Admelog,sanofi-aventis U.S. LLC,0024-5924,"Injection, solution",Intravenous; Subcutaneous,100 U/1mL,US,FDA NDC
DB00046,Admelog,sanofi-aventis U.S. LLC,0024-5925,"Injection, solution",Subcutaneous,100 U/1mL,US,FDA NDC
DB00046,Admelog,sanofi-aventis U.S. LLC,0024-5926,"Injection, solution",Intravenous; Subcutaneous,100 U/1mL,US,FDA NDC
DB00046,Admelog,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Admelog,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Admelog Solostar,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Humalog,"Physicians Total Care, Inc.",54868-5108,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,"Dispensing Solutions, Inc.",55045-3602,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,Eli Lilly and Company,0002-8725,"Injection, suspension",Subcutaneous,100,US,FDA NDC
DB00046,Humalog,REMEDYREPACK INC.,70518-1388,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,REMEDYREPACK INC.,70518-2264,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,A-S Medication Solutions,50090-4488,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,A-S Medication Solutions,50090-1375,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,Eli Lilly and Company,0002-7510,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,Eli Lilly and Company,0002-7516,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,Eli Lilly & Co. Ltd.,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Humalog,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Humalog,Eli Lilly and Company,0002-7533,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog (cartridge),Eli Lilly & Co. Ltd.,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Humalog (kwikpen),Eli Lilly & Co. Ltd.,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Humalog 200 Units/ml Kwikpen,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,200 unit / mL,Canada,DPD
DB00046,Humalog Basal,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Basal,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Basal Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Basal Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Cartridge,"Physicians Total Care, Inc.",54868-5836,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Junior KwikPen,Eli Lilly and Company,0002-7714,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Junior Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Junior Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Junior Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog KwikPen,REMEDYREPACK INC.,70518-1389,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog KwikPen,A-S Medication Solutions,50090-1663,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog KwikPen,Eli Lilly and Company,0002-8799,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog KwikPen,Eli Lilly and Company,0002-7712,"Injection, solution",Subcutaneous,200 [iU]/1mL,US,FDA NDC
DB00046,Humalog KwikPen,A-S Medication Solutions,50090-4073,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,Humalog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,Humalog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,Humalog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,Humalog Mix 25 (cartridge),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 25 (cartridge),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 25 (kwikpen),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 25 (kwikpen),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 25 (pen),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 25 (pen),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 50 (cartridge),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 50 (cartridge),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 50 (kwikpen),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix 50 (kwikpen),Eli Lilly & Co. Ltd.,,Suspension,Subcutaneous,,Canada,DPD
DB00046,Humalog Mix25,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix25,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix25,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix25 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix25 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix50,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix50,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix50,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix50 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix50 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Mix50/50,Eli Lilly and Company,0002-8793,"Injection, suspension",Subcutaneous,100,US,FDA NDC
DB00046,Humalog Mix50/50,Eli Lilly and Company,0002-7512,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Mix50/50 KwikPen,Eli Lilly and Company,0002-8798,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Mix75/25,"Physicians Total Care, Inc.",54868-4381,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Mix75/25,Eli Lilly and Company,0002-8794,"Injection, suspension",Subcutaneous,100,US,FDA NDC
DB00046,Humalog Mix75/25,Eli Lilly and Company,0002-7511,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Mix75/25 KwikPen,Eli Lilly and Company,0002-8797,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Pen,"Physicians Total Care, Inc.",54868-5899,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Pen,Eli Lilly & Co. Ltd.,,Liquid,Intramuscular; Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Humalog Tempo Pen,Eli Lilly and Company,0002-8213,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Humalog Tempo Pen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Humalog Tempo Pen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin lispro,REMEDYREPACK INC.,70518-2398,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro,Eli Lilly and Company,0002-7737,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin lispro,ImClone LLC,66733-773,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro,REMEDYREPACK INC.,70518-2802,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro,A-S Medication Solutions,50090-5391,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro Junior KwikPen,Eli Lilly and Company,0002-7752,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro KwikPen,Eli Lilly and Company,0002-8222,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro KwikPen,ImClone LLC,66733-822,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen,Eli Lilly and Company,0002-8233,"Injection, suspension",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Insulin Lispro Sanofi,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprelog,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Liprelog,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Liprelog,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Liprelog,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Liprolog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Basal,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Basal,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Basal Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Basal Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Junior Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Junior Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,Liprolog Kwikpen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,Liprolog Mix25,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Mix25,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Mix25 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Mix25 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Mix50,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Mix50,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Mix50 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Liprolog Mix50 Kwikpen,Eli Lilly Nederland B.V.,,"Injection, suspension",Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly and Company,0002-7728,"Injection, solution",Intravenous; Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Lyumjev,Eli Lilly and Company,0002-7726,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,Lyumjev,Eli Lilly & Co. Ltd.,,Solution,Intravenous; Subcutaneous,300 unit / 3 mL,Canada,DPD
DB00046,Lyumjev,Eli Lilly & Co. Ltd.,,Solution,Intravenous; Subcutaneous,100 unit / mL,Canada,DPD
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",Intravenous; Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",,100 U/ml,EU,EMA
DB00046,Lyumjev,Eli Lilly Nederland B.V.,,"Injection, solution",,200 U/ml,EU,EMA
DB00046,Lyumjev (kwikpen),Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,Lyumjev (kwikpen),Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,200 U/ml,EU,EMA
DB00046,LYUMJEV Junior KwikPen,Eli Lilly and Company,0002-8351,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,LYUMJEV Junior KwikPen,Eli Lilly & Co. Ltd.,,Solution,Intravenous; Subcutaneous,300 unit / 3 mL,Canada,DPD
DB00046,LYUMJEV KwikPen,Eli Lilly and Company,0002-8207,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,LYUMJEV KwikPen,Eli Lilly and Company,0002-8228,"Injection, solution",Subcutaneous,200 [iU]/1mL,US,FDA NDC
DB00046,LYUMJEV KwikPen,Eli Lilly & Co. Ltd.,,Solution,Intravenous; Subcutaneous,300 unit / 3 mL,Canada,DPD
DB00046,LYUMJEV KwikPen,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,600 unit / 3 mL,Canada,DPD
DB00046,LYUMJEV Tempo Pen,Eli Lilly and Company,0002-8235,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00046,LYUMJEV Tempo Pen,Eli Lilly & Co. Ltd.,,Solution,Intravenous; Subcutaneous,300 unit / 3 mL,Canada,DPD
DB00046,Lyumjev Tempo Pen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00046,Lyumjev Tempo Pen,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 U/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Abasaglar,Eli Lilly Nederland B.V.,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Basaglar,Eli Lilly and Company,0002-7711,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Basaglar,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Basaglar,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Basaglar,Eli Lilly & Co. Ltd.,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,BASAGLAR KwikPen,Eli Lilly and Company,0002-7715,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,BASAGLAR Tempo Pen,Eli Lilly and Company,0002-8214,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine,Mylan Specialty L.P.,49502-394,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine,Mylan Specialty L.P.,49502-393,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine,Winthrop U.S.,0955-1729,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine,SANOFI-AVENTIS DEUTSCHLAND GMBH,12854-433,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine,A-S Medication Solutions,50090-6184,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine,Biocon Biologics Inc.,83257-015,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine,Biocon Biologics Inc.,83257-014,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine Solostar,Winthrop U.S.,0955-1728,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine Solostar,SANOFI-AVENTIS DEUTSCHLAND GMBH,12854-432,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin Glargine Solostar,A-S Medication Solutions,50090-6178,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Insulin glargine U-300,"Winthrop U.S, a business of sanofi-aventis U.S. LLC",0955-3900,"Injection, solution",Subcutaneous,300 [iU]/1mL,US,FDA NDC
DB00047,Insulin glargine U-300 Max,"Winthrop U.S, a business of sanofi-aventis U.S. LLC",0955-2900,"Injection, solution",Subcutaneous,300 [iU]/1mL,US,FDA NDC
DB00047,Lantus,"Physicians Total Care, Inc.",54868-4626,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,"Physicians Total Care, Inc.",54868-5765,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,"Physicians Total Care, Inc.",54868-6231,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,"Dispensing Solutions, Inc.",55045-3685,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,TYA Pharmaceuticals,64725-2220,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,Remedy Repack,52125-416,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,A-S Medication Solutions,50090-0876,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,REMEDYREPACK INC.,70518-1865,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,sanofi-aventis U.S. LLC,0088-2220,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,sanofi-aventis U.S. LLC,0088-5021,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Lantus,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Lantus,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Lantus,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Lantus,Sanofi Aventis,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Lantus Solostar,REMEDYREPACK INC.,70518-1390,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus Solostar,sanofi-aventis U.S. LLC,0088-2219,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus Solostar,sanofi-aventis U.S. LLC,0088-5020,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus Solostar,A-S Medication Solutions,50090-1398,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Lantus Solostar,A-S Medication Solutions,50090-4068,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Rezvoglar KwikPen,Eli Lilly and Company,0002-8980,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Rezvoglar Kwikpen,A-S Medication Solutions,50090-6439,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,Mylan Specialty L.P.,49502-196,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,Mylan Specialty L.P.,49502-195,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,Mylan Specialty L.P.,49502-251,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,Mylan Specialty L.P.,49502-250,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,A-S Medication Solutions,50090-5835,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,Biocon Sdn.Bhd,,Solution,Subcutaneous,100 unit / mL,Canada,DPD
DB00047,Semglee,Biocon Biologics Inc.,83257-012,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,Biocon Biologics Inc.,83257-011,"Injection, solution",Subcutaneous,100 [iU]/1mL,US,FDA NDC
DB00047,Semglee,Viatris Limited,,"Injection, solution",,100 Units/ml,EU,EMA
DB00047,Semglee,Viatris Limited,,"Injection, solution",,100 Units/ml,EU,EMA
DB00047,Semglee,Viatris Limited,,"Injection, solution",,100 Units/ml,EU,EMA
DB00047,Semglee,Viatris Limited,,"Injection, solution",,100 Units/ml,EU,EMA
DB00047,Soliqua,Sanofi Aventis,,Solution,Subcutaneous,,Canada,DPD
DB00047,Soliqua 100/33,sanofi-aventis U.S. LLC,0024-5761,"Injection, solution",Subcutaneous,,US,FDA NDC
DB00047,Suliqua,SANOFI WINTHROP INDUSTRIE,,,Subcutaneous,,EU,EMA
DB00047,Suliqua,SANOFI WINTHROP INDUSTRIE,,,Subcutaneous,,EU,EMA
DB00047,Suliqua,SANOFI WINTHROP INDUSTRIE,,,Subcutaneous,,EU,EMA
DB00047,Suliqua,SANOFI WINTHROP INDUSTRIE,,,Subcutaneous,,EU,EMA
DB00047,Suliqua,SANOFI WINTHROP INDUSTRIE,,,Subcutaneous,,EU,EMA
DB00047,Suliqua Pen,SANOFI WINTHROP INDUSTRIE,,"Injection, solution",Subcutaneous,,EU,EMA
DB00047,Toujeo,sanofi-aventis U.S. LLC,0024-5869,"Injection, solution",Subcutaneous,300 U/1mL,US,FDA NDC
DB00047,Toujeo,A-S Medication Solutions,50090-2193,"Injection, solution",Subcutaneous,300 U/1mL,US,FDA NDC
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,100 Units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo,Sanofi Aventis Deutschland Gmb H,,"Injection, solution",Subcutaneous,300 units/ml,EU,EMA
DB00047,Toujeo Doublestar,Sanofi Aventis,,Solution,Subcutaneous,300 unit / mL,Canada,DPD
DB00047,TOUJEO Max,A-S Medication Solutions,50090-4177,"Injection, solution",Subcutaneous,300 U/1mL,US,FDA NDC
DB00047,TOUJEO Max,sanofi-aventis U.S. LLC,0024-5871,"Injection, solution",Subcutaneous,300 U/1mL,US,FDA NDC
DB00047,Toujeo Solostar,Sanofi Aventis,,Solution,Subcutaneous,300 unit / mL,Canada,DPD
DB00048,Collagen Film,"Shantou Youjia E-Commerce Co.,Ltd.",84067-069,Patch,Cutaneous,,US,FDA NDC
DB00048,Collagenase Santyl,Healthpoint,0064-5010,Ointment,Topical,250 [arb'U]/1g,US,FDA NDC
DB00048,Collagenase Santyl,"SMITH & NEPHEW, INC",50484-010,Ointment,Topical,250 [arb'U]/1g,US,FDA NDC
DB00048,Kimchi Vitamin chewable multivitamin,Tobico,52102-1001,"Tablet, chewable",Oral,,US,FDA NDC
DB00048,Qwo,Endo Aesthetics LLC,73611-300,"Injection, powder, lyophilized, for solution",Intralesional,0.23 mg/1mL,US,FDA NDC
DB00048,Santyl,"Smith & Nephew, Inc.",,Ointment,Topical,250 unit / g,Canada,DPD
DB00048,Xiaflex,Endo Pharmaceuticals Inc.,66887-003,"Injection, powder, lyophilized, for solution; Kit",Intralesional,0.9 mg/1,US,FDA NDC
DB00048,Xiaflex,Endo Ventures Ltd,,"Powder, for solution",Intralesional,0.9 mg / vial,Canada,DPD
DB00048,Xiapex,Swedish Orphan Biovitrum Ab,,"Injection, powder, for solution",Intralesional,0.9 mg,EU,EMA
DB00049,Elitek,sanofi-aventis U.S. LLC,0024-5150,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1.5 mg/1mL,US,FDA NDC
DB00049,Elitek,sanofi-aventis U.S. LLC,0024-5151,"Injection, powder, lyophilized, for solution; Kit",Intravenous,7.5 mg/5mL,US,FDA NDC
DB00049,Fasturtec,Sanofi Aventis,,"Powder, for solution",Intravenous,1.5 mg / vial,Canada,DPD
DB00049,Fasturtec,Sanofi Aventis,,"Powder, for solution",Intravenous,7.5 mg / vial,Canada,DPD
DB00049,Fasturtec,SANOFI WINTHROP INDUSTRIE,,"Injection, powder, for solution",Intravenous,1.5 mg/ml,EU,EMA
DB00049,Fasturtec,SANOFI WINTHROP INDUSTRIE,,"Injection, powder, for solution",Intravenous,1.5 mg/ml,EU,EMA
DB00050,Cetrorelix,Akorn,17478-793,Kit,Subcutaneous,0.25 mg/1mL,US,FDA NDC
DB00050,Cetrorelix,"Teva Pharmaceuticals, Inc.",0480-5795,Kit,Subcutaneous,0.25 mg/1mL,US,FDA NDC
DB00050,Cetrotide,"EMD Serono, Inc.",44087-1203,Kit,Subcutaneous,3 mg/3mL,US,FDA NDC
DB00050,Cetrotide,"EMD Serono, Inc.",44087-1225,Kit,Subcutaneous,0.25 mg/1mL,US,FDA NDC
DB00050,Cetrotide,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Subcutaneous,0.25 mg / vial,Canada,DPD
DB00050,Cetrotide,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Subcutaneous,3 mg / vial,Canada,DPD
DB00050,Cetrotide,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,0.25 mg,EU,EMA
DB00050,Cetrotide,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,0.25 mg,EU,EMA
DB00051,Abrilada,Pfizer Canada Ulc,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Abrilada,Pfizer Canada Ulc,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Abrilada,Pfizer Canada Ulc,,Solution,Subcutaneous,20 mg / 0.4 mL,Canada,DPD
DB00051,Abrilada,Pfizer Canada Ulc,,Solution,Subcutaneous,10 mg / 0.2 mL,Canada,DPD
DB00051,Abrilada,Pfizer Canada Ulc,,Kit; Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Abrilada,"Catalent Indiana, LLC",61434-053,"Injection, solution",Subcutaneous,20 mg/0.4mL,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0069-0325,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0069-0328,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0069-0333,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0069-0347,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0069-0319,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0025-0325,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0025-0328,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0025-0333,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0025-0347,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Abrilada,Pfizer Laboratories Div Pfizer Inc,0025-0319,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Adalimumab,Sandoz Inc.,61314-327,"Injection, solution",Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Adalimumab,Mylan Specialty L.P.,49502-417,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab,Mylan Specialty L.P.,49502-418,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab,Mylan Specialty L.P.,49502-416,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab,"Golden State Medical Supply, Inc.",51407-835,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab,"Golden State Medical Supply, Inc.",51407-834,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab,"CELLTRION USA, INC.",72606-022,Injection,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Adalimumab,"CELLTRION USA, INC.",72606-040,Injection,Subcutaneous,80 mg/0.8mL,US,FDA NDC
DB00051,Adalimumab,"CELLTRION USA, INC.",72606-041,Injection,Subcutaneous,20 mg/0.2mL,US,FDA NDC
DB00051,Adalimumab-aacf,"Fresenius Kabi USA, LLC",65219-612,Kit,Subcutaneous,,US,FDA NDC
DB00051,Adalimumab-adbm,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0595,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab-adbm,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0555,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab-adbm,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0585,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Adalimumab-adbm,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0545,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Amgevita,Amgen,,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00051,Amgevita,Amgen,,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00051,Amgevita,Amgen,,Solution,Subcutaneous,50 mg / mL,Canada,DPD
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amgevita,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amjevita,AMGEN INC,55513-411,Injection,Subcutaneous,20 mg/0.4mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-410,Injection,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-400,Injection,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Amjevita,Amgen USA Inc.,72511-400,Injection,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Amjevita,A-S Medication Solutions,50090-6411,Injection,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-413,Injection,Subcutaneous,10 mg/0.2mL,US,FDA NDC
DB00051,Amjevita,A-S Medication Solutions,50090-6428,Injection,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-399,Injection,Subcutaneous,20 mg/0.2mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-479,Injection,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-480,Injection,Subcutaneous,80 mg/0.8mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-482,Injection,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Amjevita,AMGEN INC,55513-481,Injection,Subcutaneous,80 mg/0.8mL,US,FDA NDC
DB00051,Amjevita,Amgen USA Inc.,72511-482,Injection,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Amsparity,Pfizer Europe Ma Eeig,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Cyltezo,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0370,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Cyltezo,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0405,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Cyltezo,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0400,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Cyltezo,"Boehringer Ingelheim Pharmaceuticals, Inc.",0597-0375,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Cyltezo,Boehringer Ingelheim,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Cyltezo,Boehringer Ingelheim,,Injection,Subcutaneous,40 mg,EU,EMA
DB00051,Cyltezo,Boehringer Ingelheim,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Cyltezo,Boehringer Ingelheim,,Injection,Subcutaneous,40 mg,EU,EMA
DB00051,Cyltezo,Boehringer Ingelheim,,,,40 mg,EU,EMA
DB00051,Cyltezo,Boehringer Ingelheim,,,,40 mg,EU,EMA
DB00051,Cyltezo,Boehringer Ingelheim,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Cyltezo,Boehringer Ingelheim,,Injection,Subcutaneous,40 mg,EU,EMA
DB00051,Hadlima,"Samsung Bioepis Co., Ltd.",,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Hadlima,"Samsung Bioepis Co., Ltd.",,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Hadlima,Merck Sharp & Dohme Corp.,0006-5031,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hadlima,Merck Sharp & Dohme Corp.,0006-5032,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hadlima,Organon LLC,78206-183,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hadlima,Organon LLC,78206-184,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hadlima,Organon LLC,78206-185,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hadlima,Organon LLC,78206-186,Solution,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Hadlima,Organon LLC,78206-187,Solution,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Hadlima,A-S Medication Solutions,50090-6704,Solution,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Hadlima,A-S Medication Solutions,50090-6706,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hadlima,A-S Medication Solutions,50090-6707,Solution,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Hadlima,A-S Medication Solutions,50090-6705,Solution,Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hadlima Pushtouch,"Samsung Bioepis Co., Ltd.",,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Hadlima Pushtouch,"Samsung Bioepis Co., Ltd.",,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Halimatoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Halimatoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Halimatoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Halimatoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Halimatoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Halimatoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Halimatoz,Sandoz,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Hefiya,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hukyndra,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hukyndra,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hukyndra,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hukyndra,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hukyndra,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hukyndra,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hukyndra,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,Solution,Subcutaneous,20 mg / 0.4 mL,Canada,DPD
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Hulio,Mylan Specialty L.P.,49502-381,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Hulio,Mylan Specialty L.P.,49502-382,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Hulio,Mylan Specialty L.P.,49502-380,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Hulio,Biocon Biologics Inc,83257-016,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Hulio,Biocon Biologics Inc,83257-017,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Hulio,Biocon Biologics Inc,83257-019,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,50 mg/ml,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,50 mg/ml,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hulio,Biosimilar Collaborations Ireland Limited,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,A-S Medication Solutions,50090-4487,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-3799,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-6347,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-4339,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-9374,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-0243,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-0554,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-0067,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-0067,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-2540,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-0124,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-1539,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-1539,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-0616,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-0817,"Injection, suspension; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,AbbVie Inc.,0074-3797,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Humira,A-S Medication Solutions,50090-3530,"Injection, solution; Kit",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,Abbvie,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Humira,Abbvie,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Humira,Abbvie,,Solution,Subcutaneous,80 mg / 0.8 mL,Canada,DPD
DB00051,Humira,Abbvie,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Humira,Abbvie,,Solution,Subcutaneous,80 mg / 0.8 mL,Canada,DPD
DB00051,Humira,Abbvie,,Solution,Subcutaneous,10 mg / 0.1 mL,Canada,DPD
DB00051,Humira,Abbvie,,Solution,Subcutaneous,20 mg / 0.2 mL,Canada,DPD
DB00051,Humira,Cordavis Limited,83457-554,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,Cordavis Limited,83457-124,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,Cordavis Limited,83457-243,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,Cordavis Limited,83457-616,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,Cordavis Limited,83457-817,"Injection, solution; Kit; Swab",Subcutaneous; Topical,,US,FDA NDC
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Humira,Abb Vie Deutschland Gmb H  Co. Kg,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,20 mg / 0.4 mL,Canada,DPD
DB00051,Hyrimoz,Sandoz Inc,61314-454,"Injection, solution",Subcutaneous,80 mg/0.8mL,US,FDA NDC
DB00051,Hyrimoz,Sandoz Inc,61314-473,"Injection, solution",Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Hyrimoz,Sandoz Inc,61314-476,"Injection, solution",Subcutaneous,20 mg/0.2mL,US,FDA NDC
DB00051,Hyrimoz,Sandoz Inc,61314-509,"Injection, solution",Subcutaneous,10 mg/0.1mL,US,FDA NDC
DB00051,Hyrimoz,Sandoz Inc,61314-517,"Injection, solution; Kit",Subcutaneous,,US,FDA NDC
DB00051,Hyrimoz,Sandoz Inc,61314-517,"Injection, solution; Kit",Subcutaneous,,US,FDA NDC
DB00051,Hyrimoz,Sandoz Inc,61314-531,"Injection, solution; Kit",Subcutaneous,,US,FDA NDC
DB00051,Hyrimoz,Sandoz Inc,61314-531,"Injection, solution; Kit",Subcutaneous,,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-100,"Injection, solution",Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-101,"Injection, solution",Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-102,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-103,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,20 mg / 0.2 mL,Canada,DPD
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,80 mg / 0.8 mL,Canada,DPD
DB00051,Hyrimoz,Sandoz Canada Incorporated,,Solution,Subcutaneous,80 mg / 0.8 mL,Canada,DPD
DB00051,Hyrimoz,Cordavis Limited,83457-108,"Injection, solution",Subcutaneous,20 mg/0.2mL,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-107,"Injection, solution",Subcutaneous,80 mg/0.8mL,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-113,"Injection, solution",Subcutaneous,80 mg/0.8mL,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-112,"Injection, solution; Kit",Subcutaneous,,US,FDA NDC
DB00051,Hyrimoz,Cordavis Limited,83457-112,"Injection, solution; Kit",Subcutaneous,,US,FDA NDC
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Hyrimoz,Sandoz,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Idacio,Fresenius Kabi,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Idacio,Fresenius Kabi,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Idacio,Fresenius Kabi,,Solution,Subcutaneous,40 mg / 0.8 mL,Canada,DPD
DB00051,Idacio,"Fresenius Kabi USA, LLC",65219-554,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Idacio,"Fresenius Kabi USA, LLC",65219-556,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Idacio,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Idacio,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Idacio,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Idacio,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Idacio,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Imraldi,"Samsung Bioepis Co., Ltd.",71202-002,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Imraldi,Samsung Bioepis Nl B.V.,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Kromeya,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg/0.8ml,EU,EMA
DB00051,Kromeya,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Kromeya,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Kromeya,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Kromeya,Fresenius Kabi Deutschland Gmb H,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Libmyris,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Libmyris,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Libmyris,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Libmyris,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Libmyris,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Libmyris,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Libmyris,Stada Arzneimittel Ag,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Sb5 (biib606),"Catalent Indiana, LLC",61434-005,"Injection, solution",Intravenous,40 mg/0.8mL,US,FDA NDC
DB00051,Simlandi,Jamp Pharma Corporation,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Simlandi,Jamp Pharma Corporation,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Simlandi,Jamp Pharma Corporation,,Solution,Subcutaneous,80 mg / 0.8 mL,Canada,DPD
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,20 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Solymbic,Amgen Europe B.V.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Yuflyma,Celltrion,,Solution,Subcutaneous,40 mg / 0.4 mL,Canada,DPD
DB00051,Yuflyma,Celltrion,,Solution,Subcutaneous,80 mg / 0.8 mL,Canada,DPD
DB00051,Yuflyma,Celltrion,,Solution,Subcutaneous,80 mg / 0.8 mL,Canada,DPD
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-030,Injection,Subcutaneous,40 mg/0.4mL,US,FDA NDC
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-023,Injection,Subcutaneous,80 mg/0.8mL,US,FDA NDC
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-024,Injection,Subcutaneous,20 mg/0.2mL,US,FDA NDC
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-021,Injection,Subcutaneous,20 mg/0.2mL,US,FDA NDC
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-046,Injection; Kit,Subcutaneous,,US,FDA NDC
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-046,Injection; Kit,Subcutaneous,,US,FDA NDC
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-039,Injection; Kit,Subcutaneous,,US,FDA NDC
DB00051,Yuflyma,"CELLTRION USA, INC.",72606-039,Injection; Kit,Subcutaneous,,US,FDA NDC
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,40 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Yuflyma,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,80 mg,EU,EMA
DB00051,Yusimry,Coherus BioSciences Inc,70114-210,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00051,Yusimry,Coherus BioSciences Inc,70114-220,"Injection, solution",Subcutaneous,40 mg/0.8mL,US,FDA NDC
DB00052,Bio-tropin,Novopharm Limited,,"Liquid; Powder, for solution",Subcutaneous,,Canada,DPD
DB00052,Bio-tropin,Novopharm Limited,,"Liquid; Powder, for solution",Subcutaneous,,Canada,DPD
DB00052,Genotropin,"Physicians Total Care, Inc.",54868-5601,Kit,Subcutaneous,0.2 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,"Physicians Total Care, Inc.",54868-5634,Kit,Subcutaneous,0.4 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,"Physicians Total Care, Inc.",54868-5917,Kit,Subcutaneous,0.6 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,"Physicians Total Care, Inc.",54868-5760,Kit,Subcutaneous,0.8 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2626,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,5 mg/1mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2646,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,12 mg/1mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2649,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,0.2 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2650,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,0.4 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2651,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,0.6 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2652,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,0.8 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2653,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,1 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2654,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,1.2 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2655,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,1.4 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2656,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,1.6 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2657,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,1.8 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Laboratories Div Pfizer Inc,0013-2658,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,2 mg/0.25mL,US,FDA NDC
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,5.3 mg / pen,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,12 mg / pen,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,0.6 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,0.8 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,1 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,1.2 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,1.4 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,1.6 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,1.8 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,2 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,5 mg / pen,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,0.2 mg / syr,Canada,DPD
DB00052,Genotropin,Pfizer Canada Ulc,,"Powder, for solution",Subcutaneous,0.4 mg / syr,Canada,DPD
DB00052,Humatrope,Eli Lilly and Company,0002-7335,Kit,Intramuscular; Subcutaneous,5 mg/5mL,US,FDA NDC
DB00052,Humatrope,Eli Lilly and Company,0002-8147,Kit,Intramuscular; Subcutaneous,6 mg/2.88mL,US,FDA NDC
DB00052,Humatrope,Eli Lilly and Company,0002-8148,Kit,Intramuscular; Subcutaneous,12 mg/2.88mL,US,FDA NDC
DB00052,Humatrope,Eli Lilly and Company,0002-8149,Kit,Intramuscular; Subcutaneous,24 mg/2.88mL,US,FDA NDC
DB00052,Humatrope,Eli Lilly & Co. Ltd.,,"Powder, for solution",Intramuscular; Subcutaneous,5 mg / vial,Canada,DPD
DB00052,Humatrope,Eli Lilly & Co. Ltd.,,"Liquid; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00052,Humatrope,Eli Lilly & Co. Ltd.,,"Liquid; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00052,Humatrope,Eli Lilly & Co. Ltd.,,"Liquid; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00052,Norditropin,Novo Nordisk Inc.,0169-7768,"Injection, solution",Subcutaneous,5 mg/1.5mL,US,FDA NDC
DB00052,Norditropin,Novo Nordisk Inc.,0169-7769,"Injection, solution",Subcutaneous,10 mg/1.5mL,US,FDA NDC
DB00052,Norditropin,Novo Nordisk Inc.,0169-7770,"Injection, solution",Subcutaneous,15 mg/1.5mL,US,FDA NDC
DB00052,Norditropin,"Physicians Total Care, Inc.",54868-6146,"Injection, solution",Subcutaneous,5 mg/1.5mL,US,FDA NDC
DB00052,Norditropin,Novo Nordisk,0169-7704,"Injection, solution",Subcutaneous,5 mg/1.5mL,US,FDA NDC
DB00052,Norditropin,Novo Nordisk,0169-7705,"Injection, solution",Subcutaneous,10 mg/1.5mL,US,FDA NDC
DB00052,Norditropin,Novo Nordisk,0169-7708,"Injection, solution",Subcutaneous,15 mg/1.5mL,US,FDA NDC
DB00052,Norditropin,Novo Nordisk,0169-7703,"Injection, solution",Subcutaneous,30 mg/3mL,US,FDA NDC
DB00052,Norditropin Flexpro,Novo Nordisk,,Solution,Subcutaneous,5 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Flexpro,Novo Nordisk,,Solution,Subcutaneous,10 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Flexpro,Novo Nordisk,,Solution,Subcutaneous,15 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Nordiflex,Novo Nordisk,,Solution,Subcutaneous,10 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Nordiflex,Novo Nordisk,,Solution,Subcutaneous,5 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Nordiflex,Novo Nordisk,,Solution,Subcutaneous,15 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Simplexx,Novo Nordisk,,Solution,Subcutaneous,15 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Simplexx,Novo Nordisk,,Solution,Subcutaneous,10 mg / 1.5 mL,Canada,DPD
DB00052,Norditropin Simplexx,Novo Nordisk,,Solution,Subcutaneous,5 mg / 1.5 mL,Canada,DPD
DB00052,Nutropin,"Genentech, Inc.",50242-072,Kit,Subcutaneous,5 mg/5mg,US,FDA NDC
DB00052,Nutropin,"Genentech, Inc.",50242-018,Kit,Subcutaneous,10 mg/10mg,US,FDA NDC
DB00052,Nutropin - Kit Pws(10mg) & Liq(10ml) Im Sc,Hoffmann La Roche,,"Kit; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00052,Nutropin - Kit Pws(5mg) & Liq(10ml) Im Sc,Hoffmann La Roche,,"Kit; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00052,Nutropin AQ,"Genentech, Inc.",50242-022,"Injection, solution",Subcutaneous,10 mg/2mL,US,FDA NDC
DB00052,Nutropin AQ - Sc 5mg/ml,Hoffmann La Roche,,Liquid,Subcutaneous,5 mg / mL,Canada,DPD
DB00052,Nutropin AQ NuSpin 10,"Genentech, Inc.",50242-074,"Injection, solution",Subcutaneous,10 mg/2mL,US,FDA NDC
DB00052,Nutropin AQ NuSpin 10,Hoffmann La Roche,,Solution,Subcutaneous,10 mg / 2 mL,Canada,DPD
DB00052,Nutropin AQ NuSpin 20,"Genentech, Inc.",50242-076,"Injection, solution",Subcutaneous,20 mg/2mL,US,FDA NDC
DB00052,Nutropin AQ NuSpin 20,Hoffmann La Roche,,Solution,Subcutaneous,20 mg / 2 mL,Canada,DPD
DB00052,Nutropin AQ NuSpin 5,"Genentech, Inc.",50242-075,"Injection, solution",Subcutaneous,5 mg/2mL,US,FDA NDC
DB00052,Nutropin AQ NuSpin 5,Hoffmann La Roche,,Solution,Subcutaneous,5 mg / 2 mL,Canada,DPD
DB00052,Nutropin AQ Pen 10,"Genentech, Inc.",50242-043,"Injection, solution",Subcutaneous,10 mg/2mL,US,FDA NDC
DB00052,Nutropin AQ Pen 20,"Genentech, Inc.",50242-073,"Injection, solution",Subcutaneous,20 mg/2mL,US,FDA NDC
DB00052,Nutropin AQ Pen Cartridge,Hoffmann La Roche,,Solution,Subcutaneous,10 mg / 2 mL,Canada,DPD
DB00052,Nutropin Depot,"Genentech, Inc.",50242-032,Kit,Subcutaneous,13.5 mg/1mL,US,FDA NDC
DB00052,Nutropin Depot,"Genentech, Inc.",50242-034,Kit,Subcutaneous,18 mg/1mL,US,FDA NDC
DB00052,Nutropin Depot,"Genentech, Inc.",50242-036,Kit,Subcutaneous,22.5 mg/1mL,US,FDA NDC
DB00052,Nutropinaq,Ipsen Pharma,,"Injection, solution",Subcutaneous,10 mg/2ml,EU,EMA
DB00052,Nutropinaq,Ipsen Pharma,,"Injection, solution",Subcutaneous,10 mg/2ml,EU,EMA
DB00052,Nutropinaq,Ipsen Pharma,,"Injection, solution",Subcutaneous,10 mg/2ml,EU,EMA
DB00052,Omnitrope,Sandoz,0781-4002,Kit,Subcutaneous,1.5 mg/1.13mL,US,FDA NDC
DB00052,Omnitrope,Sandoz Inc,0781-3001,"Injection, solution",Subcutaneous,5 mg/1.5mL,US,FDA NDC
DB00052,Omnitrope,Sandoz Inc,0781-3004,"Injection, solution",Subcutaneous,10 mg/1.5mL,US,FDA NDC
DB00052,Omnitrope,Sandoz Inc,0781-4004,Kit,Subcutaneous,5.8 mg/1mL,US,FDA NDC
DB00052,Omnitrope,Sandoz Canada Incorporated,,Solution,Subcutaneous,5 mg / 1.5 mL,Canada,DPD
DB00052,Omnitrope,Sandoz Canada Incorporated,,Solution,Subcutaneous,10 mg / 1.5 mL,Canada,DPD
DB00052,Omnitrope,Sandoz Canada Incorporated,,"Kit; Powder, for solution",Subcutaneous,,Canada,DPD
DB00052,Omnitrope,Sandoz Canada Incorporated,,Solution,Subcutaneous,15 mg / 1.5 mL,Canada,DPD
DB00052,Omnitrope,Sandoz,,"Injection, powder, for solution",Subcutaneous,1.3 mg/ml,EU,EMA
DB00052,Omnitrope,Sandoz,,"Injection, powder, for solution",Subcutaneous,5 mg/ml,EU,EMA
DB00052,Omnitrope,Sandoz,,"Injection, powder, for solution",Subcutaneous,5 mg/ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,5 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,5 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,5 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,10 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,10 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,10 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,15 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,15 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,15 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,5 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,5 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,5 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,10 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,10 mg/1.5ml,EU,EMA
DB00052,Omnitrope,Sandoz,,Injection,Subcutaneous,10 mg/1.5ml,EU,EMA
DB00052,Saizen,"EMD Serono, Inc.",44087-1005,Kit,Intramuscular; Subcutaneous,5 mg/3mL,US,FDA NDC
DB00052,Saizen,"EMD Serono, Inc.",44087-1088,Kit,Intramuscular; Subcutaneous,8.8 mg/3mL,US,FDA NDC
DB00052,Saizen,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,5 mg / vial,Canada,DPD
DB00052,Saizen,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,5.83 mg / mL,Canada,DPD
DB00052,Saizen,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,8 mg / mL,Canada,DPD
DB00052,Saizen,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,8 mg / mL,Canada,DPD
DB00052,Saizen 10iu - Kit,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00052,Saizen 8.8mg (5.83mg/ml),"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Subcutaneous,8.8 mg / vial,Canada,DPD
DB00052,Saizen Clickeasy,"EMD Serono, Inc.",44087-1080,Kit,Intramuscular; Subcutaneous,8.8 mg/1.51mL,US,FDA NDC
DB00052,Saizenprep,"EMD Serono, Inc.",44087-0016,Kit,Intramuscular; Subcutaneous,8.8 mg/1.51mL,US,FDA NDC
DB00052,Serostim,"EMD Serono, Inc.",44087-0088,Kit,Subcutaneous,8.8 mg/2mL,US,FDA NDC
DB00052,Serostim,"EMD Serono, Inc.",44087-0004,Kit,Subcutaneous,4 mg/1mL,US,FDA NDC
DB00052,Serostim,"EMD Serono, Inc.",44087-0005,Kit,Subcutaneous,5 mg/1mL,US,FDA NDC
DB00052,Serostim,"EMD Serono, Inc.",44087-0006,Kit,Subcutaneous,6 mg/1mL,US,FDA NDC
DB00052,Serostim,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Subcutaneous,,Canada,DPD
DB00052,Serostim,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Subcutaneous,,Canada,DPD
DB00052,Somatropin Biopartners,Bio Partners Gmb H,,"Injection, powder, for suspension, extended release",Subcutaneous,2 mg,EU,EMA
DB00052,Somatropin Biopartners,Bio Partners Gmb H,,"Injection, powder, for suspension, extended release",Subcutaneous,4 mg,EU,EMA
DB00052,Somatropin Biopartners,Bio Partners Gmb H,,"Injection, powder, for suspension, extended release",Subcutaneous,7 mg,EU,EMA
DB00052,Somatropin Biopartners,Bio Partners Gmb H,,"Injection, powder, for suspension, extended release",Subcutaneous,10 mg,EU,EMA
DB00052,Somatropin Biopartners,Bio Partners Gmb H,,"Injection, powder, for suspension, extended release",Subcutaneous,10 mg,EU,EMA
DB00052,Somatropin Biopartners,Bio Partners Gmb H,,"Injection, powder, for suspension, extended release",Subcutaneous,20 mg,EU,EMA
DB00052,Somatropin Biopartners,Bio Partners Gmb H,,"Injection, powder, for suspension, extended release",Subcutaneous,20 mg,EU,EMA
DB00052,Tev-tropin,Teva,57844-713,Kit,Subcutaneous,5 mg/1,US,FDA NDC
DB00052,Tev-tropin,Teva,57844-716,Kit,Subcutaneous,10 mg/1,US,FDA NDC
DB00052,Tev-tropin,Gate Pharmaceuticals,57844-714,Kit,Subcutaneous,10 mg/10mL,US,FDA NDC
DB00052,Valtropin,Bio Partners Gmb H,,"Injection, powder, for solution",Subcutaneous,15 mg/1.5ml,EU,EMA
DB00052,Zomacton,Ferring Pharmaceuticals Inc.,55566-1801,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,5 mg/1,US,FDA NDC
DB00052,Zomacton,Ferring Pharmaceuticals Inc.,55566-1902,Kit,Subcutaneous,10 mg/1,US,FDA NDC
DB00052,Zomacton,Ferring Pharmaceuticals Inc.,55566-1901,Kit,Subcutaneous,10 mg/1,US,FDA NDC
DB00052,Zorbtive,"EMD Serono, Inc.",44087-3388,Kit,Subcutaneous,8.8 mg/1mL,US,FDA NDC
DB00053,Cerezyme,Genzyme Corporation,58468-1983,"Injection, powder, lyophilized, for solution",Intravenous,40 U/1mL,US,FDA NDC
DB00053,Cerezyme,Genzyme Corporation,58468-4663,"Injection, powder, lyophilized, for solution",Intravenous,40 U/1mL,US,FDA NDC
DB00053,Cerezyme,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,"Powder, for solution",Intravenous,400 unit / vial,Canada,DPD
DB00053,Cerezyme,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,"Powder, for solution",Intravenous,200 unit / vial,Canada,DPD
DB00053,Cerezyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,400 U,EU,EMA
DB00053,Cerezyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,400 U,EU,EMA
DB00053,Cerezyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,400 U,EU,EMA
DB00054,Reopro,Eli Lilly and Company,0002-7140,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00054,Reopro,"Janssen Biotech, Inc.",57894-200,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00054,Reopro,Janssen Pharmaceuticals,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00055,Xigris,Eli Lilly & Co. Ltd.,0002-7559,"Injection, powder, lyophilized, for solution",Intravenous,5 mg/2.5mL,US,FDA NDC
DB00055,Xigris,Eli Lilly & Co. Ltd.,0002-7561,"Injection, powder, lyophilized, for solution",Intravenous,20 mg/10mL,US,FDA NDC
DB00055,Xigris,Eli Lilly Nederland B.V.,,"Injection, powder, for solution",Intravenous,5 mg,EU,EMA
DB00055,Xigris,Eli Lilly Nederland B.V.,,"Injection, powder, for solution",Intravenous,20 mg,EU,EMA
DB00055,Xigris (20mg/vial),Eli Lilly & Co. Ltd.,,"Powder, for solution",Intravenous,20 mg / vial,Canada,DPD
DB00055,Xigris (5mg/vial),Eli Lilly & Co. Ltd.,,"Powder, for solution",Intravenous,5 mg / vial,Canada,DPD
DB00056,Mylotarg,"Wyeth Pharmaceuticals Llc, a Subsidiary of Pfizer Inc.",0008-4510,"Injection, powder, lyophilized, for solution",Intravenous,5 mg/5mL,US,FDA NDC
DB00056,Mylotarg,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,4.5 mg / vial,Canada,DPD
DB00056,Mylotarg,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,5 mg,EU,EMA
DB00058,Alpha1-proteinase Inhibitor (human),Grifols Therapeutics Llc,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00058,Alpha1-proteinase Inhibitor (human),Grifols Therapeutics Llc,,"Powder, for solution",Intravenous,1 g / vial,Canada,DPD
DB00058,Aralast NP,Baxter Laboratories,0944-2812,Kit,Intravenous,16 mg/1mL,US,FDA NDC
DB00058,Aralast NP,Baxter Laboratories,0944-2822,Kit,Intravenous,16 mg/1mL,US,FDA NDC
DB00058,Aralast NP,Baxter Laboratories,0944-2802,Kit,Intravenous,16 mg/1mL,US,FDA NDC
DB00058,Aralast NP,"Takeda Pharmaceuticals America, Inc.",0944-2814,"Injection, powder, lyophilized, for solution; Kit",Intravenous,16 mg/1mL,US,FDA NDC
DB00058,Aralast NP,"Takeda Pharmaceuticals America, Inc.",0944-2815,"Injection, powder, lyophilized, for solution; Kit",Intravenous,16 mg/1mL,US,FDA NDC
DB00058,Glassia,"Takeda Pharmaceuticals America, Inc.",0944-2884,"Injection, solution",Intravenous,1 g/50mL,US,FDA NDC
DB00058,Glassia,Takeda,,Solution,Intravenous,1000 mg / 50 mL,Canada,DPD
DB00058,Prolastin Inj 25.0mg/ml,"Cutter Biological, Division Of Miles Lab Inc.",,"Powder, for solution",Intravenous,25 mg / mL,Canada,DPD
DB00058,Prolastin-C,"GRIFOLS USA, LLC",13533-700,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 mg/20mL,US,FDA NDC
DB00058,Prolastin-C,"GRIFOLS USA, LLC",13533-701,Injection; Kit,Intravenous,1000 mg/20mL,US,FDA NDC
DB00058,Prolastin-C,"GRIFOLS USA, LLC",13533-703,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 mg/20mL,US,FDA NDC
DB00058,Prolastin-C,Grifols Therapeutics Llc,,"Powder, for solution",Intravenous,1000 mg / vial,Canada,DPD
DB00058,Prolastin-C,"GRIFOLS USA, LLC",13533-706,"Injection, powder, lyophilized, for solution; Kit",Intravenous,,US,FDA NDC
DB00058,Prolastin-C Liquid,"GRIFOLS USA, LLC",13533-705,"Injection, solution",Intravenous,1000 mg/20mL,US,FDA NDC
DB00058,Prolastin-C Liquid,Grifols Therapeutics Llc,,Solution,Intravenous,1000 mg / 20 mL,Canada,DPD
DB00058,Pronextica Liquid,Grifols Therapeutics Llc,,Solution,Intravenous,1000 mg / 20 mL,Canada,DPD
DB00058,Respreeza,Csl Behring,,"Injection, powder, for solution",Intravenous,1000 mg,EU,EMA
DB00058,Respreeza,Csl Behring,,"Injection, powder, for solution",Intravenous,4000 mg,EU,EMA
DB00058,Respreeza,Csl Behring,,"Injection, powder, for solution",Intravenous,5000 mg,EU,EMA
DB00058,Zemaira,CSL BEHRING LLC,0053-7201,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 mg/20mL,US,FDA NDC
DB00058,Zemaira,CSL BEHRING LLC,0053-7202,"Injection, powder, lyophilized, for solution; Kit",Intravenous,4000 mg/76mL,US,FDA NDC
DB00058,Zemaira,CSL BEHRING LLC,0053-7203,"Injection, powder, lyophilized, for solution; Kit",Intravenous,5000 mg/95mL,US,FDA NDC
DB00058,Zemaira,Csl Behring,,"Kit; Powder, for solution",Intravenous,1000 mg / vial,Canada,DPD
DB00058,Zemaira,Csl Behring,,"Kit; Powder, for solution",Intravenous,4000 mg / vial,Canada,DPD
DB00058,Zemaira,Csl Behring,,"Kit; Powder, for solution",Intravenous,5000 mg / vial,Canada,DPD
DB00059,Lyophilized Pegaspargase,Baxalta US Inc.,0944-3922,"Injection, powder, lyophilized, for solution",Intramuscular,750 U/1mL,US,FDA NDC
DB00059,Lyophilized Pegaspargase,Servier Pharmaceuticals,72694-313,"Injection, powder, lyophilized, for solution",Intravenous,750 [iU]/1mL,US,FDA NDC
DB00059,Oncaspar,"Sigma Tau Pharmaceuticals, Inc.",54482-301,"Injection, solution",Intramuscular; Intravenous,750 [iU]/1mL,US,FDA NDC
DB00059,Oncaspar,Baxalta US Inc.,0944-3810,"Injection, solution",Intramuscular; Intravenous,750 [iU]/1mL,US,FDA NDC
DB00059,Oncaspar,Servier Pharmaceuticals LLC,72694-954,"Injection, solution",Intramuscular; Intravenous,750 [iU]/1mL,US,FDA NDC
DB00059,Oncaspar,Servier,,Solution,Intramuscular; Intravenous,750 unit / mL,Canada,DPD
DB00059,Oncaspar,Aventis Pharma Ltd.,,Liquid,Intramuscular; Intravenous,750 unit / mL,Canada,DPD
DB00059,Oncaspar,Les Laboratoires Servier,,"Injection, solution",Intramuscular; Intravenous,750 U/ml,EU,EMA
DB00059,Oncaspar,Les Laboratoires Servier,,,,750 U/ml,EU,EMA
DB00060,Avonex,Biogen Inc.,59627-001,"Injection, powder, lyophilized, for solution",Intramuscular,30 ug/1mL,US,FDA NDC
DB00060,Avonex,Biogen Inc.,59627-333,Kit,Intramuscular,,US,FDA NDC
DB00060,Avonex,Biogen Inc.,59627-222,Kit,Intramuscular,,US,FDA NDC
DB00060,Avonex,Biogen Inc.,59627-111,Kit,Intramuscular,,US,FDA NDC
DB00060,Avonex,Biogen Inc.,59627-002,"Injection, solution",Intramuscular,30 ug/0.5mL,US,FDA NDC
DB00060,Avonex,Biogen,,"Powder, for solution",Intramuscular,,Canada,DPD
DB00060,Avonex,Biogen,,"Powder, for solution",Intramuscular,60 mcg / mL,Canada,DPD
DB00060,Avonex,Biogen,,Solution,Intramuscular,30 mcg / 0.5 mL,Canada,DPD
DB00060,Avonex,Biogen Netherlands B.V.,,"Injection, powder, for solution",Intramuscular,30 mcg,EU,EMA
DB00060,Avonex,Biogen Netherlands B.V.,,"Injection, solution",Intramuscular,30 mcg/0.5ml,EU,EMA
DB00060,Avonex,Biogen Netherlands B.V.,,"Injection, solution",Intramuscular,30 mcg/0.5ml,EU,EMA
DB00060,Avonex,Biogen Netherlands B.V.,,"Injection, solution",Intramuscular,30 mcg/0.5ml,EU,EMA
DB00060,Avonex,Biogen Netherlands B.V.,,"Injection, solution",Intramuscular,30 mcg/0.5ml,EU,EMA
DB00060,Avonex Pen,Biogen Inc.,59627-003,"Injection, solution",Intramuscular,30 ug/0.5mL,US,FDA NDC
DB00060,Rebif,"EMD Serono, Inc.",44087-8822,Kit,Subcutaneous,,US,FDA NDC
DB00060,Rebif,"EMD Serono, Inc.",44087-8822,Kit,Subcutaneous,,US,FDA NDC
DB00060,Rebif,"EMD Serono, Inc.",44087-0022,"Injection, solution",Subcutaneous,22 ug/0.5mL,US,FDA NDC
DB00060,Rebif,"EMD Serono, Inc.",44087-0044,"Injection, solution",Subcutaneous,44 ug/0.5mL,US,FDA NDC
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,22 mcg / 0.5 mL,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,44 mcg / 0.5 mL,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,66 mcg / 1.5 mL,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,132 mcg / 1.5 mL,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,Kit; Liquid; Powder,Intralesional; Subcutaneous,,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,8.8 mcg / 0.2 mL,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,132 mcg / 1.5 mL,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,"Kit; Liquid; Powder, for solution",Subcutaneous,,Canada,DPD
DB00060,Rebif,"Emd Serono, A Division Of Emd Inc., Canada",,"Kit; Liquid; Powder, for solution",Subcutaneous,,Canada,DPD
DB00060,Rebif,Merck Europe B.V.,,"Injection, solution",Subcutaneous,22 µg/0.5ml,EU,EMA
DB00060,Rebif,Merck Europe B.V.,,"Injection, solution",Subcutaneous,44 µg/0.5ml,EU,EMA
DB00060,Rebif,Merck Europe B.V.,,"Injection, solution",Subcutaneous,22 µg/0.5ml,EU,EMA
DB00060,Rebif,Merck Europe B.V.,,"Injection, solution",Subcutaneous,44 µg/0.5ml,EU,EMA
DB00060,Rebif Rebidose,"EMD Serono, Inc.",44087-0188,Kit,Subcutaneous,,US,FDA NDC
DB00060,Rebif Rebidose,"EMD Serono, Inc.",44087-0188,Kit,Subcutaneous,,US,FDA NDC
DB00060,Rebif Rebidose,"EMD Serono, Inc.",44087-3322,"Injection, solution",Subcutaneous,22 ug/0.5mL,US,FDA NDC
DB00060,Rebif Rebidose,"EMD Serono, Inc.",44087-3344,"Injection, solution",Subcutaneous,44 ug/0.5mL,US,FDA NDC
DB00061,Adagen,"Leadiant Biosciences, Inc.",57665-001,"Injection, solution",Intramuscular,250 [iU]/1mL,US,FDA NDC
DB00062,Albuked,"Kedrion Biopharma, Inc.",76125-790,Solution,Intravenous,2.5 g/50mL,US,FDA NDC
DB00062,Albuked,"Kedrion Biopharma, Inc.",76125-791,Solution,Intravenous,10 g/50mL,US,FDA NDC
DB00062,Albuked,"Kedrion Biopharma, Inc.",76125-792,Solution,Intravenous,5 g/20mL,US,FDA NDC
DB00062,Albuked,"Kedrion Biopharma, Inc.",76125-785,Solution,Intravenous,.05 g/1mL,US,FDA NDC
DB00062,Albuked,"Kedrion Biopharma, Inc.",76125-783,Solution,Intravenous,10 g/50mL,US,FDA NDC
DB00062,Albuked,"Kedrion Biopharma, Inc.",76125-784,Solution,Intravenous,5 g/20mL,US,FDA NDC
DB00062,Albumin (Human),Octapharma Pharmazeutika Produktionsgesellschaft M.B.H.,67467-643,Solution,Intravenous,250 g/1000mL,US,FDA NDC
DB00062,Albumin (Human),Octapharma Pharmazeutika Produktionsgesellschaft M.B.H.,67467-633,Solution,Intravenous,200 g/1000mL,US,FDA NDC
DB00062,Albumin (Human),Octapharma Pharmazeutika Produktionsgesellschaft M.B.H.,67467-623,Solution,Intravenous,50 g/1000mL,US,FDA NDC
DB00062,Albumin (Human),Octapharma USA Inc,68982-633,Solution,Intravenous,200 g/1000mL,US,FDA NDC
DB00062,Albumin (Human),Octapharma USA Inc,68982-623,Solution,Intravenous,50 g/1000mL,US,FDA NDC
DB00062,Albumin (Human),Octapharma USA Inc,68982-643,Solution,Intravenous,250 g/1000mL,US,FDA NDC
DB00062,Albumin (human) 25% Solution,Baxter Ag,,Solution,Intravenous,25 %,Canada,DPD
DB00062,Albumin (human) 25% Solution USP,Grifols Therapeutics Llc,,Solution,Intravenous,25 %,Canada,DPD
DB00062,Albumin (human) 5% Solution,Baxter Ag,,Solution,Intravenous,5 %,Canada,DPD
DB00062,"Albumin (human) 5% Solution, USP",Grifols Therapeutics Llc,,Solution,Intravenous,5 %,Canada,DPD
DB00062,Albumin Human Diluent,Omega Laboratories Ltd,,Liquid,Subcutaneous,,Canada,DPD
DB00062,Albuminar-20,CSL BEHRING LLC,0053-7695,Solution,Intravenous,20 g/100mL,US,FDA NDC
DB00062,Albuminar-25,CSL BEHRING LLC,0053-7680,Solution,Intravenous,25 g/100mL,US,FDA NDC
DB00062,Albuminar-25,Zlb Behring Llc,,Solution,Intravenous,25 g / 100 mL,Canada,DPD
DB00062,Albuminar-5,CSL BEHRING LLC,0053-7670,Solution,Intravenous,2.5 g/50mL,US,FDA NDC
DB00062,Albuminex,BPL,64208-2512,Solution,Intravenous,0.25 g/1mL,US,FDA NDC
DB00062,Albuminex,BPL,64208-2510,Solution,Intravenous,0.05 g/1mL,US,FDA NDC
DB00062,Albunex,Tyco Healthcare,,Suspension,Intravenous,5 %,Canada,DPD
DB00062,Alburex - 25,Csl Behring,,Solution,Intravenous,25 %,Canada,DPD
DB00062,Alburex - 5,Csl Behring,,Solution,Intravenous,5 %,Canada,DPD
DB00062,AlbuRx,Csl Behring Ag,44206-251,Solution,Intravenous,12.5 g/50mL,US,FDA NDC
DB00062,Alburx,Csl Behring Ag,44206-310,Solution,Intravenous,12.5 g/250mL,US,FDA NDC
DB00062,Albutein,"GRIFOLS USA, LLC",68516-5215,"Injection, solution",Intravenous,10 g/50mL,US,FDA NDC
DB00062,Albutein,"GRIFOLS USA, LLC",68516-5214,"Injection, solution",Intravenous,12.5 g/250mL,US,FDA NDC
DB00062,Albutein,"GRIFOLS USA, LLC",68516-5216,"Injection, solution",Intravenous,12.5 g/50mL,US,FDA NDC
DB00062,Albutein,"GRIFOLS USA, LLC",68516-5217,"Injection, solution",Intravenous,12.5 g/250mL,US,FDA NDC
DB00062,Albutein,"GRIFOLS USA, LLC",68516-5218,"Injection, solution",Intravenous,12.5 g/250mL,US,FDA NDC
DB00062,Albutein,"GRIFOLS USA, LLC",68516-5219,"Injection, solution",Intravenous,12.5 g/250mL,US,FDA NDC
DB00062,Albutein 25% Soln USP,Grifols Biologicals Llc,,Solution,Intravenous,250 mg,Canada,DPD
DB00062,Albutein 5% Soln USP,Grifols Biologicals Llc,,Solution,Intravenous,50 mg,Canada,DPD
DB00062,Buminate,Baxalta US Inc.,0944-0482,"Injection, solution",Intravenous,0.2 g/1mL,US,FDA NDC
DB00062,Buminate,Baxalta US Inc.,0944-0491,"Injection, solution",Intravenous,0.05 g/1mL,US,FDA NDC
DB00062,Buminate,Baxalta US Inc.,0944-0490,"Injection, solution",Intravenous,0.25 g/1mL,US,FDA NDC
DB00062,Buminate 25%,Baxter Healthcare Corporation,,Solution,Intravenous,25 %,Canada,DPD
DB00062,Buminate 5%,Baxter Healthcare Corporation,,Solution,Intravenous,5 %,Canada,DPD
DB00062,Diluent for Allergenic Extract Sterile Albumin Saline With Phenol,Jubilant Hollisterstier Llc,,Liquid,Intradermal; Subcutaneous,0.03 %,Canada,DPD
DB00062,Flexbumin,"Takeda Pharmaceuticals America, Inc.",0944-0495,"Injection, solution",Intravenous,0.05 g/1mL,US,FDA NDC
DB00062,Flexbumin,"Takeda Pharmaceuticals America, Inc.",0944-0492,Solution,Intravenous,0.20 g/1mL,US,FDA NDC
DB00062,Flexbumin,"Takeda Pharmaceuticals America, Inc.",0944-0493,Solution,Intravenous,0.25 g/1mL,US,FDA NDC
DB00062,Human Albumin Grifols,"GRIFOLS USA, LLC",61953-0001,Solution,Intravenous,10 g/50mL,US,FDA NDC
DB00062,Human Albumin Grifols,"GRIFOLS USA, LLC",61953-0002,Solution,Intravenous,12.5 g/50mL,US,FDA NDC
DB00062,Human Albumin Grifols 20%,"Instituto Grifols, S.A.",,Solution,Intravenous,20 %,Canada,DPD
DB00062,Humanalbin Inj 5%,Behringwerke Ag,,Liquid,Intravenous,50 mg / mL,Canada,DPD
DB00062,Kedbumin,Kedrion S.p.A,76179-025,"Injection, solution",Intravenous,12.5 g/50mL,US,FDA NDC
DB00062,Macrotec,"Bracco Diagnostics, Inc",0270-0076,"Injection, powder, lyophilized, for suspension",Intravenous,,US,FDA NDC
DB00062,Normal Serum Albumin Human 25% USP,"Cutter Med & Biol, Division Of Miles Canada Ltd.",,Liquid,Intravenous,25 %,Canada,DPD
DB00062,Octalbin 25%,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Intravenous,25 %,Canada,DPD
DB00062,Octalbin 5%,Octapharma Pharmazeutika Produktionsges M B H,,Solution,Intravenous,5 %,Canada,DPD
DB00062,Optison,Tyco Healthcare,,Suspension,Intravenous,5 %,Canada,DPD
DB00062,Plasbumin,"GRIFOLS USA, LLC",13533-683,Solution,Intravenous,10 g/50mL,US,FDA NDC
DB00062,Plasbumin,"GRIFOLS USA, LLC",13533-685,Solution,Intravenous,2.5 g/50mL,US,FDA NDC
DB00062,Plasbumin,"GRIFOLS USA, LLC",13533-684,Solution,Intravenous,5 g/20mL,US,FDA NDC
DB00062,Plasbumin,"GRIFOLS USA, LLC",13533-692,Solution,Intravenous,5 g/20mL,US,FDA NDC
DB00062,Plasbumin,"GRIFOLS USA, LLC",13533-691,Solution,Intravenous,10 g/50mL,US,FDA NDC
DB00062,Plasbumin,"GRIFOLS USA, LLC",13533-690,Solution,Intravenous,2.5 g/50mL,US,FDA NDC
DB00062,Plasbumin-25,Grifols Therapeutics Llc,,Solution,Intravenous,250 mg / mL,Canada,DPD
DB00062,Plasbumin-5,Grifols Therapeutics Llc,,Solution,Intravenous,50 mg / mL,Canada,DPD
DB00062,Plasbumin-5 Inj 50mg/ml,"Cutter Med & Biol, Division Of Miles Canada Ltd.",,Liquid,Intravenous,50 mg / mL,Canada,DPD
DB00062,Plasmanate,"GRIFOLS USA, LLC",13533-613,Solution,Intravenous,2.5 g/50mL,US,FDA NDC
DB00062,Sterile Diluent for Allergenic Extract,"Antigen Laboratories, Inc.",49288-9934,"Injection, solution",Intradermal; Subcutaneous,,US,FDA NDC
DB00062,Sterile Diluent for Allergenic Extract - Albumin Saline With Phenol,"Alk Abello, Inc.",,Solution,Subcutaneous,0.03 %,Canada,DPD
DB00062,Sterile Diluent for Allergenic Extracts Normal Saline With Hsa,Greer Laboratories,,Liquid,Intradermal; Subcutaneous,0.03 %,Canada,DPD
DB00062,Venomil Honey Bee Venom (12mcg),Hollister Stier Laboratories Llc,,"Kit; Liquid; Powder, for solution",Intradermal,,Canada,DPD
DB00062,Venomil Wasp Venom Protein (12mcg),Hollister Stier Laboratories Llc,,"Kit; Powder, for solution",Intradermal,,Canada,DPD
DB00062,Venomil White-faced Hornet Venom Protein (12mcg),Hollister Stier Laboratories Llc,,"Kit; Powder, for solution",Intradermal,,Canada,DPD
DB00062,Venomil Yellow Hornet Venom Protein (12mcg),Hollister Stier Laboratories Llc,,"Kit; Powder, for solution",Intradermal,,Canada,DPD
DB00062,Venomil Yellow Jacket Venom Protein (12mcg),Hollister Stier Laboratories Llc,,"Kit; Powder, for solution",Intradermal,,Canada,DPD
DB00063,Eptifibatide,Aurobindo Pharma,59651-012,Injection,Intravenous,75 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,Aurobindo Pharma,59651-013,Injection,Intravenous,20 mg/10mL,US,FDA NDC
DB00063,Eptifibatide,Aurobindo Pharma,59651-014,Injection,Intravenous,200 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,Eugia US LLC,55150-218,Injection,Intravenous,75 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,Eugia US LLC,55150-219,Injection,Intravenous,20 mg/10mL,US,FDA NDC
DB00063,Eptifibatide,Eugia US LLC,55150-220,Injection,Intravenous,200 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,Accord Healthcare Inc.,16729-260,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Accord Healthcare Inc.,16729-259,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Sagent Pharmaceuticals,25021-408,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Sagent Pharmaceuticals,25021-409,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Teva Parenteral Medicines, Inc.",0703-1179,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Mylan Institutional LLC,67457-629,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Mylan Institutional LLC,67457-631,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Mylan Institutional LLC,67457-630,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Teva Parenteral Medicines, Inc.",0703-1165,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Baxter Healthcare Corporation,0338-9558,Injection,Intravenous,75 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,Baxter Healthcare Corporation,0338-9559,Injection,Intravenous,200 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,"Hainan Poly Pharm. Co., Ltd.",14335-070,Injection,Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Hainan Poly Pharm. Co., Ltd.",14335-071,Injection,Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Slate Run Pharmaceuticals, Llc",70436-026,Injection,Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Slate Run Pharmaceuticals, Llc",70436-027,Injection,Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Amneal Pharmaceuticals LLC,70121-1002,Injection,Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Amneal Pharmaceuticals LLC,70121-1003,Injection,Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,USV Private Limited,62147-0600,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,USV Private Limited,62147-0601,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,USV Private Limited,62147-0602,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Akorn,17478-903,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Akorn,17478-902,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,McKesson Corporation dba SKY Packaging,63739-970,"Injection, solution",Intravenous,75 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,McKesson Corporation dba SKY Packaging,63739-923,"Injection, solution",Intravenous,200 mg/100mL,US,FDA NDC
DB00063,Eptifibatide,McKesson Corporation dba SKY Packaging,63739-911,"Injection, solution",Intravenous,20 mg/10mL,US,FDA NDC
DB00063,Eptifibatide,Mylan Institutional LLC,72078-025,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Mylan Institutional LLC,72078-026,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,Mylan Institutional LLC,72078-027,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Slate Run Pharmaceuticals, Llc",70436-162,Injection,Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Slate Run Pharmaceuticals, Llc",70436-163,Injection,Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Hainan Shuangcheng Pharmaceuticals Co., Ltd.",52958-402,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Athenex Pharmaceutical Division, Llc.",70860-303,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Hainan Shuangcheng Pharmaceuticals Co., Ltd.",52958-040,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Athenex Pharmaceutical Division, Llc.",70860-305,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Avenacy, Inc.",83634-300,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Eptifibatide,"Avenacy, Inc.",83634-301,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Eptifibatide Accord,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous,0.75 mg/ml,EU,EMA
DB00063,Eptifibatide Accord,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous,2 mg/ml,EU,EMA
DB00063,Eptifibatide Injection,Omega Laboratories Ltd,,Solution,Intravenous,0.75 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Omega Laboratories Ltd,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Strides Pharma Canada Inc,,Solution,Intravenous,0.75 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Strides Pharma Canada Inc,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Accord Healthcare Inc,,Solution,Intravenous,0.75 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Accord Healthcare Inc,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Fresenius Kabi,,Solution,Intravenous,0.75 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Fresenius Kabi,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,TEVA Canada Limited,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,TEVA Canada Limited,,Solution,Intravenous,0.75 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Juno Pharmaceuticals Corp.,,Solution,Intravenous,0.75 mg / mL,Canada,DPD
DB00063,Eptifibatide Injection,Juno Pharmaceuticals Corp.,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00063,Integrilin,Merck Sharp & Dohme Corp.,0085-1177,"Injection, solution",Intravenous,2 mg/1mL,US,FDA NDC
DB00063,Integrilin,Merck Sharp & Dohme Corp.,0085-1136,"Injection, solution",Intravenous,0.75 mg/1mL,US,FDA NDC
DB00063,Integrilin,Merck Ltd.,,Solution,Intravenous,0.75 mg / mL,Canada,DPD
DB00063,Integrilin,Merck Ltd.,,Solution,Intravenous,2 mg / mL,Canada,DPD
DB00063,Integrilin,Glaxo Smith Kline (Ireland) Limited,,"Injection, solution",Intravenous,0.75 mg/ml,EU,EMA
DB00063,Integrilin,Glaxo Smith Kline (Ireland) Limited,,"Injection, solution",Intravenous,2 mg/ml,EU,EMA
DB00065,Avsola,AMGEN INC,55513-670,"Injection, powder, lyophilized, for solution",Intravenous,100 mg/10mL,US,FDA NDC
DB00065,Avsola,Amgen,,"Powder, for solution",Intravenous,100 mg / vial,Canada,DPD
DB00065,Flixabi,Samsung Bioepis Nl B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Flixabi,Samsung Bioepis Nl B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Flixabi,Samsung Bioepis Nl B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Flixabi,Samsung Bioepis Nl B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Flixabi,Samsung Bioepis Nl B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Inflectra,Pfizer Laboratories Div Pfizer Inc,0069-0809,"Injection, powder, lyophilized, for solution",Intravenous,100 mg/10mL,US,FDA NDC
DB00065,Inflectra,Celltrion,,"Powder, for solution",Intravenous,100 mg / vial,Canada,DPD
DB00065,Inflectra,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Inflectra,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Inflectra,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Inflectra,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Inflectra,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Infliximab,"Janssen Biotech, Inc.",57894-160,"Injection, powder, lyophilized, for solution",Intravenous,100 mg/10mL,US,FDA NDC
DB00065,Ixifi,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,100 mg / vial,Canada,DPD
DB00065,Omvyence,Janssen Pharmaceuticals,,"Powder, for solution",Intravenous,100 mg / vial,Canada,DPD
DB00065,Remicade,"Janssen Biotech, Inc.",57894-030,"Injection, powder, lyophilized, for solution",Intravenous,100 mg/10mL,US,FDA NDC
DB00065,Remicade,Janssen Pharmaceuticals,,"Powder, for solution",Intravenous,100 mg / vial,Canada,DPD
DB00065,Remicade,Janssen Biologics B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remicade,Janssen Biologics B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remicade,Janssen Biologics B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remicade,Janssen Biologics B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remicade,Janssen Biologics B.V.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remsima,Celltrion,,"Powder, for solution",Intravenous,100 mg / vial,Canada,DPD
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima,Celltrion Healthcare Hungary Kft.,,"Injection, solution",Subcutaneous,120 mg,EU,EMA
DB00065,Remsima Sc,Celltrion,,Kit; Solution,Subcutaneous,120 mg / mL,Canada,DPD
DB00065,Remsima Sc,Celltrion,,Kit; Solution,Subcutaneous,120 mg / mL,Canada,DPD
DB00065,Renflexis,Merck Sharp & Dohme Llc,0006-4305,"Injection, powder, lyophilized, for solution",Intravenous,100 mg/1,US,FDA NDC
DB00065,Renflexis,Organon LLC,78206-162,"Injection, powder, lyophilized, for solution",Intravenous,100 mg/1,US,FDA NDC
DB00065,Renflexis,"Samsung Bioepis Co., Ltd.",,"Powder, for solution",Intravenous,100 mg / vial,Canada,DPD
DB00065,Zessly,Sandoz,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Zessly,Sandoz,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Zessly,Sandoz,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Zessly,Sandoz,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Zessly,Sandoz,,"Injection, powder, for solution",Intravenous,100 mg,EU,EMA
DB00065,Zymfentra,CELLTRION USA Inc.,72606-025,Injection,Subcutaneous,120 mg/1mL,US,FDA NDC
DB00065,Zymfentra,CELLTRION USA Inc.,72606-047,Injection,Subcutaneous,120 mg/1mL,US,FDA NDC
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,75 IU/0.125ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,150 IU/0.25ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,225 IU/0.375ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,300 IU/0.50ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,450 IU/0.75ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,75 IU/0.125ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,75 IU/0.125ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,150 IU/0.25ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,225 IU/0.375ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,225 IU/0.375ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,300 IU/0.50ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,300 IU/0.50ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,450 IU/0.75ml,EU,EMA
DB00066,Bemfola,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,450 IU/0.75ml,EU,EMA
DB00066,Bemfola Needles,Gedeon Richter Plc.,,"Injection, solution",Subcutaneous,150 IU/0.25ml,EU,EMA
DB00066,Bravelle,Ferring Pharmaceuticals Inc.,55566-8505,Kit,Subcutaneous,75 [iU]/1mL,US,FDA NDC
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,50 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,50 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,50 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,75 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,75 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,75 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,100 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,100 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,100 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,150 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,150 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,150 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,200 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,200 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Intramuscular; Subcutaneous,200 IU/0.5mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Subcutaneous,150 IU/0.18mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Subcutaneous,300 IU/0.36mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Subcutaneous,600 IU/0.72mL,EU,EMA
DB00066,Fertavid,Merck Sharp & Dohme B.V.,,"Injection, solution",Subcutaneous,900 IU/1.08mL,EU,EMA
DB00066,Follistim,"Organon USA, Inc.",0052-0306,Kit,Intramuscular; Subcutaneous,,US,FDA NDC
DB00066,Follistim AQ,"Organon USA, Inc.",0052-0303,"Injection, solution",Subcutaneous,175 [iU]/0.210mL,US,FDA NDC
DB00066,Follistim AQ,Merck Sharp & Dohme Llc,0052-0313,"Injection, solution",Subcutaneous,350 [iU]/0.42mL,US,FDA NDC
DB00066,Follistim AQ,Merck Sharp & Dohme Llc,0052-0316,"Injection, solution",Subcutaneous,650 [iU]/0.78mL,US,FDA NDC
DB00066,Follistim AQ,Merck Sharp & Dohme Llc,0052-0326,"Injection, solution",Subcutaneous,975 [iU]/1.17mL,US,FDA NDC
DB00066,Follistim AQ,Organon USA Inc.,0052-0308,"Injection, solution",Intramuscular; Subcutaneous,75 [iU]/0.5mL,US,FDA NDC
DB00066,Follistim AQ,Organon USA Inc.,0052-0309,"Injection, solution",Intramuscular; Subcutaneous,150 [iU]/0.5mL,US,FDA NDC
DB00066,Follistim AQ,Organon LLC,78206-129,"Injection, solution",Subcutaneous,300 [iU]/0.36mL,US,FDA NDC
DB00066,Follistim AQ,Organon LLC,78206-130,"Injection, solution",Subcutaneous,600 [iU]/0.72mL,US,FDA NDC
DB00066,Follistim AQ,Organon LLC,78206-131,"Injection, solution",Subcutaneous,900 [iU]/1.08mL,US,FDA NDC
DB00066,Gonal-f,"EMD Serono, Inc.",44087-9030,Kit,Subcutaneous,450 [iU]/1mL,US,FDA NDC
DB00066,Gonal-f,"EMD Serono, Inc.",44087-9070,Kit,Subcutaneous,1050 [iU]/2mL,US,FDA NDC
DB00066,Gonal-f,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,5.5 mcg / vial,Canada,DPD
DB00066,Gonal-f,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,33 mcg / vial,Canada,DPD
DB00066,Gonal-f,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,77 mcg / vial,Canada,DPD
DB00066,Gonal-f,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,75 unit / vial,Canada,DPD
DB00066,Gonal-f,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,150 unit / vial,Canada,DPD
DB00066,Gonal-f,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,37.5 unit / vial,Canada,DPD
DB00066,Gonal-f,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular; Subcutaneous,1200 unit / vial,Canada,DPD
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,1050 IU/1.75ml,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,75 IU,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,450 IU/0.75ml,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,300 IU/0.5ml,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, solution",Subcutaneous,300 IU/0.5ml,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, solution",Subcutaneous,450 IU/0.75ml,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, solution",Subcutaneous,900 IU/1.5ml,EU,EMA
DB00066,Gonal-F,Merck Europe B.V.,,"Injection, solution",Subcutaneous,150 IU/0.25ml,EU,EMA
DB00066,Gonal-F Pen,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,900 unit / 1.5 mL,Canada,DPD
DB00066,Gonal-F Pen,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,450 unit / 0.75 mL,Canada,DPD
DB00066,Gonal-F Pen,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,300 unit / 0.5 mL,Canada,DPD
DB00066,Gonal-F Rff,"EMD Serono, Inc.",44087-9005,Kit,Subcutaneous,75 [iU]/1mL,US,FDA NDC
DB00066,Gonal-F Rff,A-S Medication Solutions,50090-6049,Kit,Subcutaneous,75 [iU]/1mL,US,FDA NDC
DB00066,Gonal-f RFF Pen,Emd Serono,44087-1113,"Injection, solution",Subcutaneous,300 [iU]/0.5mL,US,FDA NDC
DB00066,Gonal-f RFF Pen,Emd Serono,44087-1112,"Injection, solution",Subcutaneous,450 [iU]/0.75mL,US,FDA NDC
DB00066,Gonal-f RFF Pen,Emd Serono,44087-1114,"Injection, solution",Subcutaneous,900 [iU]/1.5mL,US,FDA NDC
DB00066,Gonal-f RFF Redi-ject,"EMD Serono, Inc.",44087-1115,"Injection, solution",Subcutaneous,300 [iU]/0.5mL,US,FDA NDC
DB00066,Gonal-f RFF Redi-ject,"EMD Serono, Inc.",44087-1116,"Injection, solution",Subcutaneous,450 [iU]/0.75mL,US,FDA NDC
DB00066,Gonal-f RFF Redi-ject,"EMD Serono, Inc.",44087-1117,"Injection, solution",Subcutaneous,900 [iU]/1.5mL,US,FDA NDC
DB00066,Gonal-f RFF Redi-ject,"EMD Serono, Inc.",44087-1118,"Injection, solution",Subcutaneous,150 [iU]/0.25mL,US,FDA NDC
DB00066,Humegon Inj 75 I.U.,Organon Canada Ltd Ltee,,"Liquid; Powder, for solution",Intramuscular,,Canada,DPD
DB00066,Menopur,Ferring Pharmaceuticals Inc.,55566-7501,Injection,Subcutaneous,,US,FDA NDC
DB00066,Ovaleap,Theramex Ireland Limited,,"Injection, solution",Subcutaneous,300 IU/0.5mL,EU,EMA
DB00066,Ovaleap,Theramex Ireland Limited,,"Injection, solution",Subcutaneous,450 IU/0.75mL,EU,EMA
DB00066,Ovaleap,Theramex Ireland Limited,,"Injection, solution",Subcutaneous,900 IU/1.5mL,EU,EMA
DB00066,Pergonal 75 I.U.,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Intramuscular,,Canada,DPD
DB00066,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,"Kit; Powder, for solution",Subcutaneous,,Canada,DPD
DB00066,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,,Canada,DPD
DB00066,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,,Canada,DPD
DB00066,Pergoveris,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,,Canada,DPD
DB00066,Pergoveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,,EU,EMA
DB00066,Pergoveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,,EU,EMA
DB00066,Pergoveris,Merck Europe B.V.,,"Injection, powder, for solution",Subcutaneous,,EU,EMA
DB00066,Pergoveris,Merck Europe B.V.,,"Injection, solution",Subcutaneous,,EU,EMA
DB00066,Pergoveris,Merck Europe B.V.,,"Injection, solution",Subcutaneous,,EU,EMA
DB00066,Pergoveris,Merck Europe B.V.,,"Injection, solution",Subcutaneous,,EU,EMA
DB00066,Puregon,Merck Ltd.,,Solution,Intramuscular; Subcutaneous,50 unit / 0.5 mL,Canada,DPD
DB00066,Puregon,Merck Ltd.,,Solution,Intramuscular; Subcutaneous,100 unit / 0.5 mL,Canada,DPD
DB00066,Puregon,Organon Canada Inc.,,Solution,Subcutaneous,833 unit / mL,Canada,DPD
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,50 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,50 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,50 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,75 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,75 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,75 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,100 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,100 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,100 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,150 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,150 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,150 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,200 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,200 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,200 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,225 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,225 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Intramuscular; Subcutaneous,225 IU/0.5mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Subcutaneous,300 IU/0.36mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Subcutaneous,600 IU/0.72mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Subcutaneous,150 IU/0.18mL,EU,EMA
DB00066,Puregon,N.V. Organon,,"Injection, solution",Subcutaneous,900 IU/1.08mL,EU,EMA
DB00066,Puregon (600 Iu),Organon Canada Ltd Ltee,,"Powder, for solution; Solution",Intramuscular; Subcutaneous,737 unit / cartridge,Canada,DPD
DB00066,Puregon 100 I.U.,Organon Canada Ltd Ltee,,"Liquid; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00066,Puregon 50 I.U.,Organon Canada Ltd Ltee,,"Liquid; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00066,Rekovelle,Ferring Pharmaceuticals,,Solution,Subcutaneous,72 mcg / 2.16 mL,Canada,DPD
DB00066,Rekovelle,Ferring Pharmaceuticals,,Solution,Subcutaneous,36 mcg / 1.08 mL,Canada,DPD
DB00066,Rekovelle,Ferring Pharmaceuticals,,Solution,Subcutaneous,12 mcg / 0.36 mL,Canada,DPD
DB00066,Rekovelle,Ferring Pharmaceuticals,,Solution,Subcutaneous,12 mcg / 0.36 mL,Canada,DPD
DB00066,Rekovelle,Ferring Pharmaceuticals,,Solution,Subcutaneous,36 mcg / 1.08 mL,Canada,DPD
DB00066,Rekovelle,Ferring Pharmaceuticals,,Solution,Subcutaneous,72 mcg / 2.16 mL,Canada,DPD
DB00066,Rekovelle,Ferring Pharmaceuticals,,"Injection, solution",Subcutaneous,12 ?g/0.36ml,EU,EMA
DB00066,Rekovelle,Ferring Pharmaceuticals,,"Injection, solution",Subcutaneous,36 ?g/1.08ml,EU,EMA
DB00066,Rekovelle,Ferring Pharmaceuticals,,"Injection, solution",Subcutaneous,72 ?g/2.16ml,EU,EMA
DB00066,Rekovelle,Ferring Pharmaceuticals,,"Injection, solution",Subcutaneous,12 ?g/0.36ml,EU,EMA
DB00066,Rekovelle,Ferring Pharmaceuticals,,"Injection, solution",Subcutaneous,36 ?g/1.08ml,EU,EMA
DB00066,Rekovelle,Ferring Pharmaceuticals,,"Injection, solution",Subcutaneous,72 ?g/2.16ml,EU,EMA
DB00066,Repronex,Ferring Pharmaceuticals,55566-7185,Kit,Intramuscular; Subcutaneous,,US,FDA NDC
DB00067,Pitressin,"Physicians Total Care, Inc.",54868-1738,"Injection, solution",Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Pitressin,Par Pharmaceutical,42023-117,Injection,Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Pitressin,Cardinal Health,55154-5925,Injection,Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Pitressin Inj 10 Unit/0.5ml,"Parke Davis Division, Warner Lambert Canada Inc.",,Liquid,Intramuscular; Subcutaneous,10 unit / .5 mL,Canada,DPD
DB00067,Pressyn Ar,Ferring Pharmaceuticals,,Liquid,Intramuscular; Subcutaneous,20 unit / 1 mL,Canada,DPD
DB00067,Vasopressin,"Physicians Total Care, Inc.",54868-5740,"Injection, solution",Intravenous; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"Physicians Total Care, Inc.",54868-6267,"Injection, solution",Intravenous; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,General Injectables & Vaccines,52584-302,"Injection, solution",Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,General Injectables & Vaccines,52584-020,"Injection, solution",Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,General Injectables & Vaccines,52584-053,"Injection, solution",Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,American Regent,0517-0410,"Injection, solution",Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,American Regent,0517-0510,"Injection, solution",Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"AMERICAN REGENT, INC.",0517-1020,"Injection, solution",Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"Fresenius Kabi USA, LLC",63323-302,"Injection, solution",Intramuscular; Subcutaneous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"HF Acquisition Co LLC, DBA HealthFirst",51662-1314,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,Cardinal Health,55154-5724,"Injection, solution",Intramuscular,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"Eagle Pharmaceuticals, Inc.",42367-570,Injection,Parenteral,20 U/1mL,US,FDA NDC
DB00067,Vasopressin,Dr. Reddys Laboratories Inc,43598-085,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,AuroMedics Pharma LLC,55150-371,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,Amneal Pharmaceuticals LLC,70121-1642,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"HF Acquisition Co LLC, DBA HealthFirst",51662-1607,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,Eugia US LLC,55150-370,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"Amphastar Pharmaceuticals, Inc.",0548-9701,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"HF Acquisition Co LLC, DBA HealthFirst",51662-1623,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"Fresenius Kabi USA, LLC",63323-930,"Injection, solution",Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"Fresenius Kabi USA, LLC",65219-039,"Injection, solution",Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"AMERICAN REGENT, INC.",0517-1030,"Injection, solution",Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,"Medical Purchasing Solutions, Llc",71872-7306,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin,Gland Pharma Limited,68083-520,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasopressin in 0.9% Sodium Chloride,Baxter Healthcare Corporation,0338-9640,Injection,Intravenous,20 [USP'U]/100mL,US,FDA NDC
DB00067,Vasopressin in 0.9% Sodium Chloride,Baxter Healthcare Corporation,0338-9647,Injection,Intravenous,40 [USP'U]/100mL,US,FDA NDC
DB00067,Vasopressin Inj 20unit/ml USP,"Lyphomed, Division Of Fujisawa Canada Inc.",,Liquid,Intramuscular; Subcutaneous,20 unit / mL,Canada,DPD
DB00067,Vasopressin Inj 20unit/ml USP,Ferring Pharmaceuticals,,Liquid,Intramuscular; Nasal; Subcutaneous,20 unit / mL,Canada,DPD
DB00067,Vasopressin Injection USP,Sandoz Canada Incorporated,,Solution,Intramuscular; Subcutaneous,20 unit / mL,Canada,DPD
DB00067,"Vasopressin Injection, USP",Fresenius Kabi,,Solution,Intramuscular; Subcutaneous,20 unit / mL,Canada,DPD
DB00067,Vasostrict,"Medical Purchasin Solutions, Llc",71872-7014,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasostrict,"Par Pharmaceutical, Inc.",42023-164,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasostrict,"Par Pharmaceutical, Inc.",42023-190,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasostrict,"Par Pharmaceutical, Inc.",42023-219,Injection,Intravenous,40 [USP'U]/100mL,US,FDA NDC
DB00067,Vasostrict,"Par Pharmaceutical, Inc.",42023-220,Injection,Intravenous,60 [USP'U]/100mL,US,FDA NDC
DB00067,Vasostrict,"Medical Purchasing Solutions, Llc",71872-7264,Injection,Intravenous,20 [USP'U]/1mL,US,FDA NDC
DB00067,Vasostrict,"Par Pharmaceutical, Inc.",42023-237,Injection,Intravenous,0.2 [USP'U]/1mL,US,FDA NDC
DB00067,Vasostrict,"Par Pharmaceutical, Inc.",42023-268,Injection,Intravenous,1 [USP'U]/1mL,US,FDA NDC
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaferon,Bayer Ag,,"Injection, powder, for solution",Subcutaneous,0.25 mg/ml,EU,EMA
DB00068,Betaseron,Bayer,50419-523,Kit,Subcutaneous,0.25 mg/1mL,US,FDA NDC
DB00068,Betaseron,Bayer HealthCare Pharmaceuticals Inc.,50419-524,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,0.25 mg/1mL,US,FDA NDC
DB00068,Betaseron,Bayer,,"Powder, for solution",Subcutaneous,0.3 mg / vial,Canada,DPD
DB00068,Extavia,Novartis Pharmaceuticals Corporation,0078-0569,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,0.25 mg/1.0mL,US,FDA NDC
DB00068,Extavia,Novartis,,"Powder, for solution",Subcutaneous,0.3 mg / vial,Canada,DPD
DB00068,Extavia,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,250 μg/ml,EU,EMA
DB00068,Extavia,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,250 μg/ml,EU,EMA
DB00068,Extavia,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,250 μg/ml,EU,EMA
DB00068,Extavia,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,250 μg/ml,EU,EMA
DB00068,Extavia,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,250 μg/ml,EU,EMA
DB00068,Extavia,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,250 μg/ml,EU,EMA
DB00068,Extavia,Novartis Europharm Limited,,"Injection, powder, for solution",Subcutaneous,250 μg/ml,EU,EMA
DB00069,Infergen,Kadmon Pharmaceuticals,66435-202,Injection,Subcutaneous,0.03 mg/1mL,US,FDA NDC
DB00069,Infergen,Kadmon Pharmaceuticals,66435-201,Injection,Subcutaneous,0.03 mg/1mL,US,FDA NDC
DB00069,Infergen,"Valeant Pharmaceuticals, Inc.",0187-2007,Injection,Subcutaneous,0.03 mg/1mL,US,FDA NDC
DB00069,Infergen,Three Rivers Pharmaceuticals Llc,,Solution,Subcutaneous,0.03 mg / mL,Canada,DPD
DB00070,Vitrase,"ISTA PHARMACUTICALS, INC",67425-001,"Injection, powder, lyophilized, for solution",Subcutaneous,6200 [USP'U]/5mL,US,FDA NDC
DB00070,Vitrase,Bausch &amp; Lomb Incorporated,24208-002,"Injection, solution",Subcutaneous,200 [USP'U]/1mL,US,FDA NDC
DB00070,Vitrase,"ISTA Pharmaceuticals, Inc.",67425-002,"Injection, solution",Subcutaneous,200 [USP'U]/1mL,US,FDA NDC
DB00071,Hypurin Nph Insulin Isophane Pork,Wockhardt Uk Ltd,,Suspension,Intramuscular; Subcutaneous,100 unit/mL,Canada,DPD
DB00071,Hypurin Regular Insulin Pork,Wockhardt Uk Ltd,,Solution,Intramuscular; Intravenous; Subcutaneous,100 unit,Canada,DPD
DB00071,Regular Purified Pork Insulin Inj,Eli Lilly & Co. Ltd.,,Liquid,Subcutaneous,100 unit / mL,Canada,DPD
DB00072,Herceptin,"Genentech, Inc.",50242-333,,Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Herceptin,"Genentech, Inc.",50242-132,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/7.4mL,US,FDA NDC
DB00072,Herceptin,"Genentech, Inc.",50242-134,Injection,Intravenous,150 mg/7.4mL,US,FDA NDC
DB00072,Herceptin,Hoffmann La Roche,,"Powder, for solution",Intravenous,440 mg / vial,Canada,DPD
DB00072,Herceptin,Roche Registration Gmb H,,"Injection, powder, for solution",Intravenous,150 mg,EU,EMA
DB00072,Herceptin,Roche Registration Gmb H,,"Injection, solution",Subcutaneous,600 mg,EU,EMA
DB00072,Herceptin,Roche Registration Gmb H,,"Injection, solution",Subcutaneous,600 mg,EU,EMA
DB00072,Herceptin Hylecta,"Genentech, Inc.",50242-077,"Injection, solution",Subcutaneous,,US,FDA NDC
DB00072,Herceptin Sc,Hoffmann La Roche,,Solution,Subcutaneous,600 mg / 5 mL,Canada,DPD
DB00072,Herzuma,Celltrion,,"Kit; Powder, for solution",Intravenous,440 mg / vial,Canada,DPD
DB00072,Herzuma,Celltrion,,"Powder, for solution",Intravenous,150 mg / vial,Canada,DPD
DB00072,Herzuma,"Cephalon, Inc.",63459-305,"Injection, powder, lyophilized, for solution; Kit",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Herzuma,"Cephalon, Inc.",63459-303,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/7.15mL,US,FDA NDC
DB00072,Herzuma,Celltrion Healthcare Hungary Kft.,,"Injection, powder, for solution",Intravenous,150 mg,EU,EMA
DB00072,Herzuma,Celltrion Healthcare Hungary Kft.,,"Injection, powder, for solution",Intravenous,420 mg,EU,EMA
DB00072,Kanjinti,AMGEN INC,55513-132,"Injection, powder, lyophilized, for solution",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Kanjinti,AMGEN INC,55513-141,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/7.15mL,US,FDA NDC
DB00072,Kanjinti,Amgen,,"Kit; Powder, for solution",Intravenous,420 mg / vial,Canada,DPD
DB00072,Kanjinti,Amgen,,"Powder, for solution",Intravenous,150 mg / vial,Canada,DPD
DB00072,Kanjinti,AMGEN INC,55513-164,"Injection, powder, lyophilized, for solution; Kit",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Kanjinti,Amgen Europe Bv,,"Injection, powder, for solution",Intravenous,150 mg,EU,EMA
DB00072,Kanjinti,Amgen Europe Bv,,"Injection, powder, for solution",Intravenous,420 mg,EU,EMA
DB00072,Ogivri,Mylan Institutional LLC,67457-847,"Injection, powder, lyophilized, for solution; Kit",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Ogivri,Mylan Institutional LLC,67457-991,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/7.4mL,US,FDA NDC
DB00072,Ogivri,Mylan Institutional LLC,67457-845,"Injection, powder, lyophilized, for solution",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Ogivri,Biosimilar Collaborations Ireland Limited,,"Powder, for solution",Intravenous,150 mg / vial,Canada,DPD
DB00072,Ogivri,Biosimilar Collaborations Ireland Limited,,"Powder, for solution",Intravenous,,Canada,DPD
DB00072,Ogivri,Biocon Biologics Inc.,83257-004,"Injection, powder, lyophilized, for solution; Kit",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Ogivri,Biocon Biologics Inc.,83257-003,"Injection, powder, lyophilized, for solution",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Ogivri,Biocon Biologics Inc.,83257-001,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/7.4mL,US,FDA NDC
DB00072,Ogivri,Biosimilar Collaborations Ireland Limited,,"Injection, powder, for solution",Intravenous,150 mg,EU,EMA
DB00072,Ogivri,Biosimilar Collaborations Ireland Limited,,"Injection, powder, for solution",Intravenous,420 mg,EU,EMA
DB00072,Ontruzant,Merck Sharp & Dohme Corp.,0006-5033,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/1,US,FDA NDC
DB00072,Ontruzant,Merck Sharp & Dohme Corp.,0006-5034,Kit,Intravenous,420 mg/1,US,FDA NDC
DB00072,Ontruzant,Organon LLC,78206-147,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/1,US,FDA NDC
DB00072,Ontruzant,Organon LLC,78206-148,Kit,Intravenous,420 mg/1,US,FDA NDC
DB00072,Ontruzant,"Samsung Bioepis Co., Ltd.",,"Powder, for solution",Intravenous,150 mg / vial,Canada,DPD
DB00072,Ontruzant,"Samsung Bioepis Co., Ltd.",,"Powder, for solution",Intravenous,440 mg / vial,Canada,DPD
DB00072,Ontruzant Solution for Infusion,Samsung Bioepis Nl B.V.,,"Powder, for solution",Intravenous,150 mg,EU,EMA
DB00072,Ontruzant Solution for Infusion,Samsung Bioepis Nl B.V.,,"Powder, for solution",Intravenous,420 mg,EU,EMA
DB00072,Perjeta-herceptin,Hoffmann La Roche,,"Kit; Powder, for solution; Solution",Intravenous,,Canada,DPD
DB00072,Phesgo,Hoffmann La Roche,,Solution,Subcutaneous,,Canada,DPD
DB00072,Phesgo,Hoffmann La Roche,,Solution,Subcutaneous,,Canada,DPD
DB00072,Phesgo,"Genentech, Inc.",50242-245,"Injection, solution",Subcutaneous,,US,FDA NDC
DB00072,Phesgo,"Genentech, Inc.",50242-260,"Injection, solution",Subcutaneous,,US,FDA NDC
DB00072,Phesgo,Roche Registration Gmb H,,"Injection, solution",Subcutaneous,,EU,EMA
DB00072,Phesgo,Roche Registration Gmb H,,"Injection, solution",Subcutaneous,,EU,EMA
DB00072,Trazimera,Pfizer Laboratories Div Pfizer Inc,0069-0305,"Injection, powder, lyophilized, for solution; Kit",Intravenous,420 mg/20mL,US,FDA NDC
DB00072,Trazimera,Pfizer Laboratories Div Pfizer Inc,0069-0308,"Injection, powder, lyophilized, for solution",Intravenous,150 mg/7.15mL,US,FDA NDC
DB00072,Trazimera,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,440 mg / vial,Canada,DPD
DB00072,Trazimera,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,150 mg / vial,Canada,DPD
DB00072,Trazimera,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,150 mg,EU,EMA
DB00072,Trazimera,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,420 mg,EU,EMA
DB00072,Z Ercepac,Accord Healthcare S.L.U.,,,Intravenous,420 mg,EU,EMA
DB00072,Zercepac,Accord Healthcare S.L.U.,,"Injection, powder, for solution",Intravenous,150 mg,EU,EMA
DB00072,Zercepac,Accord Healthcare S.L.U.,,"Injection, powder, for solution",Intravenous,60 mg,EU,EMA
DB00073,Blitzima,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Blitzima,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Mabthera,Roche Registration Gmb H,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Mabthera,Roche Registration Gmb H,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Mabthera,Roche Registration Gmb H,,"Injection, solution",Subcutaneous,1400 mg,EU,EMA
DB00073,Mabthera,Roche Registration Gmb H,,"Injection, solution",Subcutaneous,1600 mg,EU,EMA
DB00073,Riabni,AMGEN INC,55513-224,"Injection, solution",Intravenous,100 mg/10mL,US,FDA NDC
DB00073,Riabni,AMGEN INC,55513-326,"Injection, solution",Intravenous,500 mg/50mL,US,FDA NDC
DB00073,Riabni,Amgen,,Solution,Intravenous,10 mg / mL,Canada,DPD
DB00073,Ritemvia,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Ritemvia,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Rituxan,"Genentech, Inc.",50242-051,"Injection, solution",Intravenous,10 mg/1mL,US,FDA NDC
DB00073,Rituxan,"Genentech, Inc.",50242-053,"Injection, solution",Intravenous,10 mg/1mL,US,FDA NDC
DB00073,Rituxan,Hoffmann La Roche,,Solution,Intravenous,10 mg / mL,Canada,DPD
DB00073,Rituxan Hycela,"Genentech, Inc.",50242-108,"Injection, solution",Subcutaneous,,US,FDA NDC
DB00073,Rituxan Hycela,"Genentech, Inc.",50242-109,"Injection, solution",Subcutaneous,,US,FDA NDC
DB00073,Rituxan Sc,Hoffmann La Roche,,Solution,Subcutaneous,1400 mg / 11.7 mL,Canada,DPD
DB00073,Rituxan Sc,Hoffmann La Roche,,Solution,Subcutaneous,1600 mg / 13.4 mL,Canada,DPD
DB00073,Rituzena,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Rituzena,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Rixathon,Sandoz,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Rixathon,Sandoz,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Rixathon,Sandoz,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Rixathon,Sandoz,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Riximyo,Sandoz Canada Incorporated,,Solution,Intravenous,10 mg / mL,Canada,DPD
DB00073,Riximyo,Sandoz,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Riximyo,Sandoz,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Riximyo,Sandoz,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Riximyo,Sandoz,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Ruxience,Pfizer Laboratories Div Pfizer Inc,0069-0238,"Injection, solution",Intravenous,100 mg/10mL,US,FDA NDC
DB00073,Ruxience,Pfizer Laboratories Div Pfizer Inc,0069-0249,"Injection, solution",Intravenous,500 mg/50mL,US,FDA NDC
DB00073,Ruxience,Pfizer Canada Ulc,,Solution,Intravenous,10 mg / mL,Canada,DPD
DB00073,Ruxience,Pfizer Europe Ma Eeig,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00073,Ruxience,Pfizer Europe Ma Eeig,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Truxima,"Cephalon, Inc.",63459-103,"Injection, solution",Intravenous,10 mg/1mL,US,FDA NDC
DB00073,Truxima,"Cephalon, Inc.",63459-104,"Injection, solution",Intravenous,10 mg/1mL,US,FDA NDC
DB00073,Truxima,Celltrion,,Solution,Intravenous,100 mg / 10 mL,Canada,DPD
DB00073,Truxima,Celltrion,,Solution,Intravenous,500 mg / 50 mL,Canada,DPD
DB00073,Truxima,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,500 mg,EU,EMA
DB00073,Truxima,Celltrion Healthcare Hungary Kft.,,"Injection, solution, concentrate",Intravenous,100 mg,EU,EMA
DB00074,Simulect,Novartis Pharmaceuticals Corporation,0078-0393,"Injection, powder, for solution",Intravenous,10 mg/2.5mL,US,FDA NDC
DB00074,Simulect,Novartis Pharmaceuticals Corporation,0078-0331,"Injection, powder, for solution",Intravenous,20 mg/5mL,US,FDA NDC
DB00074,Simulect,Novartis,,"Powder, for solution",Intravenous,20 mg / vial,Canada,DPD
DB00074,Simulect,Novartis Europharm Limited,,"Injection, powder, for solution",Intravenous,20 mg,EU,EMA
DB00074,Simulect,Novartis Europharm Limited,,"Injection, powder, for solution",Intravenous,10 mg,EU,EMA
DB00074,Simulect,Novartis Europharm Limited,,Injection,Intravenous,10 mg,EU,EMA
DB00074,Simulect,Novartis Europharm Limited,,,Intravenous,20 mg,EU,EMA
DB00075,Okt3,"Centocor Ortho Biotech Products, L.P.",59676-101,"Injection, solution",Intravenous,5 mg/5mL,US,FDA NDC
DB00075,Orthoclone Okt 3 Sterile Solution IV 1mg/ml,Janssen Pharmaceuticals,,Solution,Intravenous,1 mg / mL,Canada,DPD
DB00076,Digibind,Glaxosmithkline Inc,0173-0230,"Injection, powder, for solution",Intravenous,38 mg/1,US,FDA NDC
DB00076,Digibind,Glaxosmithkline Inc,,"Powder, for solution",Intravenous,38 mg / vial,Canada,DPD
DB00076,DigiFab,BTG International Inc.,50633-120,"Injection, powder, for solution",Intravenous,40 mg/1,US,FDA NDC
DB00076,DigiFab,Savage Laboratories a division of Fougera Pharmaceuticals Inc.,0281-0365,"Injection, powder, lyophilized, for solution",Intravenous,38 mg/1,US,FDA NDC
DB00076,DigiFab,Btg International Inc,,"Powder, for solution",Intravenous,40 mg / vial,Canada,DPD
DB00078,Zevalin,"Spectrum Pharmaceuticals, Inc.",68152-104,Kit,Intravenous,1.6 mg/1mL,US,FDA NDC
DB00078,Zevalin,"Spectrum Pharmaceuticals, Inc.",68152-103,Kit,Intravenous,1.6 mg/1mL,US,FDA NDC
DB00078,Zevalin,Acrotech Biopharma Inc,72893-007,Injection; Kit,Intravenous,1.6 mg/1mL,US,FDA NDC
DB00078,Zevalin,Ceft Biopharma S.R.O.,,Kit,Intravenous,1.6 mg/ml,EU,EMA
DB00080,Cubicin,Merck Sharp & Dohme Llc,67919-011,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Cubicin,"OSO BioPharmaceuticals Manufacturing, LLC",70835-1001,Injection,Intravenous,350 mg/350mg,US,FDA NDC
DB00080,Cubicin,"Cubist Pharmaceuticals, Inc.",,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Cubicin,Merck Sharp & Dohme B.V.,,,Intravenous,350 mg,EU,EMA
DB00080,Cubicin,Merck Sharp & Dohme B.V.,,Solution,Intravenous,500 mg,EU,EMA
DB00080,Cubicin,Merck Sharp & Dohme B.V.,,,Intravenous,350 mg,EU,EMA
DB00080,Cubicin,Merck Sharp & Dohme B.V.,,Solution,Intravenous,500 mg,EU,EMA
DB00080,Cubicin RF,Merck Sharp & Dohme Llc,67919-012,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Cubicin RF,"Cubist Pharmaceuticals, Inc.",,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin,"Teva Parenteral Medicines, Inc.",0703-0125,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Xellia Pharmaceuticals USA LLC,70594-053,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,"Dr.Reddy's Laboratories Inc.,",43598-413,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Fresenius Kabi USA, LLC",63323-585,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Accord Healthcare Inc.,16729-435,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,BluePoint Laboratories,68001-376,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Northstar RxLLC,16714-892,"Injection, powder, lyophilized, for solution",Intravenous,50 mg/1mL,US,FDA NDC
DB00080,Daptomycin,"Civica, Inc.",72572-102,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Jiangsu Hengrui Medicine Co., Ltd.",57884-3151,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Civica, Inc.",72572-100,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,"Xellia Pharmaceuticals USA, LLC",45932-0039,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Xellia Pharmaceuticals USA LLC,70594-034,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Sagent Pharmaceuticals,25021-174,"Injection, powder, lyophilized, for solution",Intravenous,50 mg/1mL,US,FDA NDC
DB00080,Daptomycin,Meitheal Pharmaceuticals Inc.,71288-018,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Hikma Pharmaceuticals USA Inc.,0143-9378,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Fresenius Kabi USA, LLC",63323-371,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Fresenius Kabi USA, LLC",63323-871,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Sagent Pharmaceuticals,25021-179,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,"Accord Healthcare, Inc.",16729-434,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,BE Pharmaceuticals Inc.,71839-107,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Mylan Institutional LLC,67457-813,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Hospira, Inc.",0409-0106,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Cipla USA Inc.,69097-807,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Sandoz Inc.,0781-3295,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Hospira Inc.,0409-2757,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,BE Pharmaceuticals Inc.,71839-108,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,BluePoint Laboratories,68001-467,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Camber Pharmaceuticals Inc.,31722-102,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Cipla USA Inc.,69097-850,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Meitheal Pharmaceuticals Inc.,71288-017,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Meitheal Pharmaceuticals Inc.,71288-016,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Hospira, Inc.",0409-0120,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,"Qilu Pharmaceutical Co., Ltd.",67184-0549,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Eugia US LLC,55150-344,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Dr. Reddy's Laboratories Inc.,",43598-476,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Apotex Corp.,60505-6229,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Hospira, Inc.",0409-0122,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Slate Run Pharmaceuticals, Llc",70436-033,"Injection, powder, lyophilized, for suspension",Intravenous,500 mg/20mL,US,FDA NDC
DB00080,Daptomycin,"Camber Pharmaceuticals, Inc.",31722-216,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Camber Pharmaceuticals, Inc.",31722-215,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Northstar RxLLC,72603-152,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Northstar RxLLC,72603-147,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,ASPIRO PHARMA LIMITED,72201-1009,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Xellia Pharmaceuticals USA LLC,70594-066,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin,Xellia Pharmaceuticals USA LLC,70594-060,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,"Hainan Poly Pharm., Co., Ltd.",14335-120,"Injection, powder, lyophilized, for suspension",Intravenous,500 mg/20mL,US,FDA NDC
DB00080,Daptomycin,Sintetica US LLC,83090-011,"Injection, powder, lyophilized, for suspension",Intravenous,500 mg/20mL,US,FDA NDC
DB00080,Daptomycin,Mylan Institutional LLC,67457-941,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00080,Daptomycin,Hospira Inc.,0409-5933,"Injection, powder, lyophilized, for solution",Intravenous,350 mg/7mL,US,FDA NDC
DB00080,Daptomycin for Injection,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,350 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection,TEVA Canada Limited,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection,Dr Reddy's Laboratories Ltd,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection,Sandoz Canada Incorporated,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection,Accord Healthcare Inc,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection,Juno Pharmaceuticals Corp.,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection,Dr Reddy's Laboratories Ltd,,"Powder, for solution",Intravenous,350 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection RF,Baxter Laboratories,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection RF,Auro Pharma Inc,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin for Injection RF,Eugia Pharma Inc.,,"Powder, for solution",Intravenous,500 mg / vial,Canada,DPD
DB00080,Daptomycin Hospira,Pfizer Europe Ma Eeig,,,Intravenous,350 mg,EU,EMA
DB00080,Daptomycin Hospira,Pfizer Europe Ma Eeig,,,Intravenous,350 mg,EU,EMA
DB00080,Daptomycin Hospira,Pfizer Europe Ma Eeig,,,Intravenous,500 mg,EU,EMA
DB00080,Daptomycin Hospira,Pfizer Europe Ma Eeig,,Injection,Intravenous,500 mg,EU,EMA
DB00080,Daptomycin in Sodium Chloride,Baxter Healthcare Corporation,0338-0712,"Injection, solution",Intravenous,350 mg/50mL,US,FDA NDC
DB00080,Daptomycin in Sodium Chloride,Baxter Healthcare Corporation,0338-0714,"Injection, solution",Intravenous,500 mg/50mL,US,FDA NDC
DB00080,Daptomycin in Sodium Chloride,Baxter Healthcare Corporation,0338-0716,"Injection, solution",Intravenous,700 mg/100mL,US,FDA NDC
DB00080,Daptomycin in Sodium Chloride,Baxter Healthcare Corporation,0338-0718,"Injection, solution",Intravenous,1000 mg/100mL,US,FDA NDC
DB00080,Dapzura RT,Baxter Healthcare Corporation,60977-145,"Injection, powder, lyophilized, for solution",Intravenous,500 mg/10mL,US,FDA NDC
DB00081,Bexxar,Glaxosmithkline Inc,0007-3260,Kit,Intravenous,,US,FDA NDC
DB00081,Bexxar,Glaxosmithkline Inc,0007-3260,Kit,Intravenous,,US,FDA NDC
DB00081,Bexxar Dosimetric,Glaxosmithkline Inc,0007-3261,Injection,Intravenous,0.61 mCi/1mL,US,FDA NDC
DB00081,Bexxar Therapeutic,Glaxosmithkline Inc,0007-3262,Injection,Intravenous,5.6 mCi/1mL,US,FDA NDC
DB00081,Bexxar Therapy,Glaxosmithkline Inc,,Kit; Solution,Intravenous,14 mg / mL,Canada,DPD
DB00082,Somavert,Pharmacia and Upjohn Company LLC,0009-5176,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,10 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia and Upjohn Company LLC,0009-5178,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,15 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia and Upjohn Company LLC,0009-5180,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,20 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia and Upjohn Company LLC,0009-5199,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,25 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia and Upjohn Company LLC,0009-5200,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,30 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia &amp; Upjohn Company LLC,0009-7166,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,10 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia &amp; Upjohn Company LLC,0009-7168,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,15 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia &amp; Upjohn Company LLC,0009-7188,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,20 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia &amp; Upjohn Company LLC,0009-7199,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,25 mg/1mL,US,FDA NDC
DB00082,Somavert,Pharmacia &amp; Upjohn Company LLC,0009-7200,"Injection, powder, lyophilized, for solution; Kit",Subcutaneous,30 mg/1mL,US,FDA NDC
DB00082,Somavert,Pfizer Canada Ulc,,"Kit; Powder, for solution",Subcutaneous,15 mg / vial,Canada,DPD
DB00082,Somavert,Pfizer Canada Ulc,,"Kit; Powder, for solution",Subcutaneous,20 mg / vial,Canada,DPD
DB00082,Somavert,Pfizer Canada Ulc,,"Kit; Powder, for solution",Subcutaneous,25 mg / vial,Canada,DPD
DB00082,Somavert,Pfizer Canada Ulc,,"Kit; Powder, for solution",Subcutaneous,30 mg / vial,Canada,DPD
DB00082,Somavert,Pfizer Canada Ulc,,"Kit; Powder, for solution",Subcutaneous,10 mg / vial,Canada,DPD
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,10 mg,EU,EMA
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,15 mg,EU,EMA
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,20 mg,EU,EMA
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,20 mg,EU,EMA
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,25 mg,EU,EMA
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,25 mg,EU,EMA
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,30 mg,EU,EMA
DB00082,Somavert,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Subcutaneous,30 mg,EU,EMA
DB00083,Botox,Abbvie,,"Powder, for solution",Intramuscular,100 unit / vial,Canada,DPD
DB00083,Botox,Abbvie,,"Powder, for solution",Intramuscular,50 unit / vial,Canada,DPD
DB00083,Botox,Abbvie,,"Powder, for solution",Intramuscular,200 unit / vial,Canada,DPD
DB00083,BOTOX Cosmetic,Abbvie,,"Powder, for solution",Intramuscular,100 unit / vial,Canada,DPD
DB00083,BOTOX Cosmetic,Abbvie,,"Powder, for solution",Intramuscular,50 unit / vial,Canada,DPD
DB00083,Dysport,Medicis Pharmaceutical Corporation,99207-500,"Injection, powder, lyophilized, for solution",Intramuscular,300 [USP'U]/1,US,FDA NDC
DB00083,Dysport Aesthetic,Ipsen Biopharmaceuticals Canada Inc,,"Powder, for solution",Intramuscular,300 unit / vial,Canada,DPD
DB00083,Dysport Therapeutic,Ipsen Biopharmaceuticals Canada Inc,,"Powder, for solution",Intramuscular,500 unit / vial,Canada,DPD
DB00083,Dysport Therapeutic,Ipsen Biopharmaceuticals Canada Inc,,"Powder, for solution",Intramuscular,300 unit / vial,Canada,DPD
DB00083,Nuceiva,Evolus Incorporated,,"Powder, for solution",Intramuscular,100 unit / vial,Canada,DPD
DB00083,Nuceiva,Evolus Pharma B.V.,,"Injection, powder, for solution",Intramuscular,100 U,EU,EMA
DB00083,Nuceiva,Evolus Pharma B.V.,,"Injection, powder, for solution",Intramuscular,50 U,EU,EMA
DB00083,Nuceiva,Evolus Pharma B.V.,,"Injection, powder, for solution",Intramuscular,50 U,EU,EMA
DB00083,Nuceiva,Evolus Pharma B.V.,,"Injection, powder, for solution",Intramuscular,50 U,EU,EMA
DB00083,Xeomin,Merz Pharmaceuticals,,"Powder, for solution",Intramuscular,100 unit / vial,Canada,DPD
DB00083,Xeomin,Merz Pharmaceuticals,,"Powder, for solution",Intramuscular,50 unit / vial,Canada,DPD
DB00083,Xeomin Cosmetic,Merz Pharmaceuticals,,"Powder, for solution",Intramuscular,100 unit / vial,Canada,DPD
DB00085,Alka-pan Tablets,Morter Healthsystem,,Tablet,Oral,,Canada,DPD
DB00085,Bio-zyme Tab 50mg,"Metagenics, Inc.",,Tablet,Oral,50 mg,Canada,DPD
DB00085,Duchol Ect,Duchesnay Inc.,,"Tablet, delayed release",Oral,,Canada,DPD
DB00085,Dygest,Creative Nutrition Canada Corp.,,Tablet,Oral,,Canada,DPD
DB00085,Enzyme Tablets,General Nutrition Canada Inc.,,Tablet,Oral,,Canada,DPD
DB00085,Festal Plus,OASIS TRADING,72689-0010,Tablet,Oral,,US,FDA NDC
DB00085,Medichol,Medic Laboratory LtÉe,,Tablet,Oral,,Canada,DPD
DB00085,Neo Life Enzyme Tab,Golden Neo Life International Ltd.,,Tablet,Oral,,Canada,DPD
DB00085,Pancreatin and Enzyme Formula - Tablet,Health Wise Nutrition Inc.,,Tablet,Oral,,Canada,DPD
DB00085,Pancreatin Tab 400mg,Jamieson Laboratories Ltd,,Tablet,Oral,400 mg / tab,Canada,DPD
DB00085,Pancreatine Enzymes,Gahler Enterprises Ltd.,,Tablet,Oral,,Canada,DPD
DB00085,Pancrelipase HP,Nordmark Arzneimittel GmbH & Co. KG,61974-0003,Powder,Not applicable,1 kg/1kg,US,FDA NDC
DB00085,Pancrex Granules,Paines and Byrne Ltd.,,,Oral,1 g / g,Canada,DPD
DB00085,Pancrex V Capsules,Paines and Byrne Ltd.,,Capsule,Oral,340 mg / cap,Canada,DPD
DB00085,Pancrex V Forte Tablets 1gm/tab,Paines and Byrne Ltd.,,"Tablet, delayed release",Oral,1 g / tab,Canada,DPD
DB00085,Pancrex V Powder,Paines and Byrne Ltd.,,Powder,Oral,,Canada,DPD
DB00085,Pancrex V Tab 0.33gm,Paines and Byrne Ltd.,,"Tablet, delayed release",Oral,330 mg / tab,Canada,DPD
DB00085,Phytozyme Tab 150mg,Phyto Health Corporation,,Tablet,Oral,150 mg,Canada,DPD
DB00085,Pro Gest Tab,Pure Life International Prods Inc.,,Tablet,Oral,,Canada,DPD
DB00085,Stozyme,"Chunwoo Pharmaceutical Co., Ltd.",72850-0004,Tablet,Oral,,US,FDA NDC
DB00085,Zypanax,Therapeutic Foods Co.,,Tablet,Oral,,Canada,DPD
DB00086,Kabikinase - Pws 1500000units/vial,Pharmacia & Upjohn Inc,,"Powder, for solution",Intracoronary; Intravenous,1500000 unit / vial,Canada,DPD
DB00086,Kabikinase - Pws 250000 Unit/vial,Pharmacia & Upjohn Inc,,"Powder, for solution",Intracoronary; Intravenous,250000 unit / vial,Canada,DPD
DB00086,Kabikinase - Pws 750000units/vial,Pharmacia & Upjohn Inc,,"Powder, for solution",Intracoronary; Intravenous,750000 unit / vial,Canada,DPD
DB00086,Streptase,Csl Behring,,"Powder, for solution",Intracoronary; Intravenous,750000 unit / vial,Canada,DPD
DB00086,Streptase,Csl Behring,,"Powder, for solution",Intracoronary; Intravenous,1500000 unit / vial,Canada,DPD
DB00086,Streptase,Csl Behring,,"Powder, for solution",Intracoronary; Intravenous,250000 unit / vial,Canada,DPD
DB00086,Streptase Inj 1500000 Unit/vial,Hoechst Canada Inc.,,"Powder, for solution",Intravenous,1500000 unit / vial,Canada,DPD
DB00086,Streptase Inj 250000unit/vial,Hoechst Canada Inc.,,"Powder, for solution",Intravenous,250000 unit / vial,Canada,DPD
DB00086,Streptase Inj 750000unit/vial,Hoechst Canada Inc.,,"Powder, for solution",Intravenous,750000 unit / vial,Canada,DPD
DB00087,Campath,Bayer,50419-357,Injection,Intravenous,30 mg/1mL,US,FDA NDC
DB00087,Campath,Genzyme Corporation,58468-0357,Injection,Intravenous,30 mg/1mL,US,FDA NDC
DB00087,Lemtrada,Genzyme Corporation,58468-0200,"Injection, solution, concentrate",Intravenous,12 mg/1.2mL,US,FDA NDC
DB00087,Lemtrada,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,Solution,Intravenous,12 mg / 1.2 mL,Canada,DPD
DB00087,Lemtrada,Sanofi Belgium,,"Injection, solution, concentrate",Intravenous,12 mg,EU,EMA
DB00087,Mabcampath,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,Solution,Intravenous,30 mg / mL,Canada,DPD
DB00087,Mabcampath,Genzyme Corporation,,Solution,Intravenous,10 mg / mL,Canada,DPD
DB00088,Ceredase,Genzyme Corporation,58468-1060,"Injection, solution, concentrate",Intravenous,80 U/1mL,US,FDA NDC
DB00089,ProstaScint Kit for the Preparation of Indium In 111 Capromab Pendetide,"Jazz Pharmaceuticals, Inc.",57902-817,Kit,Intravenous,0.5 mg/1mL,US,FDA NDC
DB00090,Aldurazyme,Genzyme Corporation,58468-0070,"Injection, solution, concentrate",Intravenous,2.9 mg/5mL,US,FDA NDC
DB00090,Aldurazyme,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,Solution,Intravenous,0.58 mg / mL,Canada,DPD
DB00090,Aldurazyme,Sanofi B.V.,,"Injection, solution, concentrate",Intravenous,100 U/ml,EU,EMA
DB00090,Aldurazyme,Sanofi B.V.,,"Injection, solution, concentrate",Intravenous,100 U/ml,EU,EMA
DB00090,Aldurazyme,Sanofi B.V.,,"Injection, solution, concentrate",Intravenous,100 U/ml,EU,EMA
DB00091,Apo-cyclosporine Oral Solution,Apotex Corporation,,Solution,Oral,100 mg / mL,Canada,DPD
DB00091,Aqua-stasis,Dr Marc's Manufacturing And Sales,70414-201,Liquid,Ophthalmic,0.0005 g/100mL,US,FDA NDC
DB00091,Cequa,"Sun Pharmaceutical Industries, Inc.",47335-506,Solution / drops,Ophthalmic; Topical,0.0009 g/1mL,US,FDA NDC
DB00091,Cequa,"Sun Pharmaceutical Industries, Inc.",47335-507,Solution / drops,Ophthalmic; Topical,0.0009 mg/1mL,US,FDA NDC
DB00091,Cequa,Sun Pharmaceutical Industries Limited,,Solution,Ophthalmic,0.09 % w/v,Canada,DPD
DB00091,Cyclo-derm,Dr Marc's Manufacturing And Sales,70414-104,Liquid,Topical,0.25 g/100mL,US,FDA NDC
DB00091,Cyclosporine,"Physicians Total Care, Inc.",54868-5522,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,"Physicians Total Care, Inc.",54868-6232,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,Bedford Pharmaceuticals,55390-122,"Injection, solution",Intravenous,50 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Apotex Corporation,60505-0354,Solution,Oral,100 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Amerincan Health Packaging,62584-827,Capsule,Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,"Morton Grove Pharmaceuticals, Inc.",60432-140,Solution,Oral,100 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Cardinal Health,55154-6349,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,American Health Packaging,68084-879,"Capsule, gelatin coated",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine,American Health Packaging,68084-921,"Capsule, gelatin coated",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,Mayne Pharma Inc.,51862-458,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine,Mayne Pharma Inc.,51862-460,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,"Eon Labs, Inc.",0185-0932,Capsule,Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine,"Eon Labs, Inc.",0185-0933,Capsule,Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,"AMERICAN REGENT, INC.",0517-0866,"Injection, solution",Intravenous,50 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Padagis US LLC,0574-0866,"Injection, solution",Intravenous,50 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,"Teva Pharmaceuticals USA, Inc.",0172-7313,Solution,Oral,100 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Apotex Corp.,60505-0133,"Capsule, gelatin coated",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine,Apotex Corp.,60505-0134,"Capsule, gelatin coated",Oral,100 mg/1,US,FDA NDC
DB00091,CycloSPORINE,"Actavis Pharma, Inc.",0591-2222,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,CycloSPORINE,"Actavis Pharma, Inc.",0591-2223,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,CycloSPORINE,"Actavis Pharma, Inc.",0591-2224,Solution,Oral,100 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,bryant ranch prepack,63629-8640,"Injection, solution",Intravenous,50 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Sandoz Canada Incorporated,,Capsule,Oral,25 mg,Canada,DPD
DB00091,Cyclosporine,Mylan Pharmaceuticals Inc.,0378-8760,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,"KVK-Tech, Inc.",10702-808,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Apotex Corp,60505-6202,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,"Lupin Pharmaceuticals, Inc.",68180-214,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,A-S Medication Solutions,50090-5977,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Cyclosporine,Strides Pharma Science Limited,64380-127,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine,Strides Pharma Science Limited,64380-128,"Capsule, liquid filled",Oral,50 mg/1,US,FDA NDC
DB00091,Cyclosporine,Strides Pharma Science Limited,64380-129,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-837,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-838,"Capsule, liquid filled",Oral,50 mg/1,US,FDA NDC
DB00091,Cyclosporine,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-839,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine A,Letco Medical,62991-1533,Powder,Not applicable,1 g/1g,US,FDA NDC
DB00091,Cyclosporine Modified,"IVAX Pharmaceuticals, Inc.",0172-7310,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"IVAX Pharmaceuticals, Inc.",0172-7311,"Capsule, liquid filled",Oral,50 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"IVAX Pharmaceuticals, Inc.",0172-7312,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"Teva Pharmaceuticals USA, Inc.",0093-5740,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"Teva Pharmaceuticals USA, Inc.",0093-5741,"Capsule, liquid filled",Oral,50 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"Teva Pharmaceuticals USA, Inc.",0093-5742,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"Teva Pharmaceuticals USA, Inc.",0093-9018,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"Teva Pharmaceuticals USA, Inc.",0093-9019,"Capsule, liquid filled",Oral,50 mg/1,US,FDA NDC
DB00091,Cyclosporine Modified,"Teva Pharmaceuticals USA, Inc.",0093-9020,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,"CycloSPORINE, Modfied",Apotex Corp.,60505-4630,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,"CycloSPORINE, Modfied",Apotex Corp.,60505-4631,"Capsule, liquid filled",Oral,50 mg/1,US,FDA NDC
DB00091,"CycloSPORINE, Modfied",Apotex Corp.,60505-4632,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Cyclosporine/Chondroitin PF,"Imprimis Njof, Llc",71384-514,Emulsion,Ophthalmic,1 mg/1mL,US,FDA NDC
DB00091,Cyclosporine/Chondroitin Sulfate PF,ImprimisRx NJ,70261-514,Emulsion,Ophthalmic,1 mg/1mL,US,FDA NDC
DB00091,Gengraf,AbbVie Inc.,0074-0541,Capsule,Oral,50 mg/1,US,FDA NDC
DB00091,Gengraf,AbbVie Inc.,0074-6479,Capsule,Oral,100 mg/1,US,FDA NDC
DB00091,Gengraf,AbbVie Inc.,0074-6463,Capsule,Oral,25 mg/1,US,FDA NDC
DB00091,Gengraf,AbbVie Inc.,0074-3108,Capsule,Oral,25 mg/1,US,FDA NDC
DB00091,Gengraf,AbbVie Inc.,0074-3109,Capsule,Oral,100 mg/1,US,FDA NDC
DB00091,Gengraf,AbbVie Inc.,0074-7269,Solution,Oral,100 mg/1mL,US,FDA NDC
DB00091,Gengraf,Cardinal Health,55154-2396,Capsule,Oral,25 mg/1,US,FDA NDC
DB00091,Gengraf,Cardinal Health,55154-2395,Capsule,Oral,100 mg/1,US,FDA NDC
DB00091,Hydro-stasis,Dr Marc's Manufacturing And Sales,70414-202,Liquid,Ophthalmic,0.0005 g/100mL,US,FDA NDC
DB00091,Ikervis,Santen Oy,,,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Ikervis,Santen Oy,,,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Ikervis,Santen Oy,,,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Ikervis,Santen Oy,,,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Ikervis,Santen Oy,,,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Nail Cyclosporin-A,Dr Marc's Manufacturing And Sales,70414-105,Liquid,Topical,0.25 g/100mL,US,FDA NDC
DB00091,Neoral,Cardinal Health,55154-3418,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Neoral,Novartis Pharmaceuticals Corporation,0078-0246,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Neoral,Novartis Pharmaceuticals Corporation,0078-0248,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Neoral,Novartis Pharmaceuticals Corporation,0078-0274,Solution,Oral,100 mg/1mL,US,FDA NDC
DB00091,Neoral,Novartis,,Capsule,Oral,100 mg,Canada,DPD
DB00091,Neoral,Novartis,,Solution,Oral,100 mg / mL,Canada,DPD
DB00091,Neoral,Novartis,,Capsule,Oral,25 mg,Canada,DPD
DB00091,Neoral,Novartis,,Capsule,Oral,50 mg,Canada,DPD
DB00091,Neoral,Novartis,,Capsule,Oral,10 mg,Canada,DPD
DB00091,PMS-cyclosporine,Pharmascience Inc,,Capsule,Oral,25 mg,Canada,DPD
DB00091,PMS-cyclosporine,Pharmascience Inc,,Capsule,Oral,100 mg,Canada,DPD
DB00091,PMS-cyclosporine,Pharmascience Inc,,Capsule,Oral,50 mg,Canada,DPD
DB00091,Restasis,"Physicians Total Care, Inc.",54868-4793,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Restasis,A-S Medication Solutions,50090-4476,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Restasis,A-S Medication Solutions,50090-1242,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Restasis,"Allergan, Inc.",0023-9163,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Restasis,Abbvie,,Emulsion,Ophthalmic,0.05 % w/v,Canada,DPD
DB00091,Restasis MultiDose,"Allergan, Inc.",0023-5301,Emulsion,Ophthalmic,0.5 mg/1mL,US,FDA NDC
DB00091,Restasis MultiDose,Abbvie,,Emulsion,Ophthalmic,0.05 % w/v,Canada,DPD
DB00091,Sandimmune,Novartis Pharmaceuticals Corporation,0078-0240,"Capsule, liquid filled",Oral,25 mg/1,US,FDA NDC
DB00091,Sandimmune,Novartis Pharmaceuticals Corporation,0078-0241,"Capsule, liquid filled",Oral,100 mg/1,US,FDA NDC
DB00091,Sandimmune,Novartis Pharmaceuticals Corporation,0078-0109,Injection,Intravenous,50 mg/1mL,US,FDA NDC
DB00091,Sandimmune,Novartis Pharmaceuticals Corporation,0078-0110,Solution,Oral,100 mg/1mL,US,FDA NDC
DB00091,Sandimmune Cap 50mg,Sandoz,,Capsule,Oral,50 mg,Canada,DPD
DB00091,Sandimmune I.V.,Novartis,,Solution,Intravenous,50 mg / mL,Canada,DPD
DB00091,Sandimmune Oral Sol 100mg/ml,Sandoz,,Liquid,Oral,100 mg / mL,Canada,DPD
DB00091,Sandimmune Soft Gelatin Cap 100mg,Sandoz,,Capsule,Oral,100 mg,Canada,DPD
DB00091,Sandimmune Soft Gelatine Cap 25mg,Sandoz,,Capsule,Oral,25 mg,Canada,DPD
DB00091,Sandoz Cyclosporine,Sandoz Canada Incorporated,,Capsule,Oral,100 mg,Canada,DPD
DB00091,Sandoz Cyclosporine,Sandoz Canada Incorporated,,Capsule,Oral,25 mg,Canada,DPD
DB00091,Sandoz Cyclosporine,Sandoz Canada Incorporated,,Capsule,Oral,50 mg,Canada,DPD
DB00091,Teva-cyclosporine,TEVA Canada Limited,,Emulsion,Ophthalmic,0.05 % w/v,Canada,DPD
DB00091,Verkazia,Santen Incorporated,,Emulsion,Ophthalmic,0.1 % w/v,Canada,DPD
DB00091,Verkazia,Santen Incorporated,65086-001,Emulsion,Ophthalmic; Topical,1 mg/1mL,US,FDA NDC
DB00091,Verkazia,Santen Oy,,Emulsion,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Verkazia,Santen Oy,,Emulsion,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Verkazia,Santen Oy,,Emulsion,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Verkazia,Santen Oy,,Emulsion,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Verkazia,Santen Oy,,Emulsion,Ophthalmic,1 mg/ml,EU,EMA
DB00091,Vevye,Novaliq GmbH,83339-002,Solution / drops,Ophthalmic,1 mg/1mL,US,FDA NDC
DB00091,Vevye,"Harrow Eye, LLC",82667-900,Solution / drops,Ophthalmic,1 mg/1mL,US,FDA NDC
DB00092,Amevive,Astellas Pharma Inc,0469-0021,Kit,Intramuscular,15 mg/0.5mL,US,FDA NDC
DB00092,Amevive,Astellas Pharma Inc,,"Powder, for solution",Intramuscular,15 mg / 0.5 mL,Canada,DPD
DB00094,Bravelle,Ferring Pharmaceuticals,,"Powder, for solution",Intramuscular; Subcutaneous,75 unit / vial,Canada,DPD
DB00094,Fertinorm Hp 150 - Pws Diluent Im Sc,"Emd Serono, A Division Of Emd Inc., Canada",,"Kit; Liquid; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00094,Fertinorm Hp 75 - Pws Diluent Im Sc,"Emd Serono, A Division Of Emd Inc., Canada",,"Liquid; Powder, for solution",Intramuscular; Subcutaneous,,Canada,DPD
DB00094,Metrodin 75 I.U.,Industria Farmaceutica Serono Spa,,"Powder, for solution",Intramuscular,75 unit / amp,Canada,DPD
DB00095,Raptiva,"Emd Serono, A Division Of Emd Inc., Canada",,"Powder, for solution",Subcutaneous,150 mg / vial,Canada,DPD
DB00095,Raptiva,Serono Europe Limited,,"Injection, powder, for solution",Subcutaneous,100 mg/ml,EU,EMA
DB00095,Raptiva,Serono Europe Limited,,"Injection, powder, for solution",Subcutaneous,100 mg/ml,EU,EMA
DB00095,Raptiva,Serono Europe Limited,,"Injection, powder, for solution",Subcutaneous,100 mg/ml,EU,EMA
DB00097,Chorionic Gonadotropin,"Physicians Total Care, Inc.",54868-4121,Kit,Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00097,Chorionic Gonadotropin,"APP Pharmaceuticals, LLC",63323-025,Kit,Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00097,Chorionic Gonadotropin,"Fresenius Kabi USA, LLC",63323-030,Kit,Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00097,Ovidrel,"EMD Serono, Inc.",44087-1150,"Injection, solution",Subcutaneous,250 ug/0.5mL,US,FDA NDC
DB00097,Ovidrel,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,250 mcg / 0.5 mL,Canada,DPD
DB00097,Ovidrel,"Emd Serono, A Division Of Emd Inc., Canada",,Solution,Subcutaneous,250 mcg / 0.5 mL,Canada,DPD
DB00097,Ovitrelle,Merck Europe B.V.,,"Injection, solution",Subcutaneous,250 micrograms/0.5ml,EU,EMA
DB00097,Ovitrelle,Merck Europe B.V.,,"Injection, solution",Subcutaneous,250 micrograms,EU,EMA
DB00097,Pregnyl,"Physicians Total Care, Inc.",54868-4997,Kit,Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00097,Pregnyl,Merck Sharp & Dohme Llc,0052-0315,"Injection, powder, lyophilized, for solution; Kit",Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00097,Pregnyl,A-S Medication Solutions,50090-5923,"Injection, powder, lyophilized, for solution; Kit",Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00097,Pregnyl,Organon LLC,78206-150,"Injection, powder, lyophilized, for solution; Kit",Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00097,Pregnyl,A-S Medication Solutions,50090-7089,"Injection, powder, lyophilized, for solution; Kit",Intramuscular,10000 [USP'U]/10mL,US,FDA NDC
DB00098,Thymoglobulin,Genzyme Corporation,58468-0080,"Injection, powder, lyophilized, for solution",Intravenous,5 mg/1mL,US,FDA NDC
DB00098,Thymoglobulin,Sanofi Aventis,,"Powder, for solution",Intravenous,25 mg / vial,Canada,DPD
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 U/0.5ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,12000000 U/0.2ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Accofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,70000000 U/0.73ml,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Biograstim,Ab Z Pharma Gmb H,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Hexal,Hexal Ag,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Filgrastim Ratiopharm,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Granix,"Cephalon, LLC",63459-910,"Injection, solution",Subcutaneous,300 ug/0.5mL,US,FDA NDC
DB00099,Granix,"Cephalon, LLC",63459-912,"Injection, solution",Subcutaneous,480 ug/0.8mL,US,FDA NDC
DB00099,Granix,"Cephalon, LLC",63459-918,"Injection, solution",Subcutaneous,300 ug/1mL,US,FDA NDC
DB00099,Granix,"Cephalon, LLC",63459-920,"Injection, solution",Subcutaneous,480 ug/1.6mL,US,FDA NDC
DB00099,Grastofil,Apotex Corporation,,Solution,Intravenous; Subcutaneous,300 mcg / 0.5 mL,Canada,DPD
DB00099,Grastofil,Apotex Corporation,,Solution,Intravenous; Subcutaneous,480 mcg / 0.8 mL,Canada,DPD
DB00099,Grastofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Grastofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,30000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Grastofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Grastofil,Accord Healthcare S.L.U.,,"Injection, solution",Intravenous; Subcutaneous,48000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Neupogen,"Physicians Total Care, Inc.",54868-2522,"Injection, solution",Intravenous,300 ug/1mL,US,FDA NDC
DB00099,Neupogen,"Physicians Total Care, Inc.",54868-5020,"Injection, solution",Intravenous,300 ug/0.5mL,US,FDA NDC
DB00099,Neupogen,"Physicians Total Care, Inc.",54868-3050,"Injection, solution",Intravenous,480 ug/0.8mL,US,FDA NDC
DB00099,Neupogen,AMGEN INC,55513-530,"Injection, solution",Intravenous; Subcutaneous,300 ug/1mL,US,FDA NDC
DB00099,Neupogen,AMGEN INC,55513-546,"Injection, solution",Intravenous; Subcutaneous,480 ug/1.6mL,US,FDA NDC
DB00099,Neupogen,AMGEN INC,55513-924,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.5mL,US,FDA NDC
DB00099,Neupogen,AMGEN INC,55513-209,"Injection, solution",Intravenous; Subcutaneous,480 ug/0.8mL,US,FDA NDC
DB00099,Neupogen,Amgen,,Solution,Intravenous; Subcutaneous,300 mcg / mL,Canada,DPD
DB00099,Neupogen,Amgen,,Solution,Intravenous; Subcutaneous,600 mcg / mL,Canada,DPD
DB00099,Neupogen,Amgen,,Solution,Intravenous; Subcutaneous,600 mcg / mL,Canada,DPD
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,12000000 [units of filgrastim]/0.2mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,12000000 [units of filgrastim]/0.2mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,12000000 [units of filgrastim]/0.2mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,48000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,48000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,48000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,12000000 [units of filgrastim]/0.2mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,30000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestim,Pfizer Europe Ma Eeig,,"Injection, solution",Intravenous; Subcutaneous,48000000 [units of filgrastim]/0.5mL,EU,EMA
DB00099,Nivestym,Pfizer Laboratories Div Pfizer Inc,0069-0293,"Injection, solution",Intravenous; Subcutaneous,300 ug/1mL,US,FDA NDC
DB00099,Nivestym,Pfizer Laboratories Div Pfizer Inc,0069-0294,"Injection, solution",Intravenous; Subcutaneous,480 ug/1.6mL,US,FDA NDC
DB00099,Nivestym,Pfizer Laboratories Div Pfizer Inc,0069-0291,"Injection, solution",Subcutaneous,300 ug/0.5mL,US,FDA NDC
DB00099,Nivestym,Pfizer Laboratories Div Pfizer Inc,0069-0292,"Injection, solution",Subcutaneous,480 ug/0.8mL,US,FDA NDC
DB00099,Nivestym,Pfizer Canada Ulc,,Solution,Intravenous; Subcutaneous,300 mcg / 0.5 mL,Canada,DPD
DB00099,Nivestym,Pfizer Canada Ulc,,Solution,Intravenous; Subcutaneous,480 mcg / 0.8 mL,Canada,DPD
DB00099,Nivestym,Pfizer Canada Ulc,,Solution,Intravenous; Subcutaneous,300 mcg / mL,Canada,DPD
DB00099,Nivestym,Pfizer Canada Ulc,,Solution,Intravenous; Subcutaneous,480 mcg / 1.6 mL,Canada,DPD
DB00099,Nypozi,"Tanvex Biopharma Usa, Inc.",,Solution,Intravenous; Subcutaneous,300 mcg / 0.5 mL,Canada,DPD
DB00099,Nypozi,"Tanvex Biopharma Usa, Inc.",,Solution,Intravenous; Subcutaneous,480 mcg / 0.8 mL,Canada,DPD
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,30 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Ratiograstim,Ratiopharm Inc,,"Injection, solution",Intravenous; Subcutaneous,48 MIU,EU,EMA
DB00099,Releuko,Amneal Pharmaceuticals LLC,70121-1569,"Injection, solution",Intravenous; Subcutaneous,300 ug/1mL,US,FDA NDC
DB00099,Releuko,Amneal Pharmaceuticals LLC,70121-1571,"Injection, solution",Intravenous; Subcutaneous,480 ug/1.6mL,US,FDA NDC
DB00099,Releuko,Amneal Pharmaceuticals LLC,70121-1568,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.5mL,US,FDA NDC
DB00099,Releuko,Amneal Pharmaceuticals LLC,70121-1570,"Injection, solution",Intravenous; Subcutaneous,480 ug/0.8mL,US,FDA NDC
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,300 µg/0.5 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,300 µg/0.5 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,300 µg/0.5 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,300 µg/0.5 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,480 µg/0.8 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,480 µg/0.8 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,480 µg/0.8 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,480 µg/0.8 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,300 µg/0.5 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,300 µg/0.5 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,300 µg/0.5 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,480 µg/0.8 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,480 µg/0.8 ml,EU,EMA
DB00099,Tevagrastim,Teva,,"Injection, solution",Intravenous; Subcutaneous,480 µg/0.8 ml,EU,EMA
DB00099,Zarxio,Sandoz Inc.,61314-318,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.5mL,US,FDA NDC
DB00099,Zarxio,Sandoz Inc.,61314-326,"Injection, solution",Intravenous; Subcutaneous,480 ug/0.8mL,US,FDA NDC
DB00099,Zarxio,Sandoz Inc.,61314-304,"Injection, solution",Intravenous; Subcutaneous,300 ug/0.5mL,US,FDA NDC
DB00099,Zarxio,Sandoz Inc.,61314-312,"Injection, solution",Intravenous; Subcutaneous,480 ug/0.8mL,US,FDA NDC
DB00099,Zarxio,Sandoz Inc.,61314-246,"Injection, solution",Intravenous; Subcutaneous,300 ug/1mL,US,FDA NDC
DB00099,Zarxio,Sandoz Inc.,61314-266,"Injection, solution",Intravenous; Subcutaneous,480 ug/1.6mL,US,FDA NDC
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,60 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00099,Zarzio,Sandoz,,"Injection, solution",Intravenous; Subcutaneous,96 MU/ml,EU,EMA
DB00100,BeneFIX,"Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",58394-003,Kit,Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,"Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",58394-001,Kit,Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,"Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",58394-008,Kit,Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,"Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.",58394-002,Kit,Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC,58394-635,"Injection, powder, lyophilized, for solution; Kit",Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC,58394-636,"Injection, powder, lyophilized, for solution; Kit",Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC,58394-634,"Injection, powder, lyophilized, for solution; Kit",Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC,58394-633,"Injection, powder, lyophilized, for solution; Kit",Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC,58394-637,"Injection, powder, lyophilized, for solution; Kit",Intravenous; Topical,,US,FDA NDC
DB00100,BeneFIX,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00100,BeneFIX,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00100,BeneFIX,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00100,BeneFIX,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00100,BeneFIX,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00100,BeneFIX,Pfizer Canada Ulc,,"Powder, for solution",Intravenous,1500 unit / vial,Canada,DPD
DB00100,Benefix,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00100,Benefix,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00100,Benefix,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00100,Benefix,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00100,Benefix,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00100,Benefix,Pfizer Europe Ma Eeig,,"Injection, powder, for solution",Intravenous,1500 IU,EU,EMA
DB00100,Benefix - (250iu),Wyeth Ltd.,,"Kit; Liquid; Powder, for solution",Intravenous,,Canada,DPD
DB00100,Benefix - (500iu),Wyeth Ltd.,,"Kit; Liquid; Powder, for solution",Intravenous,,Canada,DPD
DB00100,Benefix -(1000iu),Wyeth Ltd.,,"Kit; Liquid; Powder, for solution",Intravenous,,Canada,DPD
DB00100,Idelvion,Csl Behring,,"Kit; Powder, for solution",Intravenous,500 IU/1,Canada,DPD
DB00100,Idelvion,Csl Behring,,"Kit; Powder, for solution",Intravenous,1000 IU/1,Canada,DPD
DB00100,Idelvion,Csl Behring,,"Kit; Powder, for solution",Intravenous,2000 IU/1,Canada,DPD
DB00100,Ixinity,Cangene Biopharma,53270-0273,Kit,Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Cangene Biopharma,53270-0274,Kit,Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0285,Kit,Intravenous,1000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0286,Kit,Intravenous,1500 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0287,Kit,Intravenous,250 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0282,Kit,Intravenous,500 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0283,Kit,Intravenous,1000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0284,Kit,Intravenous,1500 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0288,Kit,Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Aptevo Biotherapeutics Llc,70504-0289,Kit,Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Cangene Biopharma,53270-0270,Kit,Intravenous,500 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Cangene Biopharma,53270-0271,Kit,Intravenous,1000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,Cangene Biopharma,53270-0272,Kit,Intravenous,1500 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,"Medexus Pharma, Inc.",59137-287,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,"Medexus Pharma, Inc.",59137-282,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,"Medexus Pharma, Inc.",59137-283,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,"Medexus Pharma, Inc.",59137-284,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1500 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,"Medexus Pharma, Inc.",59137-288,"Injection, powder, lyophilized, for solution; Kit",Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00100,Ixinity,"Medexus Pharma, Inc.",59137-289,"Injection, powder, lyophilized, for solution; Kit",Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00100,Rebinyn,Novo Nordisk,0169-7905,"Injection, powder, lyophilized, for solution; Kit",Intravenous,125 [iU]/1mL,US,FDA NDC
DB00100,Rebinyn,Novo Nordisk,0169-7901,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/1mL,US,FDA NDC
DB00100,Rebinyn,Novo Nordisk,0169-7902,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/1mL,US,FDA NDC
DB00100,Rebinyn,Novo Nordisk,0169-7903,"Injection, powder, lyophilized, for solution; Kit",Intravenous,750 [iU]/1mL,US,FDA NDC
DB00100,Rixubis,"Takeda Pharmaceuticals America, Inc.",0944-3026,"Injection, powder, lyophilized, for solution; Kit",Intravenous,250 [iU]/5mL,US,FDA NDC
DB00100,Rixubis,"Takeda Pharmaceuticals America, Inc.",0944-3028,"Injection, powder, lyophilized, for solution; Kit",Intravenous,500 [iU]/5mL,US,FDA NDC
DB00100,Rixubis,"Takeda Pharmaceuticals America, Inc.",0944-3030,"Injection, powder, lyophilized, for solution; Kit",Intravenous,1000 [iU]/5mL,US,FDA NDC
DB00100,Rixubis,"Takeda Pharmaceuticals America, Inc.",0944-3032,"Injection, powder, lyophilized, for solution; Kit",Intravenous,2000 [iU]/5mL,US,FDA NDC
DB00100,Rixubis,"Takeda Pharmaceuticals America, Inc.",0944-3034,"Injection, powder, lyophilized, for solution; Kit",Intravenous,3000 [iU]/5mL,US,FDA NDC
DB00100,Rixubis,Takeda,,"Kit; Powder, for solution",Intravenous,500 unit / vial,Canada,DPD
DB00100,Rixubis,Takeda,,"Kit; Powder, for solution",Intravenous,1000 unit / vial,Canada,DPD
DB00100,Rixubis,Takeda,,"Kit; Powder, for solution",Intravenous,2000 unit / vial,Canada,DPD
DB00100,Rixubis,Takeda,,"Kit; Powder, for solution",Intravenous,250 unit / vial,Canada,DPD
DB00100,Rixubis,Takeda,,"Kit; Powder, for solution",Intravenous,3000 unit / vial,Canada,DPD
DB00100,Rixubis,Baxalta Innovations Gmb H,,"Injection, powder, for solution",Intravenous,250 IU,EU,EMA
DB00100,Rixubis,Baxalta Innovations Gmb H,,"Injection, powder, for solution",Intravenous,500 IU,EU,EMA
DB00100,Rixubis,Baxalta Innovations Gmb H,,"Injection, powder, for solution",Intravenous,1000 IU,EU,EMA
DB00100,Rixubis,Baxalta Innovations Gmb H,,"Injection, powder, for solution",Intravenous,2000 IU,EU,EMA
DB00100,Rixubis,Baxalta Innovations Gmb H,,"Injection, powder, for solution",Intravenous,3000 IU,EU,EMA
DB00102,Regranex,"Ortho-McNeil-Janssen Pharmaceuticals, Inc.",0045-0810,Gel,Topical,100 ug/1g,US,FDA NDC
DB00102,Regranex,Healthpoint,0064-0810,Gel,Topical,100 ug/1g,US,FDA NDC
DB00102,Regranex,"Smith & Nephew, Inc.",50484-810,Gel,Topical,100 ug/1g,US,FDA NDC
DB00102,Regranex,Janssen Cilag International Nv,,Gel,Cutaneous,0.01 %,EU,EMA
DB00102,Regranex (becaplermin) 0.01%,Janssen Pharmaceuticals,,Gel,Topical,100 mcg / g,Canada,DPD
DB00103,Fabrazyme,Genzyme Corporation,58468-0041,"Injection, powder, lyophilized, for solution",Intravenous,5 mg/1mL,US,FDA NDC
DB00103,Fabrazyme,Genzyme Corporation,58468-0040,"Injection, powder, lyophilized, for solution",Intravenous,5 mg/1mL,US,FDA NDC
DB00103,Fabrazyme,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,"Powder, for solution",Intravenous,5 mg / vial,Canada,DPD
DB00103,Fabrazyme,"Sanofi Genzyme, a Division of Sanofi Aventis Canada Inc",,"Powder, for solution",Intravenous,35 mg / vial,Canada,DPD
DB00103,Fabrazyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,35 mg,EU,EMA
DB00103,Fabrazyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,35 mg,EU,EMA
DB00103,Fabrazyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,35 mg,EU,EMA
DB00103,Fabrazyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,5 mg,EU,EMA
DB00103,Fabrazyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,5 mg,EU,EMA
DB00103,Fabrazyme,Sanofi B.V.,,"Injection, powder, for solution",Intravenous,5 mg,EU,EMA
DB00104,BYNFEZIA Pen,"Sun Pharmaceutical Industries, Inc.",62756-452,Injection,Subcutaneous,2.5 mg/1mL,US,FDA NDC
DB00104,Mycapssa,Amryt Pharmaceuticals Designated Activity Company,69880-120,"Capsule, delayed release",Oral,20 mg/1,US,FDA NDC
DB00104,Mycapssa,"Chiesi USA, Inc.",10122-550,"Capsule, delayed release",Oral,20 mg/1,US,FDA NDC
DB00104,Mycapssa,Amryt Pharmaceuticals DAC,,"Capsule, delayed release",Oral,20 mg,EU,EMA
DB00104,Ocphyl,Pendopharm Division Of Pharmascience Inc,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00104,Ocphyl,Pendopharm Division Of Pharmascience Inc,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00104,Ocphyl,Pendopharm Division Of Pharmascience Inc,,Solution,Intravenous; Subcutaneous,50 mcg / mL,Canada,DPD
DB00104,Octreotide,"Fresenius Kabi USA, LLC",63323-378,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide,"Fresenius Kabi USA, LLC",63323-379,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide,"Fresenius Kabi USA, LLC",63323-365,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide,"Fresenius Kabi USA, LLC",63323-377,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide,"Fresenius Kabi USA, LLC",63323-376,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,55648-636,Injection,Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,55648-633,Injection,Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,55648-635,Injection,Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,55648-634,Injection,Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,55648-632,Injection,Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,64679-636,Injection,Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,64679-633,Injection,Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,64679-635,Injection,Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,64679-634,Injection,Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide acetate,Wockhardt,64679-632,Injection,Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sandoz,0781-9165,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sandoz,0781-9164,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-160,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-161,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-162,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-163,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-164,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-375,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-376,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Bedford Pharmaceuticals,55390-377,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-348,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-349,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-351,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-093,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-094,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-095,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-350,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sun Pharmaceutical Industries Limited,62756-352,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Hikma Pharmaceuticals USA Inc.,0641-6174,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Hikma Pharmaceuticals USA Inc.,0641-6175,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Hikma Pharmaceuticals USA Inc.,0641-6176,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Hikma Pharmaceuticals USA Inc.,0641-6177,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Hikma Pharmaceuticals USA Inc.,0641-6178,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,USV North America Inc.,76135-005,Injection,Intravenous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,USV North America Inc.,76135-006,Injection,Intravenous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,USV North America Inc.,76135-009,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,USV North America Inc.,76135-010,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,USV North America Inc.,76135-011,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-451,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-452,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-453,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-454,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-455,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-685,"Injection, solution",Intravenous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-686,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Teva Parenteral Medicines, Inc.",0703-3301,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Teva Parenteral Medicines, Inc.",0703-3311,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Teva Parenteral Medicines, Inc.",0703-3321,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Teva Parenteral Medicines, Inc.",0703-3333,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Teva Parenteral Medicines, Inc.",0703-3343,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Bachem Americas, Inc.",52416-109,Powder,Not applicable,1 g/1g,US,FDA NDC
DB00104,Octreotide Acetate,Mylan Institutional LLC,67457-239,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Mylan Institutional LLC,67457-245,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Mylan Institutional LLC,67457-246,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sandoz Inc,0781-3166,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sandoz Inc,0781-3167,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sandoz Inc,0781-3168,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sandoz Inc,0781-3165,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sandoz Inc,0781-3164,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-687,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-688,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,23155-689,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,bryant ranch prepack,63629-8831,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-463,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-464,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-465,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-466,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Sagent Pharmaceuticals,25021-467,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Gland Pharma Limited,68083-515,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Gland Pharma Limited,68083-516,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Gland Pharma Limited,68083-517,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,Gland Pharma Limited,68083-560,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Glenmark Pharmaceuticals Inc., USA",68462-896,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate,"Glenmark Pharmaceuticals Inc., USA",68462-897,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Octreotide Acetate Injection,Generic Medical Partners Inc,,Solution,Intravenous; Subcutaneous,50 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Injection,Generic Medical Partners Inc,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Injection,Generic Medical Partners Inc,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Injection - 100mcg/ml,Sandoz Canada Incorporated,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Injection - 200mcg/ml,Sandoz Canada Incorporated,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Injection - 500mcg/ml,Sandoz Canada Incorporated,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Injection - 50mcg/ml,Sandoz Canada Incorporated,,Solution,Intravenous; Subcutaneous,50 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Omega,Omega Laboratories Ltd,,Solution,Intravenous; Subcutaneous,50 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Omega,Omega Laboratories Ltd,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Omega,Omega Laboratories Ltd,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00104,Octreotide Acetate Omega,Omega Laboratories Ltd,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00104,Octreotide for Injectable Suspension,TEVA Canada Limited,,"Injection, powder, for suspension, extended release; Kit",Intramuscular,10 mg / vial,Canada,DPD
DB00104,Octreotide for Injectable Suspension,TEVA Canada Limited,,"Injection, powder, for suspension, extended release; Kit",Intramuscular,20 mg / vial,Canada,DPD
DB00104,Octreotide for Injectable Suspension,TEVA Canada Limited,,"Injection, powder, for suspension, extended release; Kit",Intramuscular,30 mg / vial,Canada,DPD
DB00104,Octreotide Injection,TEVA Canada Limited,,Solution,Intravenous; Subcutaneous,50 mcg / mL,Canada,DPD
DB00104,Octreotide Injection,TEVA Canada Limited,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00104,Octreotide Injection,TEVA Canada Limited,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00104,Octreotide Injection,TEVA Canada Limited,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00104,Octreotide Injection,Mont Pharma Inc,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00104,Octreotide Injection,Mont Pharma Inc,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00104,Octreotide Injection,Mont Pharma Inc,,Solution,Intravenous; Subcutaneous,50 mcg / mL,Canada,DPD
DB00104,Octreotide Injection,Mont Pharma Inc,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00104,Sandostatin,Novartis Pharmaceuticals Corporation,0078-0183,"Injection, solution",Intravenous; Subcutaneous,200 ug/1mL,US,FDA NDC
DB00104,Sandostatin,Novartis Pharmaceuticals Corporation,0078-0184,"Injection, solution",Intravenous; Subcutaneous,1000 ug/1mL,US,FDA NDC
DB00104,Sandostatin,Novartis Pharmaceuticals Corporation,0078-0180,"Injection, solution",Intravenous; Subcutaneous,50 ug/1mL,US,FDA NDC
DB00104,Sandostatin,Novartis Pharmaceuticals Corporation,0078-0181,"Injection, solution",Intravenous; Subcutaneous,100 ug/1mL,US,FDA NDC
DB00104,Sandostatin,Novartis Pharmaceuticals Corporation,0078-0182,"Injection, solution",Intravenous; Subcutaneous,500 ug/1mL,US,FDA NDC
DB00104,Sandostatin,Novartis,,Solution,Intravenous; Subcutaneous,200 mcg / mL,Canada,DPD
DB00104,Sandostatin,Novartis,,Solution,Intravenous; Subcutaneous,50 mcg / mL,Canada,DPD
DB00104,Sandostatin,Novartis,,Solution,Intravenous; Subcutaneous,100 mcg / mL,Canada,DPD
DB00104,Sandostatin,Novartis,,Solution,Intravenous; Subcutaneous,500 mcg / mL,Canada,DPD
DB00104,Sandostatin Lar,Novartis,,"Injection, powder, for suspension, extended release",Intramuscular,10 mg / vial,Canada,DPD
DB00104,Sandostatin Lar,Novartis,,"Injection, powder, for suspension, extended release",Intramuscular,20 mg / vial,Canada,DPD
DB00104,Sandostatin Lar,Novartis,,"Injection, powder, for suspension, extended release",Intramuscular,30 mg / vial,Canada,DPD
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0340,Kit,Intramuscular,10 mg/1,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0341,Kit,Intramuscular,20 mg/1,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0342,Kit,Intramuscular,30 mg/1,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0646,Kit,Intramuscular,1.667 mg/1mL,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0647,Kit,Intramuscular,3.33 mg/1mL,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0648,Kit,Intramuscular,5 mg/1mL,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0811,"Injection, powder, for suspension; Kit",Intramuscular,1.667 mg/1mL,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0818,"Injection, powder, for suspension; Kit",Intramuscular,3.33 mg/1mL,US,FDA NDC
DB00104,Sandostatin LAR Depot,Novartis Pharmaceuticals Corporation,0078-0825,"Injection, powder, for suspension; Kit",Intramuscular,5 mg/1mL,US,FDA NDC
DB00104,Sandostatin LAR Depot Demonstration kit,Novartis Pharmaceuticals Corporation,0078-9342,Kit,Intramuscular,30 mg/1,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Limited,0085-0571,Kit,Intralesional; Intramuscular; Intravenous; Subcutaneous,38 ug/1mL,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Limited,0085-1110,Kit,Intramuscular; Intravenous; Subcutaneous,69 ug/1mL,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Limited,0085-0539,Kit,Intramuscular; Intravenous; Subcutaneous,192 ug/1mL,US,FDA NDC
DB00105,Intron A,Schering-Plough Corporation,0085-1242,"Injection, solution",Subcutaneous,11.6 ug/0.2mL,US,FDA NDC
DB00105,Intron A,Schering-Plough Corporation,0085-1235,"Injection, solution",Subcutaneous,19.2 ug/0.2mL,US,FDA NDC
DB00105,Intron A,Schering-Plough Corporation,0085-1254,"Injection, solution",Subcutaneous,38.4 ug/0.2mL,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Llc,0085-4350,"Injection, powder, for solution; Kit",Intralesional; Intramuscular; Intravenous; Subcutaneous,38 ug/1mL,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Llc,0085-4351,"Injection, powder, for solution; Kit",Intramuscular; Intravenous; Subcutaneous,69 ug/1mL,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Llc,0085-4352,"Injection, powder, for solution; Kit",Intramuscular; Intravenous; Subcutaneous,192 ug/1mL,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Llc,0085-1168,"Injection, solution",Intramuscular; Subcutaneous,11.6 ug/0.5mL,US,FDA NDC
DB00105,Intron A,Merck Sharp & Dohme Llc,0085-1133,"Injection, solution",Intralesional; Intramuscular; Subcutaneous,19.2 ug/0.5mL,US,FDA NDC
DB00105,Intron A,Merck Ltd.,,"Liquid; Powder, for solution",Intralesional; Intramuscular; Intravenous; Subcutaneous,,Canada,DPD
DB00105,Intron A,Merck Ltd.,,Solution,Intramuscular; Intravenous; Subcutaneous,6000000 unit / mL,Canada,DPD
DB00105,Intron A,Merck Ltd.,,Solution,Intramuscular; Intravenous; Subcutaneous,10000000 unit / mL,Canada,DPD
DB00105,Intron A,Merck Ltd.,,Liquid,Subcutaneous,15000000 unit / mL,Canada,DPD
DB00105,Intron A,Merck Ltd.,,Liquid,Subcutaneous,25000000 unit / mL,Canada,DPD
DB00105,Intron A,Merck Ltd.,,Liquid,Subcutaneous,50000000 unit / mL,Canada,DPD
DB00105,Intron A,Merck Ltd.,,"Kit; Liquid; Powder, for solution",Intralesional; Intramuscular; Intravenous; Subcutaneous,,Canada,DPD
DB00105,Intron A - Kit (pws+diluent) 3000000iu/vial,Schering Plough (Brinny) Co.,,"Liquid; Powder, for solution",Intralesional; Intramuscular; Subcutaneous,,Canada,DPD
DB00105,Intron A - Kit (pws+diluent) 5000000iu/vial,Schering Plough (Brinny) Co.,,"Liquid; Powder, for solution",Intralesional; Intramuscular; Subcutaneous,,Canada,DPD
DB00105,Intron A - Liq 5000000iu/ml,Schering Plough (Brinny) Co.,,Liquid,Intralesional; Intramuscular; Subcutaneous,5000000 unit / mL,Canada,DPD
DB00105,Intron A Inj 10000000unit/vial,Avondale (Brinny) Chemical Company,,Liquid,Subcutaneous,10000000 unit / vial,Canada,DPD
DB00105,Intron A Inj 3000000unit/vial,Avondale (Brinny) Chemical Company,,Liquid,Subcutaneous,3000000 unit / vial,Canada,DPD
DB00105,Intron A Inj 5000000unit/vial,Avondale (Brinny) Chemical Company,,Liquid,Subcutaneous,5000000 unit / vial,Canada,DPD
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,3000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,3000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,3000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,3000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,5000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,5000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,5000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,5000000 IU/0.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,10000000 IU/ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,10000000 IU/ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,10000000 IU/ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,10000000 IU/ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,18000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,18000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,18000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,30000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,30000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,30000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,60000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,60000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,Injection,Subcutaneous,60000000 IU,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,18000000 IU/3ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Introna,Merck Sharp & Dohme B.V.,,"Injection, solution",Intravenous; Subcutaneous,25000000 IU/2.5ml,EU,EMA
DB00105,Rebetron Ready To Use Solution (albumin(human)free) (6000000 Iu/ml and 200mg Capsules),Schering Plough,,Capsule; Kit; Liquid,Oral; Subcutaneous,,Canada,DPD
DB00105,Rebetron Solution (albumin (human) Free) (18 Miu Multi-dose Pen / 200mg Capsules),Schering Plough,,Capsule; Kit; Liquid,Oral; Subcutaneous,,Canada,DPD
DB00107,Bakumokon 5% Minoxidil,"DS LABORATORIES, INC.",58798-001,Liquid,Topical,,US,FDA NDC
DB00107,Bakumokon 7% Minoxidil Sulfate,"DS LABORATORIES, INC.",58798-002,Liquid,Topical,,US,FDA NDC
DB00107,Oxytocin,"Teva Parenteral Medicines, Inc.",0703-6271,Injection,Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,"Teva Parenteral Medicines, Inc.",0703-6275,Injection,Intravenous,100 [USP'U]/10mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-168,"Injection, solution",Intravenous,10 [USP'U]/500mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-167,"Injection, solution",Intravenous,10 [USP'U]/500mL,US,FDA NDC
DB00107,Oxytocin,Hikma Farmaceutica,62778-118,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,Hikma Farmaceutica,62778-119,Injection,Intramuscular; Intravascular,100 [USP'U]/10mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-048,"Injection, solution",Intravenous,10 [USP'U]/1000mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-105,"Injection, solution",Intravenous,2 [USP'U]/100mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-056,"Injection, solution",Intravenous,30 [USP'U]/500mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-055,"Injection, solution",Intravenous,30 [USP'U]/500mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-054,"Injection, solution",Intravenous,30 [USP'U]/500mL,US,FDA NDC
DB00107,Oxytocin,Baxter Laboratories,10019-291,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-170,"Injection, solution",Intravenous,30 [USP'U]/500mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-169,"Injection, solution",Intravenous,20 [USP'U]/1000mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-234,"Injection, solution",Intravenous,30 [USP'U]/1000mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-233,"Injection, solution",Intravenous,20 [USP'U]/500mL,US,FDA NDC
DB00107,Oxytocin,Par Pharmaceutical,42023-140,Injection,Intravenous,10 [iU]/1mL,US,FDA NDC
DB00107,Oxytocin,Par Pharmaceutical,42023-141,Injection,Intravenous,10 [iU]/1mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-050,"Injection, solution",Intravenous,20 [USP'U]/1000mL,US,FDA NDC
DB00107,Oxytocin,Sagent Pharmaceuticals,25021-456,"Injection, solution",Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,Cantrell Drug Company,52533-051,"Injection, solution",Intravenous,2 [USP'U]/100mL,US,FDA NDC
DB00107,Oxytocin,West-Ward Pharmaceuticals Corp,0143-9743,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,West-Ward Pharmaceuticals Corp,0143-9742,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,Cardinal Health,55154-9356,"Injection, solution",Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,Hikma Pharmaceuticals USA Inc.,0641-6114,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,Hikma Pharmaceuticals USA Inc.,0641-6115,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,"Fresenius Kabi USA, LLC",63323-012,"Injection, solution",Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,Cardinal Health,55154-9577,"Injection, solution",Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin,"Cardinal Health 107, LLC",55154-9584,"Injection, solution",Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Oxytocin Inj 10unit/ml USP,"Lyphomed, Division Of Fujisawa Canada Inc.",,Liquid,Intramuscular; Intravenous,10 unit / mL,Canada,DPD
DB00107,Oxytocin Injection USP,Pfizer Canada Ulc,,Solution,Intramuscular; Intravenous,10 unit / mL,Canada,DPD
DB00107,"Oxytocin Injection, USP",Fresenius Kabi,,Solution,Intramuscular; Intravenous,10 unit / mL,Canada,DPD
DB00107,Pitocin,Watson Pharmaceuticals,0591-3553,Injection,Intravenous,10,US,FDA NDC
DB00107,Pitocin,"King Pharmaceuticals, Inc.",60793-265,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Pitocin,"King Pharmaceuticals, Inc.",60793-267,Injection,Intramuscular; Intravenous,10 [USP'U]/1mL,US,FDA NDC
DB00107,Pitocin,"Par Pharmaceutical, Inc.",42023-130,Injection,Intravenous,10 [iU]/1mL,US,FDA NDC
DB00107,Pitocin,"Monarch Pharmaceuticals, Inc.",61570-416,Injection,Intravenous,10,US,FDA NDC
DB00107,Pitocin,"Par Pharmaceutical, Inc.",42023-116,Injection,Intravenous,10 [iU]/1mL,US,FDA NDC
DB00107,Syntocinon,Novartis,0078-0060,"Injection, solution",Intramuscular; Intravenous,10 [iU]/1mL,US,FDA NDC
DB00107,Truemed Group LLC,Truemed Group LLC,82922-006,"Injection, solution",Intramuscular,5 mg/5mg,US,FDA NDC
DB00108,Tysabri,Elan Pharmaceuticals,59075-730,Injection,Intravenous,300 mg/15mL,US,FDA NDC
DB00108,Tysabri,Biogen Inc.,64406-008,Injection,Intravenous,300 mg/15mL,US,FDA NDC
DB00108,Tysabri,Biogen,,Solution,Intravenous,300 mg / 15 mL,Canada,DPD
DB00108,Tysabri,Biogen Netherlands B.V.,,"Injection, solution, concentrate",Intravenous,300 mg,EU,EMA
DB00108,Tysabri,Biogen Netherlands B.V.,,"Injection, solution, concentrate",Intravenous,150 mg,EU,EMA
